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Abstract 
Improving cognitive function is a growing area of interest for pharmaceutical companies. 
With an ageing population, cognitive decline is becoming a greater problem. 
Understanding the physiological effects of nootropic drugs and the changes that occur 
during cognitive enhancement will enable the design of safer treatments to enhance 
cognition.  In this thesis cognitive enhancing strategies are investigated using 
neurophysiological and proteomic approaches. The effects of two classes of putatively 
cognitive enhancing drugs on emergent network oscillatory activities in hippocampal slices 
are investigated. The effect of an enriched environment, which causes an improvement in 
cognitive function, on the expression level of proteins in the hippocampus is also 
investigated.  
The development of a new muscarinic acetylcholine receptor (mAChR) agonist that is 
selective for the M1 mAChR subtype, called 77-LH-281, has recently been achieved. 77-
LH-281 binds to an allosteric site of the M1 mAChR which accounts for its increased 
selectivity over other mAChR agonists. This agonist causes gamma frequency oscillatory 
activity in hippocampal slices, a pattern of network activity that the in vivo equivalent of 
which is associated with cognitive processes. This gamma activity is dependent upon both 
excitatory and inhibitory networks. 77-LH-281 does not promote epileptiform-like activity 
in naïve slices as well as a range of models of epileptiform activity, unlike non-subtype 
selective mAChR agonists like oxotremorine-M. Oxotremorine-M changes the slow inter-
ictal-like events following application of 4-AP and NBQX into continuous beta frequency 
oscillations. This action is not mediated by the M1 mAChR. Thus selective M1 mAChR 
display a preferable range of oscillatory activities compared to non-subtype selective 
mAChR agonists.  
Ampakines are a further class of nootropic drugs. Ampakines are positive modulators of 
AMPA-type glutamate receptors and they cause improvements in cognitive function of 
laboratory animals and humans. The ampakines investigated in this thesis are CX691, 
which increases the amplitude of currents through the AMPA receptor, and CX546, which 
increases the length of time the AMPA receptor is open. These ampakines do not induce 
oscillatory activity in naïve hippocampal slices, but they increase the frequency of inter-
ictal-like epileptiform activity. CX546 also induces ictal-like activity in the 4-AP induced 
epileptiform event model. Ampakines may therefore promote epileptiform activity in 
individuals that are susceptible to epilepsy.  3 
Exposure to an enriched environment leads to improvements in cognitive performance. 
This behavioural change is mediated by changes at the level of the proteome. Exposure to 
an enriched environment changes the expression of many classes of proteins including 
signalling proteins and proteins that are involved in the structural changes that occur 
during cognitive enhancement. One of the proteins that significantly changes in expression 
is a protein that is associated with cognitive deficits, known as MeCP2. MeCP2 is a 
transcriptional repressor and increases in expression in the enriched environment.  
This thesis demonstrates the diversity of molecular, cellular and network level approaches 
that can be used to induce and investigate cognitive enhancement. A combination of these 
approaches enables the in vitro evaluation of current cognitive enhancing strategies and 
may lead to the the development of novel approaches to enhance cognitive function.      4 
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Abbreviations 
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CX546     1-(1,4-Benzodioxan-6-ylcarbonyl)piperidine      
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EPSC      Excitatory postsynaptic current 
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GABA     g-amino butyric acid 
hnRNP.K    Heterogeneous nuclear ribonucleoprotein K 
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mAChR    Muscarinic acetylchole receptor 
MALDI-ToF    Matrix assisted laser desorbtion ionisation-time of flight 
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MK801  (+)-5-methyl-10,11- dihydro-5H-dibenzo[a,d]cyclohepten-5,10-
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NMDA     N-methyl D-aspartate 
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RT-PCR    Reverse transcriptase polymerase chain reaction 
SDS      Sodium dodecyl sulphate 
SLM      Stratum lacunosum moleculare 
SO      Stratum oriens 
TBST      Tris buffered saline solution (+ Tween) 
TM      Trans-membrane13 
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1.1  General introduction 
This thesis investigates different cognitive enhancement strategies in the hippocampus, a 
structure in the brain responsible for many cognitive processes including learning and 
memory formation. Cognitive enhancement, as defined by this thesis, is a measurable 
improvement in brain function. Strategies to improve cognition are important in 
ameliorating the symptoms of cognitive decline that occur in many neurological disorders 
including Alzheimer’s Disease and schizophrenia.   
The major focus of this thesis is the investigation of the effect that putative cognitive 
enhancing drugs have on the communication between cells and networks within the 
hippocampus. These compounds are tested in both physiological models of brain activity 
and in several models of epileptiform activity. The compounds investigated are muscarinic 
acetylcholine receptor agonists and positive allosteric modulators of AMPA type glutamate 
receptors, called ampakines. These compounds were chosen for their propensity to affect 
synaptic transmission between neurones and emergent network activities in the 
hippocampus.  
A secondary focus of this thesis is the investigation of the effects of a model of cognitive 
enhancement on the global protein expression of the hippocampus. The expression of a 
range of selected proteins is investigated following exposure to an enriched environment, 
which is known to lead to improvements in cognitive function.  
These strategies will allow the evaluation of current opinions in the field of cognitive 
enhancement, as well as providing further insight into the mechanisms of action of a range 
of nootropic drugs.    
1.2  The hippocampus  
The hippocampus is the most well characterised cortical brain region and is ideally suited 
for studying network activity due to its highly laminar structure. In humans the 
hippocampus is located in the temporal lobe below the neocortex and is involved in 
mnemonic processing and the representation of place in the environment (O'Keefe and 
Dostrovsky, 1971; Scoville and Milner, 1957). The hippocampus is so named due to its 
resemblance to a seahorse (hippos = horse, kampos = monster, sea monster; Greek).   
The hippocampal formation is divided into four sub-fields- the cornu ammonis (CA) 1-4 
(Lorento de No, 1934), and the dentate gyrus. The CA3 and CA1 regions occupy most of John Broad, 2009     Chapter 1 15 
the hippocampus. The dentate gyrus projects to the cells of the CA3 region along the 
mossy fibre pathway, and the CA3 region projects to the CA1 and dentate gyrus regions 
along the Schaffer collaterals. Cells from the CA1 region project through the subiculum 
and project out to the entorhinal cortex layer V neurones.   
Both the hippocampus and the dentate gyrus are three-layered cortices. The dentate gyrus 
contains the polymorphic layer (the hilus) containing the granule cell axons, the granule 
layer (the stratum granulosum) containing the granule cell bodies, and the molecular layer 
(stratum moleculare) containing the granule cell dendrites. The hippocampus contains a 
polymorphic layer (the stratum oriens) containing the basal dendrites of the pyramidal 
cells, a pyramidal cell layer (the stratum pyramidale) containing the pyramidal cell bodies, 
and a molecular layer (the stratum radiatum and the stratum lacunosum-moleculare) 
containing the distal apical dendrites of the pyramidal cells. The principal cells make up 
about 90% of the neurones within the hippocampus, and these cells form projections to the 
adjacent area. 
The dentate gyrus acts as a gate for sensory inputs from the entorhinal cortex entering the 
hippocampus (Finnerty and Jefferys, 1993). Inputs into the dentate gyrus come from the 
perforant pathway and axons from the dentate gyrus project to both the CA3 and the CA1 
regions of the hippocampus. The CA3 region contains recurrent axonal arborizations that 
innervate local pyramidal cells within the CA3 region. The Schaffer collaterals then project 
to the CA1 region.  
The CA1 region receives inputs from the Schaffer collaterals from the CA3 region. The 
CA1 region also receives inputs from the entorhinal cortex and projects through the 
subiculum into the entorhinal cortex. The unidirectional perforant path-dentate gyrus-CA3-
CA1 series of connections is known as the trisynaptic loop of the hippocampus, and is 
made by excitatory connections between the principal cells of each area.  
The hippocampus is made up of two major classes of neurones- pyramidal cells and 
interneurones. Pyramidal cells are the principal cells of the hippocampus. These bipolar 
neurones have their cell bodies in the stratum pyramidale and have spiny dendritic trees 
that project basally to apically. These cells are glutamatergic and excitatory. 
Interneurones account for only 8-10% of neurones in the hippocampus but display a much 
greater diversity than the relatively homogenous population of pyramidal cells (Freund and 
Buzsaki, 1996). There are at least 21 different classes of interneuron identified in the CA1 John Broad, 2009     Chapter 1 16 
region of the hippocampus. The interneurones have many different neurochemical, 
pharmacological, anatomical and electrophysiological properties, although many do have 
restricted target regions, lack spines, and are GABAergic. 
The interneurones are categorised by these different parameters. The interneurones 
innervate either pyramidal cells, excitatory inputs into the hippocampus, or other 
interneurones. The major classes of interneurones that innervate pyramidal cells are the 
basket cells, axo-axonic cells, bistratfied and oriens-laculosum moleculare interneurones. 
These synapse onto the soma, axon initial segment, and stratum oreins and stratum 
radiatum/lacunosum moleculare respectively (Klausberger and Somogyi, 2008). These 
interneurones express parvalbumin or cholecystekinin, as well as a variety of other 
biochemical markers (Klausberger et al., 2005). This diversity allows highly variable 
functionality and resonances to exist within the interneuronal population, important in the 
generation and pacing of oscillatory activities.     
Neurotransmitters within the hippocampus 
The cells within the hippocampus release neurotransmitters that act mainly upon two 
different classes of receptors at the synapses between cells. The first class is ligand gated 
ion channels, or ionotropic receptors, which act within 1-100 ms. When activated, these 
receptors open a pore in the cell membrane that allows current to flow through the pore. 
The second major type of receptor is the metabotropic receptors, or G-protein coupled 
receptors. G-protein coupled receptors act over 100-2000 ms and activate intracellular 
second messenger systems in order to change the cellular excitability or gene expression 
within the target cell (Marinissen and Gutkind, 2001). 
Glutamate receptors 
It was only in the 1960s that amino acids were first identified as being able to mediate 
synaptic transmission. We now know that glutamate is the major excitatory 
neurotransmitter within the central nervous system (Fonnum, 1984). Glutamate activates 
both ionotropic receptors- known as AMPA, kainate, and NMDA receptors (Dingledine et 
al., 1999) and metabotropic receptors, known as metabotropic glutamate receptors 
(mGluRs) (Pin and Duvoisin, 1995).  
AMPA receptors are the most highly expressed neurotransmitter receptor within the central 
nervous system. They are ionotropic glutamate receptors and are expressed at the majority John Broad, 2009     Chapter 1 17 
of the excitatory synapses within the brain. They are made up of 4 subunits (Matsuda et al., 
2005), and these individual subunits are called GluR1-4. Each subunit has 3 
transmembrane (TM) domains and an M2 re-entrant loop that forms the functional inner 
pore of the receptor. The channel properties depend on the expression of the individual 
subunit composition. AMPA receptor subunits contain a Q/R editing site and a flip/flop 
domain (Dingledine et al., 1999), allowing for a large range of channel conductances, open 
times and desensitisation kinetics. AMPA receptors are mainly monovalent cation channels 
and allow Na
+ and K
+ to pass through the ion pore. However, AMPA receptors that do not 
contain the GluR2 subunit are permeable to Ca
2+ (Hollmann et al., 1991).  
Kainate receptors are a subset of ionotropic glutamate receptors that also conduct fast 
excitatory synaptic transmission. These receptors contain the GluR 5-7, KA1 or KA2 
subunits (Dingledine et al., 1999), and they are named as they have a higher affinity for 
kainate than AMPA. They are highly expressed upon interneurones and application of 
nanomolar concentrations of kainate has been shown to produce oscillatory rhythms within 
the hippocampus (Fisahn, 2005; Fisahn et al., 2004).   
NMDA receptors are a further class of ionotropic glutamate receptor. NMDA receptors are 
again made up of 4 subunits. The receptor must contain 2 NR1 subunits, as well as 2 
NR2A-D subunits to be functional (Laube et al., 1998). Heterodimeric subunits are 
common, although heterotrimeric subunits exist (Brothwell et al., 2008). The NMDA 
receptor is often blocked at polarised potentials by the presence of a Mg
2+ ion (Nowak et 
al., 1984). Strong depolarisation leads to the removal of the Mg
2+ block of the NMDA 
receptor and allows current to flow through the receptor (Jahr and Stevens, 1990). The 
NMDA receptor is a non-selective cation channel, and as such allows Ca
2+ entry into the 
cell (MacDermott et al., 1986). This process mediates one form of long-term potentiation 
(LTP), a long lasting change in synaptic strength that is thought to underlie memory 
formation (Kandel, 1997).  
The final class of glutamate receptors is the metabotropic glutamate receptors (mGluRs). 
There are 8 mGluRs and they modulate excitatory and inhibitory transmission. They are 
large 7 transmembrane domain proteins that activate diverse G-proteins, which in turn can 
activate phospholipase C and activate or inhibit adenylate cyclase (Nakanishi, 1992). 
Agonists of mGluRs can cause oscillatory activity within the hippocampus (Cobb et al., 
2000).  
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GABA receptors 
GABA is the major inhibitory neurotransmitter within the central nervous system, aside 
from the spinal cord. Like glutamate receptors, GABA activates ionotropic receptors, the 
GABAA receptors, and metabotropic receptors, the GABAB receptors. GABA provides the 
major inhibitory drive to the hippocampus in adults. However, GABA can be excitatory 
during early development (Ben Ari et al., 1989) and seizures (Ben Ari, 2006), due to a 
disruption of the chloride gradient.   
The GABAA receptor is a ligand gated ion channel that is made up of 5 subunits (Nayeem 
et al., 1994). For a functional ion channel at least one α and β subunit must be present, with 
the other subunits made up of α, β, γ, δ, ε, π, θ or ρ subunits (Sieghart et al., 1999). Again, 
the different expression of the channels leads to different channel properties. Each subunit 
is made up of 4 transmembrane domains and the M2 transmembrane domain lines the pore 
and forms the selectivity filter for the ion channel. When two molecules of GABA bind to 
the receptor, the ion channel opens and allows the movement of anions, primarily Cl
- ions 
and to a lesser degree bicarbonate (HCO3
-) ions (Bormann et al., 1987).  
The GABAB receptor is the corresponding metabotropic receptor that mediates inhibitory 
synaptic transmission on a slower time course. The GABAB receptor is a 7 transmembrane 
domain receptor and has a requirement to form heterodimers of GABABR1 and GABABR2 
to allow functional expression of GABAB (Marshall et al., 1999). The GABAB receptor is 
linked through the Gαi G-protein and activation of the GABAB receptor causes an 
inhibition of presynaptic Ca
2+ channels (Wu and Saggau, 1995) and opens postsynaptic K
+ 
channels (Dutar and Nicoll, 1988). At postsynaptic loci GABAB receptor activation leads 
to hyperpolarisation of the cell through the activation of inwardly rectifying K
+ channels, 
acting to decrease excitability of the network. At presynaptic loci GABAB activation 
inhibits the release of neurotransmitters including GABA (Misgeld et al., 1995), leading to 
an increase in local excitability (Leung et al., 2005). High doses of GABAB antagonists 
and the genetic depletion of GABAB R1 (Brown et al., 2003; Schuler et al., 2001) are pro-
convulsive, indicating the network effect of GABAB activation is to decrease excitability 
predominatly through postsynaptic mechanisms.   
Acetylcholine receptors 
Acetylcholine receptors are highly expressed in the hippocampus. They consist of both 
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receptors (nAChRs) are made up of 5 subunits, much like the GABAA receptors described 
above (Changeux and Edelstein, 1998). They contain 4 transmembrane spanning domains, 
with the TM2 region as the selectivity filter. They are permeable to monovalent cations. 
Only the nAChR made up entirely of α7 subunits is permeable to Ca
2+ (Seguela et al., 
1993).   
Muscarinic acetylcholine receptors have been shown to be present in the many different 
areas of the central nervous system, initially by radioligand binding studies, then by the use 
of oligonucleotide probes (Buckley et al., 1988), and finally by the use of 
immunocytochemistry (Levey et al., 1995). In the hippocampus, the different receptor 
subtypes are found differentially expressed in different areas. The M1 receptor subtype is 
strongly expressed in the pyramidal cell layer of the hippocampus and the granule cell 
layer of the dentate gyrus. The M2 receptor is found mainly in non-pyramidal neurones and 
in discrete bands of fibres surrounding the pyramidal cells; out with the hippocampus it is 
found in the medial septum and the diagonal band of Broca, important cholinergic inputs to 
the hippocampus (Hajos et al., 1998). The M3 receptor is enriched in pyramidal neurones, 
the stratum lacunosum-moleculare and in the outer third of the molecular layer of the 
dentate gyrus. The M4 receptor is expressed in non-pyramidal neurones, fibre pathways 
and in the inner third of the molecular layer. The M1 and M3 receptors are largely found 
postsynaptically, whereas the M2 and M4 receptors are localised pre-synaptically, and the 
distribution of the receptors is highly complementary. M1 receptors display 3-fold higher 
expression level than M3 receptors in the hippocampus, and the receptor reserve of the M1 
receptor is estimated to be above 75% (Porter et al., 2002). The M1 receptor is therefore the 
predominant excitatory muscarinic acetylcholine receptor subtype found in the 
hippocampus. 
The receptors also have a complementary expression in the perforant pathways (the main 
excitatory input into the hippocampus) and associational/commissural projections (the 
major pathways for integration of information along the septotemporal axis) (Rouse et al., 
1999). In the perforant pathway, the M2, M3 and M4 receptors are found presynaptically, 
with the M3 receptor dominant in the lateral perforant pathway. The M2 and M4 receptors 
are found presynaptically on the associational pathway, and the M4 receptor is also found 
on the commissural pathway. This differential expression all over the hippocampus allows 
complex regulation of the differing physiological responses mediated by cholinergic 
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The mAChRs act through a number of different second messenger cascade systems in the 
central nervous system. M1, M3 and M5 predominantly act through Gaq as postsynaptic 
receptors, and the M2 and M4 receptors act mainly through Gai/o as presynaptic receptors. 
Cholinergic excitation is known to cause depolarisation of pyramidal cells, with an 
associated increase in input resistance. Cholinergic receptor activation leads to the 
blockade of a calcium activated potassium conductance, depression of the after 
hyperpolarisation (AHP) and increases in cell firing, (Cole and Nicoll, 1984b). The M-
current is also blocked (Cole and Nicoll, 1983). The M1 receptor is known to depolarise the 
pyramidal cells via increases in IH (a hyperpolarisation activated current) and Icat (a 
calcium activated non-specific cation current) (Mann and Paulsen, 2005).  The M3 receptor 
is thought to block the leak potassium conductance (Pitler and Alger, 1990; Porter et al., 
2002). Cholinergic excitation is known to release calcium from intracellular stores in CA1 
pyramidal neurones, mediated by inositol 1,4,5 triphosphate (Power and Sah, 2002). This 
leads to a rise in free intracellular calcium in the soma and nuclear regions.  
Muscarinic receptors are known to regulate the release of several neurotransmitters in the 
hippocampus. Although mAChR activation excites GABAergic interneurones, GABA 
release is reduced (Behrends and ten Bruggencate, 1993) via the M2 and M4 mAChR 
induced suppression of the pre-synaptic release machinery of the GABAergic 
interneurones (Zhang et al., 2002). In turn, muscarinic receptor mediated transmission is 
regulated by several receptors. GABAB receptors, via pre- and post-synaptic mechanisms, 
prevent muscarinic mediated excitation of CA1 pyramidal cells (Morton et al., 2001). 
There is therefore a reciprocal inhibition between acetylcholine and GABA transmission. 
The tonic activation of pre-synaptic adenosine A1 receptors inhibits muscarinic mediated 
depolarisation of CA1 pyramidal cells.   
Oscillations in the hippocampus 
One of the most noticeable features of the brain, when recording electro-encelphalograms 
(EEGs) using scalp electrodes from mammals, is the presence of regular patterned 
oscillatory activity. This activity is a function of neuronal assemblies and can be grouped 
into distinct frequency bands, and recorded from the rodent hippocampus during different 
activities. Low frequency oscillations (0.5-2 Hz) can be observed during slow wave sleep, 
whereas rhythmic components with medium frequencies (5-10 Hz) and fast frequencies 
(40-100 Hz) are found during REM sleep and exploratory activities. Similar rhythms can 
be observed in hippocampal slice preparations, in which application of various agonists to 
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occur in vitro in hippocampal slices are also grouped in discrete frequency bands. These 
include delta frequency oscillations, with oscillation frequencies that lie between 0.5 and 4 
Hz, theta frequency oscillations, with oscillation frequencies that lie between 4 and 12 Hz, 
beta frequency oscillations, with oscillation frequencies that lie in the range of 13 to 30 Hz, 
gamma frequency oscillations, with oscillation frequencies that lie in the range of 30 to 
100 Hz, and fast ripples, with oscillation frequencies that lie in the range of 100 to 400 Hz 
(these are sometimes known as high frequency oscillations). Some of the physiological 
oscillations that occur in the hippocampal slices investigated in this thesis are detailed in 
figure 3.1.A.   
Pathophysiological oscillations are also found in vivo and in vitro in the hippocampus and 
in other cortical structures. These are often associated with CNS disorders such as 
epilepsy, schizophrenia and Parkinson’s disease. Rectifying these aberrant oscillations has 
been suggested as an approach to evaluate the therapeutic benefit of treatments of these 
diseases (Cobb and Davies, 2005).  
Theta frequency oscillations 
The theta frequency oscillation is thought to be critical for temporal coding and the 
modification of synaptic strengths, with LTP enhanced during theta frequency oscillations 
(Huerta and Lisman, 1993). The major currents that underlie theta frequency oscillations 
are generated by the entorhinal input, the CA3 Schaffer collaterals, and voltage dependent 
Ca
2+ currents in pyramidal cell dendrites.  
An intact septal input from the medial septal-diagonal band of Broca (MS-DBB) is 
necessary for in vivo theta oscillations (Fischer et al., 1999) leading to the hypothesis that a 
rhythmic input from the septal projections was required to impose the rhythmic activity. 
The MS-DBB contains both cholinergic and GABAergic projections to the hippocampus. 
The MS-DBB is able to generate and maintain its own theta rhythm in vitro (Garner et al., 
2005).   
The extracellular field is composed of the summed IPSPs on the soma and EPSPs on the 
dendrites of pyramidal cells. It has been proposed that the interplay between the inhibitory 
feed-forward input from the septum and the excitatory input from the perforant pathway 
generates the theta frequency oscillation. EPSPs from the perforant path act to provide 
rhythmic excitation to the pyramidal cells, and cholinergic projections from the MS-DBB 
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to a slow depolarisation of basket cell interneurones, whilst the activity of the GABAergic 
neurones projecting from the MS-DBB rhythmically hyperpolarises basket cell 
interneurones. Basket cell interneurones in turn provide phasic inhibition of the soma of 
pyramidal cells. The tonic cholinergic excitation of interneurones, coupled with the theta 
frequency phasic inhibition of interneurones by GABAergic projections from the MS-
DBB, may be responsible for the phasic output of interneurones (Buzsaki, 2002).     
These oscillations can, however, also be observed in cultured hippocampal cells and 
septally de-afferated hippocampi, with in vivo micro-infusion of carbachol and bicuculline 
(Colom et al., 1991). This suggests the hippocampus must have an intrinsic network 
oscillator, in order to synchronise emergent activity.  
The primary intrinsic hippocampal network oscillator is thought to be found in the CA3 
region of the hippocampus, although it has also been suggested that the intrinsic oscillator 
is the CA2 region (Fischer, 2004). Carbachol cannot stimulate theta frequency oscillations 
in the CA1 region in the absence of the CA3 region (Williams and Kauer, 1997). The 
propagation of the oscillatory activity is dependent on synaptic transmission via AMPA 
receptors and also dependent on NMDA receptors. The oscillation is initiated by the 
depolarisation of the CA2/CA3 pyramidal cells by activation of muscarinic acetylcholine 
receptors, causing pyramidal cells to discharge (Fischer, 2004). However, activation of the 
M1 mAChR on pyramidal cells alone is too slow to account for the generation of theta 
frequency membrane potential oscillations. mAChR activation depolarises pyramidal cells 
which leads to the modulation of intrinsic membrane currents like IM, Ih and IA, and the 
pyramidal cells show resonant frequency preferences within the theta frequency range 
(Pike et al., 2000). Stratum oriens/lacunosum moleculare (O-LM) interneurones also 
display a resonant frequency within the theta frequency range. Theta frequency 
subthreshold membrane oscillations can be induced in O-LM interneurones by the 
activation by mAChRs located on the interneurone (Chapman and Lacaille, 1999). These 
interneurones also can provide phasic inhibition to pyramidal cell dendrites, pacing the 
oscillation.  
Gamma frequency oscillations  
As mentioned above, another major relevant oscillatory rhythm recorded both in vivo and 
in vitro is the gamma frequency oscillation, which is thought to allow some forms of 
cognitive processing and perceptual binding to occur (Gray and Singer, 1989; Mann and 
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structure to co-ordinate the activity of individual neurones. Gamma frequency oscillations 
are often found superimposed upon the theta oscillations in vivo in the hippocampus, an 
interaction which can be disrupted by the blockade of mAChRs (Hentschke et al., 2007).  
Gamma oscillations can be induced in the hippocampus in vitro by the application of 
kainate, the application of mGluR agonists, and the application of cholinergic agonists 
such as carbachol (Buhl et al., 1998; Fisahn et al., 1998). Although these oscillations are 
within the same frequency band they display a differential pharmacology. Kainate and 
mGluR agonist-induced oscillations are maintained in the presence of AMPA receptor 
antagonists (Fisahn et al., 2004), whereas cholinergic induced oscillations are blocked by 
AMPA receptor antagonists (Fisahn et al., 1998). All gamma oscillations are dependent on 
fast inhibition mediated by GABAA receptors.  
The predominant class of interneurone that is assumed to underpin gamma frequency 
oscillatory activity within the hippocampus is the parvalbumin expressing persomatic fast 
spiking basket cell. These interneurones make up ~20% of the interneurones in the 
hippocampus (Freund and Buzsaki, 1996), display an intrinsic resonance of about 40 Hz 
(Pike et al. 2000), fire an action potential at 1 per gamma cycle, display mutual inhibitory 
connections between basket cells, and the current sinks and sources of the gamma 
frequency oscillation is located in the perisomatic region (Mann et al., 2005). As basket 
cells can innervate ~1000 pyramidal cells they are ideally placed to synchronise pyramidal 
cell activities (Cobb et al., 1995).   
Gamma frequency oscillations have been modelled extensively in silico, in order to gain 
further mechanistic understanding of the oscillation. Initially, in a model by Traub et al 
(Traub et al., 1996), the frequency of oscillations was dependent on GABAA conductance, 
time delay and the driving current to interneurones. A synchronised inhibitory synaptic 
conductance occurs if a sufficiently large population of neurones fire within a short space 
of time. In this model the tonic excitatory driving current needs to be homogenous to allow 
synchronisation to occur and strong inhibitory synapses are required to maintain global 
synchronicity. The introduction of shunting inhibition between basket cells in a model of 
gamma frequency oscillations allows greater coherence to emerge with an increased 
heterogeneity in tonic excitatory drive and firing frequency (Vida et al., 2006).      
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Beta frequency oscillations 
Beta frequency oscillations (Boddeke et al., 1997) are possibly the least well characterised 
of all the cholinergic induced hippocampal oscillatory activities. They are often grouped 
together with gamma frequency oscillations, as they are rarely observed in absence of 
gamma oscillations, and seem to have a similar physiology and pharmacology (Shimono et 
al., 2000). The functional significance of beta oscillations within the hippocampus is 
currently unknown. A twice gamma oscillation threshold tetanic stimulus to the CA1 
region causes a shift from gamma oscillations to beta oscillations (Traub et al., 1999). This 
stimulation is associated with a loss of synchrony in the network, and is thought to be due 
to an increase in the Ca
2+-dependant AHP current. Subthalamic network oscillations within 
the beta frequency range arise during dopamine deficiency in Parkinson’s disease, and 
these oscillations are associated with reduced movement (Levy et al., 2002).     
1.3  Epilepsy 
The hippocampus is able to generate oscillatory activity due the high levels of recurrent 
interconnectivity that is present in this area. Most of this oscillatory activity is of a 
physiological nature, as mentioned previously, and is associated with different states of 
alertness and cognitive tasks (Gray and Singer, 1989). However, pathological oscillations, 
such as those associated with epilepsy, can also arise from the hippocampus. The 
hippocampus and the entorhinal cortex play a predominant role in the causation of seizures 
in temporal lobe epilepsy (Goddard et al., 1969).  
Epilepsy is a common major neurological disorder, affecting over 0.5 % of the world 
population (Kaneko et al., 2002). Epilepsy is manifest in a range of ways, stretching from 
absence seizures, in which patients stare vacantly, right up to tonic-clonic seizures in 
which patients lose consciousness and jerk violently. It was defined by Jackson (1890; see 
Swash 2005) as an 
“episodic disorder of the nervous system arising from the excessively 
synchronous and sustained discharge of a group of neurones”. 
Seizure activity is characterised by excessive activity of neurones in the central nervous 
system. The term epilepsy refers to repetitive and numerous seizures, which occur at 
unpredictable occasions. Seizures are characterised by excessive bursting of CNS 
neurones. At the cellular level, epilepsy events can be observed as paroxysmal 
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1964). Epilepsy can be caused by many factors, including cerebral trauma, injury, toxins, 
tumours, and genetic causes, whilst the cause of some idiopathic epilepsies are poorly 
understood.  
Seizures are manifest at the EEG level as periodic large amplitude oscillatory activity 
known as ictal events. Ictal events are associated with repetitive firing of pyramidal cells, 
and the depolarisation block of interneurones (Ziburkus et al., 2006). They are manifest at 
the extracellular level as hypersynchronous bursting discharges as observed in figure 3.1 B. 
Inter-ictal events, which are characterised as single population events, are often present 
between these ictal events. The presence of inter-ictal events is used as a biomarker to 
diagnose epilepsy (Jefferys, 1993).  
Particular types of epilepsy are initially characterised by the location at which the seizures 
are generated, and whether the seizures are localised or generalised. A degree of 
hyperexcitability and hypersynchrony of neurones leads to seizure generation. 
Hyperexcitability can occur following excessive depolarisation of neurones. 
Hypersynchrony can occur when too many neurones are depolarised at the same time 
(Najm et al., 2001). Throughout the central nervous system neurones are activated by 
depolarisation, and in turn innervate and depolarise other neurones. Neurones require some 
degree of excitability and synchronicity, as in the generation of oscillatory activity. It is the 
unregulated depolarisations of many neurones within a narrow time frame that leads to the 
generation and propagation of seizures.  
The hippocampus is particularly susceptible to the generation of seizures due to the high 
levels of interconnectivity and excitatory synaptic transmission that occurs in this brain 
region (Schwartzkroin, 1993). Over half of partial epilepsies originate in temporal lobe 
structures (Luciano, 1993). The seizure susceptibility of the hippocampus arises due to the 
strong and recurrent excitatory connections between the CA3 pyramidal cells (MacVicar et 
al., 1982).The elements that allow physiological oscillations within the hippocampus also 
underlie the susceptibility of the hippocampus to pathological oscillatory activity.  
The approach to treating epilepsy is to decrease the excitability and synchronicity of 
neurones. This is achieved mainly through two ways- a suppression of function of sodium 
or calcium ion channels that mediate cellular depolarisation (such as phenytoin or 
ethosuximide), or the enhancement of GABA receptor mediated synaptic inhibition (the 
use of benzodiazepines or barbituates). Other drugs such as phencyclidine, ketamine or 
MK-801 have anticonvulsant effects through their action as NMDA glutamate receptor John Broad, 2009     Chapter 1 26 
antagonists, but are not used clinically as they have psychological side effects (Krystal et 
al., 1994). The majority of patients with epilepsy respond well to therapy but 
approximately 20% of patients with primary generalised epilepsy and 35% of patients with 
focal epilepsy display seizures that cannot be retracted (Reutens and Berkovic, 1995; 
Spencer et al., 1981).  
Many compounds have the potential to cause or exacerbate epilepsy, acting through the 
modulation of ion channels or receptors. For a drug to be pro-epileptogenic the drug must 
promote hyperexcitability and hypersynchrony of neurones. Both the modulation of 
glutamatergic and cholinergic synaptic transmission have been implicated previously in 
epileptogenesis (Sakai et al., 2001; Turski et al., 1989; Wong et al., 2002). The pro-
epileptogenic nature of putatively cognitive enhancing drugs must be extensively 
investigated, as any effective cognitive enhancing strategy must not also lead to the 
generation of seizures.    
Experimental models of epilepsy 
In order to evaluate the potential of compounds to be pro- or anti-epileptogenic, several 
animal models are used.  The in vitro hippocampal slice model allows the easy application 
of drugs at a known concentration and the manipulation of environmental factors. Several 
drugs and conditions are used to model the epileptic hippocampus. The models all increase 
the excitability of neurones and cause a synchronisation of the output of these neurones 
(Gulyas-Kovacs et al., 2002) and they induce ictal like and inter-ictal like activity. 
The in vitro models used to investigate the mechanisms of epileptiform activity in this 
thesis include: 
1.  The application of the K
+ channel blocker 4-AP. 
2.  The application of bicuculline, a GABAA receptor antagonist. 
3.  The removal of Mg
2+ from the extracellular medium to allow NMDA mediated 
transmission 
4.  The use of a combination of 4-AP and the AMPA/kainate glutamate receptor 
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These mechanistically distinct models of epileptiform activity were chosen as they 
modulate different and complementary parts of the hippocampal network. 4-AP changes 
the intrinsic excitability of hippocampal neurones, bicuculline removes fast GABAergic 
inhibitory transmission, and the zero Mg
2+ model enhances NMDA transmission. In the 
combined 4-AP/NBQX model an attempt was made to isolate the interneurone network to 
allow the further investigations into hippocampal networks.  
The 4-AP model 
Inter-ictal-like activity is induced in hippocampal slices following the application of the K
+ 
channel blocker 4-AP. 4-AP can induce epileptiform activity in vivo (Szente and Baranyi, 
1987) and in vitro (Perreault and Avoli, 1992). Application of 4-AP leads to three main 
actions: (1) the blockade of the fast K
+ A current (IA) and the slower delay (D) current (ID), 
increasing axonic and presynaptic excitability, and (2) direct actions on voltage dependent 
calcium channels (Lundh and Thesleff, 1977).  
IA is the current responsible for the fast repolarisation of the action potential after firing. At 
the concentrations used in this and other studies (<75 µM) 4-AP does not significantly 
block the IA current (Storm, 1988). The ID current, which is a slowly inactivating K
+ 
current, allows the cell to integrate synaptic inputs over tens of seconds. Without this 
current, inputs into the pyramidal cells quickly summate and action potentials occur 
(Storm, 1988). The IADP, which is the current that regulates burst firing in neurones (Brown 
and Randall, 2009), is increased by a reduction of IA and ID and the increase of the 
magnitude of this current leads to paroxysmal depolarising shifts at the intracellular level 
(Perreault and Avoli, 1991). The inter-ictal activity that is induced by application of 4-AP 
originates in the CA3 region and propagates to the CA1 region (Perreault and Avoli, 1992).     
The bicuculline model 
Bicuculline is a competitive GABAA receptor antagonist acting at the orthosteric GABA 
binding site. Blockade of fast inhibition prevents feed-forward and feedback inhibition in 
the network and decreases the inhibitory drive to the network (Miles and Wong, 1987). 
Application of bicuculline leads to seizure activity in vivo (Ben-Ari et al., 1981). The 
activity induced within the hippocampal slice model is reminiscent of the inter-ictal spike 
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GABAergic feedback inhibition normally exerts tight control over the pyramidal cells 
within the CA3 region. When fast inhibition is removed by the block of GABAA receptors 
recurrent synaptic connections between pyramidal cells facilitates the propagation of 
depolarising action potentials through the network. Following the application of 
bicuculline subthreshold excitatory postsynaptic potentials can trigger paroxysmal 
depolarisation shifts in the membrane potential (Psarropoulou and Descombes, 1999). CA3 
pyramidal cells respond to mossy fibre stimulation as if the fibres were stimulated several 
times as opposed to the single occasion, again due to the removal of feedback and feed-
forward inhibition within the network.  
Methyl derivatives of bicuculline have been reported to block SK channels, which mediate 
the afterhyperpolarisation potential (AHP) (Khawaled et al., 1999). The AHP is 
responsible for spike frequency adaptation in pyramidal cells, an important regulator of 
excitability. The block of the AHP by bicuculline methyl derivatives would lead to an 
increased excitability of the network, presumably contributing to the emergence of inter-
ictal-like events in hippocampus.    
The low magnesium model 
The removal of Mg
2+ ions from the extracellular bathing medium of the hippocampal slice 
leads to the eventual emergence of inter-ictal-like events. Although low Mg
2+ solutions 
would be expected to lower the firing threshold for action potentials (Hille et al., 1975), the 
removal of the Mg
2+ block of the NMDA receptor is enough for the generation of 
synchronous activity (Traub et al., 1994). This is reinforced by the sensitivity of these 
events to NMDA receptor antagonists. Paroxysmal depolarising shifts, the intracellular 
correlate of the inter-ictal-like activity observed at the extracellular level, are observed in 
the CA3 pyramidal cells following the removal of Mg
2+ ions from the bathing medium. As 
the low Mg
2+ model does not directly interfere with the interneurone network, the model is 
useful for the study of the role of the GABAA receptor in the generation and spread of 
oscillatory activity (Tancredi et al., 1990), although the effects of this receptor that are 
mediated through the NMDA receptor are greatly reduced following the removal of the 
Mg
2+ block.  
The combined 4-AP and NBQX model 
The 4-AP/NBQX is a model of epileptiform activity in the hippocampus first identified by 
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application of 4-AP described above are modulated by the application of the 
AMPA/kainate glutamate receptor antagonist NBQX. This model putatively isolates the 
interneurone network, and as such is used in this thesis to determine the effect potentially 
epileptogenic compounds on the interneuronal network. However, several caveats to the 
interpretation of the activities observed in this model need to be observed.  
Initially, the concentration of 2 µM NBQX used in this thesis may not completely block 
AMPA/kainate receptors. NBQX is a competitive antagonist at these receptors (Honore et 
al., 1988; Sheardown et al., 1990), and as 4-AP strongly increases glutamate release (Pena 
and Tapia, 2000; Tapia, 1996), NBQX antagonism may be overcome. Secondly, although 
Perrault and Avoli confirmed the necessity for GABAA meditated synaptic transmission in 
their events, this does not mean the events are solely carried by the interneurone network. 
GABA may rather have a role in the initiation or pacing of these events as for the 
oscillatory activity described above. Thirdly, the important role of NMDA receptors in 
oscillatory activity is not considered in this model. In the interpretation of the data from the 
4-AP/NBQX model these caveats will be observed and discussed. 
1.4  Cognitive Enhancement 
Many strategies, including the use of drugs, exercise and environmental conditions have 
produced measurable changes in the ability of rodents, primates and humans to complete 
cognitive tasks (Carey et al., 2001; Ingvar et al., 1997; Varty et al., 2000).  
Cognitive deficits occur in many disorders of the central nervous system, including 
Alzheimer’s disease, schizophrenia and in some forms of epilepsy. An attempt to delay and 
even reverse the cognitive decline that occurs following these disorders is an important 
therapeutic area for pharmaceutical companies. Drugs that increase nicotinic acetylcholine 
receptor function are currently used to ameliorate the cognitive and mnemonic decline in 
Alzheimer’s disease sufferers (Newhouse et al., 1997). Memory loss in Alzheimer’s 
disease is thought to be associated with a loss of cholinergic projections, and boosting 
cholinergic activity with anticholinesterase inhibitors or nAChR agonists prevents the 
progression of cognitive decline observed in Alzheimer’s disease sufferers (Friedman, 
2004). Nicotinic receptor drugs may also be useful in controlling the positive symptoms of 
schizophrenia (Martin et al., 2004). Unfortunately, nAChR agonists can promote 
epileptiform activity (Roshan-Milani et al., 2003), and so other strategies to promote 
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The enhancement of glutamatergic function has also long been associated with enhancing 
cognition. The enhancement of both NMDA and non-NMDA mediated excitatory 
transmission causes cognitive enhancement in animal models (Kandel, 1997; Lynch, 
2002). As mentioned above, the NMDA receptor mediates one form of LTP. LTP is 
understood to be the cellular basis of memory formation (Kandel, 1997). The blockade of 
NMDA receptors by MK-801 or ketamine leads to impairment of memory formation 
(Sharma and Kulkarni, 1991). The use of positive modulators of AMPA receptors, known 
as ampakines, leads to cognitive enhancement in rodents and humans (Hampson et al., 
1998; Ingvar et al., 1997; Ito et al., 1990).  
The activation of mAChRs has been reported to be pro-cognitive. Activation of mAChRs 
can facilitate memory formation (Markram and Segal, 1990). Conversely the mAChR 
antagonists atropine and scopolamine are known to prevent memory storage in rodents 
(Blozovski et al., 1977; Grauer and Kapon, 1996) and humans. A partial agonist of the M1 
receptor, sabcomeline, improves the reversal learning of primates (Harries et al., 1998). 
Also, application of a M2 mAChR antagonist, which causes dose-dependent increases in 
acetylcholine release, leads to improvements in passive avoidance tasks and working 
memory in primates.  
The enhancement of oscillatory activity has been implicated in cognitive enhancement. 
Carbachol can enhance LTP through cholinergically induced oscillations (Huerta and 
Lisman, 1993), but this effect is abolished following the knock-out of the M1 mAChR 
(Shinoe et al., 2005). As noted above, agonists of mAChRs induce gamma frequency 
oscillatory activity (Fisahn et al., 1998). Following the genetic depletion of the M1 subtype 
of mAChR gamma frequency oscillations are not induced by mAChR agonists (Fisahn et 
al., 2002). Gamma frequency oscillations are associated with cognitive function and 
aberrant gamma frequency oscillations are associated with schizophrenia (Tallon-Baudry 
and Bertrand, 1999). Consequently the M1 subtype mAChR is a potential target for 
cognitive enhancing strategies.    
Aside from the use of nootropic drugs, some environmental conditions can lead to the 
enhancement of cognition in rodents. The environmental enrichment protocol causes 
spatial re-mapping in the hippocampus, and leads to behavioural changes and 
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1.4.1  Putative cognitive enhancers 
The M1 mAChR agonist 77-LH-281  
The compound used in this thesis to investigate the role of M1 receptor in physiological 
oscillatory activity, epileptogenesis and the possible enhancement of cognition is 77-LH-
281. This is an allosteric full agonist of M1 receptors (Langmead et al. 2008). 77-LH-281 is 
a chemical analogue of AC-42, which binds to an ectopic site on the M1 muscarinic 
acetylcholine receptor (Langmead et al., 2006). This site is thought to be located in the N-
terminus/TM1 and the third outer loop/TM7 domains of the M1 receptor (Spalding et al., 
2002), away from the orthosteric acetylcholine binding site located in TM3. In contrast, N-
desmethylclozapine, a clozapine metabolite with affinity for the M1 receptor, occupies a 
binding site that overlaps the orthosteric binding site of the M1 mAChR (Spalding et al., 
2006).  
Activation of the M1 receptor by carbachol (Marino et al., 1998) and N-
desmethylclozapine (Sur et al., 2003) potentiates NMDA receptor currents in CA1 
pyramidal cells. As NMDA receptor mediated currents are responsible for one form of 
LTP enhancement this potentiation may increase mnemonic function and enhance 
cognition. M1 mAChR agonists have also been implicated in the treatment of Alzheimer’s 
Disease (Fisher et al., 1996). It is interesting therefore to investigate the potential of 77-
LH-281 to enhance cognitive function, and attempt to assess the potential unwanted effects 
of this agonist in epileptiform models. 
Ampakines    
Aside from muscarinic acetylcholine receptor agonists, another class of nootropic drug are 
ampakines. Ampakines are positive allosteric modulators of AMPA type glutamate 
receptors (Arai and Kessler, 2007). Different ampakines exert their effect through 
decreasing desensitisation of AMPA receptors, lengthening open times in response to 
agonist application, improving the binding of glutamate to AMPA receptors and increasing 
the conductance of the AMPAR channel. Therefore in the presence of ampakines fast 
glutamatergic transmission is more efficient and a similar release of glutamate will cause a 
greater depolarisation of the postsynaptic membrane potential than in the absence of 
ampakines. As ampakines enhance excitatory glutamatergic transmission, they can 
facilitate synaptic plasticity and enhance learning (Lynch, 2004).  John Broad, 2009     Chapter 1 32 
There are two major structural classes of ampakines, both of which positively modulate 
AMPAR transmission but have different effects on the AMPA mediated current. 
Benzothiazides, which include the drugs cyclothiazide and IDRA-21, one of the earliest 
ampakines identified, block the desensitisation of AMPA receptors (Xia and Arai, 2005) 
but they have little effect on the deactivation of AMPA receptors. Deactivation and 
desensitisation of AMPA receptors occurs on a time scale fast enough to affect the 
excitatory postsynaptic current (Lynch, 2004).   
Benzamide drugs have effects on the open times and conductance of AMPA receptors. 
They all reduce the deactivation kinetics of AMPA receptors and they slow the rate at 
which the synaptic responses decay (Arai et al., 2004; Nagarajan et al., 2001). However, 
different compounds have different actions depending on the chemical structure of the 
ampakine. For example CX546 has been shown to greatly prolong the decay of AMPA 
receptor mediated excitatory postsynaptic currents (EPSCs) but has little effect on the 
amplitude of the EPSC (Nagarajan et al., 2001).  In contrast, CX516 increases the 
amplitude of the excitatory post-synaptic current but has a much smaller effect on the rate 
of decay of synaptic responses (Arai et al., 2004). The concentration of CX516 needs to be 
much higher (within the millimolar range) to observe this effect on EPSC decay time than 
the effect on response amplitude. CX691 also increases the amplitude of the EPSC, and is 
20-50 times more potent than CX516 (Johnson et al. 1999).  
As well as effects at the cellular level, ampakines have effects at the synaptic level. At the 
Schaffer collateral-CA1 pyramidal neurone synapse, application of some ampakines 
increases the amplitude of fEPSPs. Under an LTP paradigm, application of ampakines 
facilitates the induction of LTP in vivo (Staubli et al., 1994) in response to theta burst 
stimulation. Depending on the specific ampakine, the effect on LTP can vary in vitro. 
Application of CX546 increases the amplitude of LTP whereas cyclothiazide does not. 
Both CX546 and cyclothiazide lower the threshold for LTP induction.    
In a model of epileptiform activity in which inter-ictal-like events are induced by the 
removal of Mg
2+ ions from the extracellular bathing medium, subsequent application of the 
ampakine cyclothiazide causes a significant increase in the length of defined seizure-like 
events in hippocampal slices (Lasztoczi and Kardos, 2006). Cyclothiazide also produces 
epileptiform activity in hippocampal cultures and in vivo (Qi et al., 2006). This effect is 
partially due to the effect of cyclothiazide blocking GABAA receptors (Deng and Chen, 
2003), much like the bicuculline model of epileptiform activity described above. The other 
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AMPA receptor open time or EPSP amplitude, may be less prone to the generation of 
epileptiform activity in the hippocampus as the receptor can still desensitise under high 
levels of stimulation. They are more specific for the AMPA receptor than cyclothiazide as 
they have little affinity for the GABAA receptor. 
1.4.2  Environmental Enrichment 
Environmental enrichment and cognitive enhancement 
An enriched environment is an environment that exposes animals to a spatially complex 
inanimate stimulation and increased social contact. Hebb (1949) noticed rats raised in his 
home performed better in cognitive tasks than rats raised in the lab, indicating that 
increased stimuli at home could be responsible for this effect (Toscano et al., 2006). As 
such environmental enrichment is a model of cognitive enhancement as animals perform 
better than control rats in a number of measurements of cognitive ability. This is mediated 
through the modulation of the structure and growth of neuronal cells (Nilsson et al., 1999). 
Such changes may be responsible for the increase in the synaptic strength of the perforant 
path in the hippocampi of animals exposed to an enriched environment. Environmental 
enrichment can also induce the production of new neurones, which occurs, amongst other 
areas, within the subgranular layer of the dentate gyrus in the hippocampus. Neurogenesis 
and gliogenesis (the production of new neuronal and glial cells respectively) is known to 
occur at levels five times greater in animals in the enriched environment than in control 
animals. However, neurogenesis is not required for the behavioural effects observed in 
animals exposed to the enriched environment (Meshi et al., 2006).  
Environmental enrichment can also ameliorate cognitive deficits induced by a number of 
conditions (Guilarte et al., 2003; Toscano et al., 2003) including developmental lead 
exposure and exposure to prenatal ethanol.   
It is known that changes in the expression of genes occur following exposure to an 
enriched environment (Rampon et al., 2000). It was therefore decided to investigate the 
changes that occur at the global proteomic method using a gel electrophoresis approach 
combined with mass spectrometry to identify the specific protein changes that occur 
following environmental enrichment. This approach allows measurement of changes at the 
proteome level that underlie the improvement in cognitive function. Possible future 
therapeutic targets for nootropic drugs and biomarkers for the protein changes that occur 
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Expression of MeCP2 and environmental enrichment 
Rett syndrome is a postnatal developmental disorder within the autism spectrum affecting 
the development of 1 in 10000 girls aged 6-12 months. The disorder is due to mutations in 
a gene called MECP2 that encodes for a Methyl-CpG binding protein that regulates gene 
expression. It consists of a methylated CpG binding domain, a transcriptional repression 
domain and a C-terminal domain, as well as a pair of nuclear localisation signals 
(Chahrour and Zoghbi, 2007). MeCP2 is postulated to be a transcriptional repressor, 
because when it binds to CpG dinucleotides it recruits the co-repressor Sin3a and histone 
deacetylases 1 and 2. Environmental enrichment induces histone modification and 
inhibitors of histone deacetylases have been shown to restore learning and memory 
(Fischer et al., 2007). This leads to the compacting of chromatin, which prevents promoter 
regions binding and gene expression to occur. Aberrant, mosaic expression of MeCP2 
leads to mental and physical abnormalities with neurones encoding the mutant protein 
displaying the mutant phenotype. This is not a neurodegenerative disorder as the neurones 
do not die, but it is rather a neurodevelopmental disorder. Recently it was shown (Guy et 
al., 2007) that this phenotype can be reversed in an mouse model of Rett syndrome 
following the conditional re-expression of wild-type MeCP2. One of the target genes for 
MeCP2 is the gene encoding brain-derived neurotrophic factor (BDNF), a protein critical 
for the formation and maintenance of long term potentiation (Kang et al., 1997), a cellular 
mechanism implicated in the genesis of memory. A lack of activity dependent transcription 
of BDNF has been postulated to be one of the underlying causes of the Rett syndrome 
phenotype. As a decreased level of MeCP2 in the brain leads to cognitive impairment, 
likewise it is possible that an increased level of MeCP2 may occur in the environmental 
enrichment model of cognitive enhancement. Several previous studies have investigated 
the effect of environmental enrichment alleviating the symptoms of Rett syndrome (Kondo 
et al., 2008; Nag et al., 2009). Therefore it is worthwhile investigating the expression of 
MeCP2 following exposure to an enriched environment.    
1.5  Aims 
In this project there are three main aims: 
1.  To investigate the effect of putative nootropic compounds, mAChR agonists and 
ampakines, on physiological and pathophysiological network properties of the 
hippocampus. John Broad, 2009     Chapter 1 35 
2.  To gain mechanistic insight into the networks that underlie the oscillatory activity 
induced by the application of these nootropic compounds.   
3.  To investigate the change in expression of putative cognition related proteins following 
exposure to an enriched environment 
A range of pharmacological, physiological and proteomic approaches are used to 
investigate these cognitive enhancing strategies. Insight into the effect of these strategies 
on hippocampal networks and protein expression will enable the evaluation of each 
strategy and allow further development of the field of cognitive enhancement.
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2.1 In vitro Hippocampal Slice Experiments 
2.1.1 Hippocampal Slice preparation 
Animals were supplied by Harlan UK Ltd. and housed in group cages under controlled 
environmental conditions (temperature 19-23°C, 12hr light/dark cycles). Animals had ad 
libitum access to food and water.  
Male Wistar rat (3 weeks) were cervically dislocated and decapitated in accordance with 
UK home office guidelines under the authority of the UK Animals (Scientific Procedures) 
Act, 1986. A scalpel was used to make an incision along the middle of the skin on the top 
of the head, revealing the skull. Ice-cold (0-4°C) ACSF (composition (mM) NaCl 124, KCl 
3, NaHCO3 26, NaH2PO4 1.25, MgSO4 1, D-glucose 10 and CaCl2 2) was then poured over 
the skull to wash away excess blood and to cool the brain. Incisions were then made at 
either side of the neck bones using sharp dissecting scissors and the skull was cut from 
back to front along the midline to reveal the brain. The sides of the skull were pulled back 
and the brain placed into ~70 ml of ice cold ACSF using a small spatula. The cerebellum 
and pre-frontal cortex was then removed and the brain was hemisected in the sagittal plane 
down the midline. Depending on the orientation of slice required, the brain was glued onto 
a wax block using cryoacrylate adhesive at the back of the brain on the cut that the 
cerebellum had been removed with for coronal sections, or on the sagittal plane of the 
midline for horizontal sections. Slices were cut to a thickness of 450 µm using a vibrating 
microtome (Campden Instruments, UK) in ice cold ACSF, the hippocampus removed and 
the hippocampal slices transferred to an interface holding chamber containing room 
temperature oxygenated (95% O2/ 5% CO2) ACSF (23°C) using a large bore pipette. The 
slices were maintained at room temperature and allowed to recover for 1 hour before use.  
2.1.2 Electrophysiology 
2.1.2.1  Recording set-up 
The recording chamber (Digitimer Research Instruments, UK), microscope (Koyawa, 
Japan) and manipulators holding recording and stimulating electrodes were all mounted on 
a pressure sensitive anti-vibration table (Intracel, U.K) surrounded by a Faraday cage. All 
of the remaining electrical recording equipment, including an Axoclamp 2B current and 
voltage clamp analyser (Molecular Devices, USA), a signal processor (Brownlee precision 
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digital converter (Digidata 1320 series, Molecular Devices, CA) and PC, were mounted on 
racks out side of the Faraday cage.  
An interface type chamber (Digitimer Research Instruments, UK) was chosen for 
extracellular and intracellular recordings. This consisted of 2 separate 15 mm diameter 
chambers in which the slices were placed on nylon netting and a 1 cm
2 piece of lens tissue 
(Whatman, UK). The slices were kept in a warm, humidified oxygen enriched atmosphere 
at the interface of warmed ACSF. The ACSF was perfused at a rate of ~2 ml/min using a 
peristaltic pump (Gilson, France).  
Recording electrodes for extracellular and intracellular recordings were pulled from 
standard-wall (1.2 mm external diameter/0.69 mm internal diameter) borosilicate glass 
capillaries on a Brown and Flaming-type horizontal electrode puller model P-87 (Sutter 
Instruments, USA). Extracellular recording electrodes were pulled to a standard D.C. 
resistance of <1 M  and filled with ACSF. Intracellular recording electrodes were pulled 
to a resistance of between 80-120 M  and filled with 3M potassium methyl sulphate and 
2% Neurobiotin (Vectastain, US if the cells were later to be processed for morphology.    
Filled electrodes were then mounted into electrode holders, where the filling solution came 
into contact with silver chloride-coated silver wire. The electrode was then inserted into a 
unity-gage head stage (current gain 0.1: Axon Instruments) and connected to the Axoclamp 
2B amplifier. A silver chloride-coated silver reference electrode connected to the head 
stage was placed into the bath.  
Nickel/chromium bipolar stimulation electrodes were constructed from 2 lengths of 0.05 
mm diameter nickel/chromium (80%/20%) wire, twisted together and cut at the tip to allow 
focal stimulation. An isolated stimulator box (Digitimer Ltd., England) provided electrical 
stimulation, triggered by the output of the Digidata from the P.C. All stimulating and 
recording electrodes were mounted on micromanipulators (Narishinge MC35, Japan). This 
allowed for precise electrode placement as the electrodes could be moved in a coarse or 
fine manner in all axes.   
2.1.2.2  Extracellular Field Recordings 
These experiments were performed in an interface recording chamber, using ACSF-filled 
microelectrodes with a resistance of <1 M .  John Broad, 2009    Chapter 2 39 
Spontaneous emergent network activity 
In order to assess the effect of compounds on the emergent activity of neuronal networks, 
extracellular recordings were made, in the majority of slices, from the CA3 region of the 
hippocampus. This configuration allows the effect of compounds on populations of cells to 
be examined. 1 hour after hippocampal slices were made, slices were then transferred to 
the recording chamber and allowed to equilibrate from room temperature to the recording 
chamber temperature (34 ± 1 ºC).  
The recording electrodes were then gently placed in contact with the surface of the 
hippocampal slice, close to the stratum pyramidale towards the stratum radiatum within 
the CA3 area. The slices were then covered to retain the humidity of the chamber using a 
glass slide, preventing the slice from drying. Positive and negative trace deflections as 
measured by the extracellular field electrodes in the external space were the indication of 
synchronous population activity. These trace deflections were then amplified 2000 times 
by a Brownlee 440 signal processor, either in one operation or in 2 stages of 10 and then 
200 times amplification. The recordings were band pass filtered at 1 to 1 kHz to remove 
extraneous noise and 50 Hz line frequency noise was subtracted using a humbug device 
(Quest Scientific, Canada). This processed analogue signal was then digitised using a 
Digidata 1320A converter at 10 kHz, and then fed to a P.C. to be captured on hard disk 
using pClamp 8.0 software (Axon Instruments, Union City, CA, USA). 
Evoked field excitatory post-synaptic potential (fEPSP) recordings  
Extracellular recordings were made in the CA1 region of the hippocampus. Recording 
electrodes were placed onto the stratum radiatum of the hippocampus. Stimulating 
electrodes were placed on the Schaffer collaterals and a stimulus was given at 20 s 
intervals. The fEPSPs were recorded at a rate of 20 kHz and the data were captured using 
WinLTP software. The stimulus consisted of a square wave pulse of 100  s duration and 0-
30 mA constant current amplitude, to generate a half-maximal response for each 
experiment.  
2.1.2.3  Intracellular current clamp recordings 
For intracellular recordings, electrodes (80-120 M ) were filled with 3 M potassium 
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allow minimal damage to the pyramidal cells upon entry. Intracellular recordings were 
made from the stratum pyramidale of the CA1 region of the hippocampus.  
The pyramidal cells were impaled by advancing the recording electrode through the CA1 
stratum pyramidale using a Narishinge (MC35, Japan) water hydrolic drive. Square 
negative current pulses (0.1 nA) were applied through the recording electrode to provide an 
indication of when the tip was approaching a cell membrane, signified by an increase in 
resistance and a consequent increase in the voltage response to the current pulse. When the 
tip of the electrode was touching the cell membrane, an oscillatory ‘buzz’ was applied to 
break into the cell. The cellular response to 500 ms 0.1 nA positive and negative current 
steps was assessed, before the application of a 60 s bolus of the compound of interest was 
added. The membrane potential was continuously recorded for 30 s before and 4-6 mins 
after the application of the 60 s bolus in current clamp bridge mode. The cellular response 
to 500 ms 0.1 nA positive and negative current steps was assessed again.  
2.1.2.4  Data analysis 
For the extracellular recordings of drug-induced emergent network activity frequency 
analysis was performed after 30 mins drug application. For network oscillations of the 
delta, theta, beta, gamma types and ictal-like events, 5 s epochs of trace were randomly 
selected within the 30
th minute and power spectral analysis was performed on the trace. For 
inter-ictal-like events, the frequency of events over 1 minute of recording was determined. 
For the 4-AP/NBQX induced slow inter-ictal-like events, the frequency of events over 5 
minutes of recording was determined due to the inherent infrequent nature of these events.  
For the EPSP recordings, the mean amplitude of 15 events (over 5 minutes) 30 minutes 
after drug application was used to determine drug effects.   
For the intracellular current clamp recordings, the input resistance was measured using 
hyperpolarising 0.1 nA current injections and measuring the change in the membrane 
potential just prior to, and 5 minutes after drug application. Membrane potential was also 
determined just prior to and 5 minutes after drug application.  
Comparisons between the effect of drugs on membrane potential and input resistance were 
made using paired Student’s T test. Comparisons between the effect of drugs on fEPSP 
amplitude and inter-ictal-like event frequency were performed using Wilcoxon signed rank 
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significance was assumed at P < 0.05, denoted by * in the figures. P < 0.01 is denoted by 
**, and P < 0.001 by ***.     
2.2 Environmental Enrichment experiments 
The following methods are reproduced in the methods section of the paper referred to in 
the appendix (McNair et al. 2007).   
2.2.1 Tissue Preparation 
2.2.1.1  Animals 
Animals were supplied by Harlan UK Ltd. and housed in group cages under controlled 
environmental conditions (temperature 19-23°C, 12 hr light/dark cycles). Animals had ad 
libitum access to food and water. At three weeks of age the environmental enrichment 
protocol was initiated. Animals were transferred to black Perspex cages (100 x 50 x 60 cm) 
containing several novel objects including tubes, a running wheel, ladders, platforms and 
beams, as well as food corner, a suspended water bottle, and sawdust base. The enrichment 
objects were rearranged every 3 days to ensure a degree of spatial novelty. The animals in 
the poor environment had none of the novel enrichment objects. The enrichment protocol 
lasted for 6 weeks, and each of the cages contained 6 animals.  
2.2.1.2  Tissue extraction 
After 6 weeks of the environmental enrichment protocol, the animals were killed by 
cervical dislocation followed by decapitation in accordance with local ethical guidelines 
and U.K. legislation. Brains were rapidly transferred to ice cold (0-3°C) oxygenated 
ACSF. Hippocampi were dissected free, snap frozen in liquid nitrogen and stored at -80°C 
until required.    
2.2.2 DiGE experiment 
For each individual protein sample the CA1 region from three to four hippocampal slices 
were pooled and lysed in 150 ml of buffer containing 10 mM tris pH 8, 5 mM magnesium 
acetate, 8 M urea and 2 % ASB14. Lysed tissue was then subjected to five freeze thaw 
cycles and left at room temperature for 1 hour to aid solubilization of proteins. Samples 
were subsequently sonicated (4 x 4 minute cycles, with 2 minutes between each cycle to 
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clean up using an ammonium precipitation, protein pellets were re-suspended in 
approximately 70 ml of lysis buffer and protein concentration determined using Pierce’s 
BCA Protein assay kit.  
2.2.2.1  Protein concentration determination 
Sample protein concentration was determined using a Pierce BCA (bicinchoninic acid) 
protein assay reagent kit (Pierce, U.S.A.) using the microplate protocol. A BSA standard 
curve was produced using the protocol with a working range of 20-20000 µg/ml, diluted 
using the lysis buffer. The following dilutions were used: 
Volume of Dilutent  Volume and Source of BSA  Final BSA Concentration 
0 
125  l 
325  l 
175  l 
325  l 
325  l 
325  l 
400  l 
400  l 
300  l of Stock 
375  l of Stock 
325  l of Stock 
175  l of vial B dilution 
325  l of vial C dilution 
325  l of vial E dilution 
325  l of vial F dilution 
100  l of vial G dilution 
0 
2000  g/ml 
1500  g/ml 
1000  g/ml 
750  g/ml 
500  g/ml 
250  g/ml 
125  g/ml 
25  g/ml 
0  g/ml = Blank 
Table 1. Preparation of Diluted Albumen (BSA) standards 
 
The working reagent was then prepared in excess according to the protocol. 3 samples per 
replicate were used, with a 1 in 10 dilution (10 µl in 100 µl lysis buffer) to preserve the 
protein extract. 25 µl of each BSA dilution or sample and 200 µl working reagent was 
added to each well, mixed on a plate shaker for 1 minute, and incubated at 37 °C for 30 
minutes in a water bath. The plate was allowed to cool to room temperature and the 
absorbance was measured using an Opsys MR plate reader (Dynex Technologies, U.K.) 
and Revelation Quickline software (version 4.03, Dynex Technologies, U.K.) at a 
wavelength of 562 nm. The standard curve was plotted automatically using a quadratic 
curve fit and the concentration of each unknown standard was obtained from this curve.  
2.2.2.2  Sample CyDye labeling  
The experiments detailed below (until section 2.2.3) were performed by K.M McNair. 
Fifty micrograms of each protein sample was labeled with 400 pmol of either Cy2, 3 or 5 
according to the manufacturer’s instructions (GE Healthcare, Amersham, Little Chalfont, 
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dimension Cy2, 3 and 5 samples were pooled and added to the same volume of 2× sample 
buffer containing 8 M urea, 2 % ASB14, 20 mg/ml DTT and 2 % IPG buffer and then 
corrected to a final volume of 450  l using rehydration buffer (8 M urea, 2% ASB14, 2 
mg/ml DTT and 1% IPG buffer). 
2.2.2.3  2D gel electrophoresis 
The 1st dimension of the 2D gel electrophoresis process was performed using the 
rehydration method (Rabilloud et al., 1994). Isoelectric focusing was carried out on pH 3–
10 non-linear (NL) 24 cm IPG strips. The second dimension was run on 12.5%, 
homogenous polyacrylamide gels poured between low fluorescence glass plates (GE 
Health Care). Gels were scanned immediately after the running of the second dimension on 
a Typhoon™ 9400 variable mode imager. 
2.2.2.4  DiGE gel analysis 
Gel images were analyzed in differential in-gel analysis (DIA) mode in DeCyder software 
with spots displaying greater than 1.5-fold change in spot density being tentatively defined 
as being differentially expressed. All experiments incorporated a Cy2 internal standard. 
Following gel-to-gel matching of spots, statistical analysis (Student’s t-test) of normalized 
protein abundance changes between samples was performed using a BVA software module 
as described (Alban et al., 2003). 
2.2.2.5  Spot picking and mass spectrometry analysis 
Protein spots shown to be significantly different (P < 0.05) from control following 
treatment were picked, digested (Porcine trypsin 0.2  g, Promega, UK) and spotted onto a 
Voyager DE-Pro Maldi-Tof target plate for subsequent mass spectrometry analysis 
(Perceptive Biosystems, CA, USA) using the Ettan Spot Handling Workstation (GE Health 
Care). Maldi-Tof mass spectrometry was performed in positive reflector mode using a 
laser setting around 2350. The low mass gate setting was set at 750 Da, and the spectra 
were acquired over a range of 750–3500 Da. The accelerating voltage was 20 kV, the grid 
voltage set to 76 % and the guide wire voltage set to 0.006 %, with an extraction delay 
time of 160 ns. One hundred shots per spectrum were collected, with a combination of 
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Spectra were then exported to Data Explorer™ (version 4, Applied Biosystems, Cheshire, 
UK) where they were internally calibrated using the 842.5099 and 2211.1046 trypsin 
peaks, processed to reduce background noise, and a monoisotopic peak list was generated 
and entered into the Mascot peptide mass fingerprint (PMF) database. Data were searched 
using the NCBInr database. 
Those peptide mixtures that were unidentified by Maldi-Tof analysis were sent for tandem 
MS analysis. Tryptic peptides were solubilized in 0.5 % formic acid and fractionated by 
nanoflow HPLC on a C18 reverse phase column, eluting with a continuous linear gradient 
to 40 % acetonitrile over 20 min. The eluate was analyzed by online electrospray tandem 
mass spectrometry using a Qstar Pulsar (Applied Biosystems). Mass spectrometric analysis 
was performed in IDA mode (AnalystQS software, Applied Biosystems), selecting the four 
most intense ions for MSMS analysis. A survey scan of 400–1500 Da was collected for 3 s 
followed by 5 s MSMS scans of 50–2000 Da using the standard rolling collision energy 
settings. Masses were then added to the exclusion list for 3 min. Peaks were extracted 
using the Mascot script (BioAnalyst, Applied Biosystems) and automatically exported to 
the Mascot (Matrix Science, London, UK) search engine. 
For both the PMF and MS/MS searches, proteins were matched with the identified peptides 
and each protein was assigned a Mascot score, which was a probability-based Mowse score 
(Perkins et al., 1999). In the case of PMF the significance threshold was 62, and in the case 
of MS/MS this threshold was 36. 
2.2.3 Western Blotting  
Both 1D and 2D western blotting techniques were used to analyse the expression of 
proteins identified. For each hippocampus 600  l of ASB14 lysis buffer was added and the 
tissue was ground in a 1.5 ml centrifuge tube using a plastic pestle. Samples were then 
freeze-thawed five times in liquid nitrogen and a water bath heated to 30°C. The samples 
were then left at room temperature for 1 hour to aid solubilisation before 4 cycles of 4 
minutes sonication, with one minute between cycles. The samples were then centrifuged at 
13000 rpm for 15 minutes on a lab bench centrifuge (MSE microcentaur, Scotlab, UK) and 
the supernatant collected, before 10  l was removed to determine the protein concentration 
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2.2.3.1  1D Western Blotting techniques 
Samples of 25  l containing 30  g protein, 10 % sample reducing agent and 25 % loading 
buffer (Invitrogen, U.K.) were loaded into each well of a pre-cast 4-10 % 12-well sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gel (Invitrogen, U.K.) 
to separate the proteins by charge. One lane contained rainbow markers (Amersham, 
U.K.). Five replicates for each sample were loaded onto the gel. The gels were placed in 
gel tanks and the covered in NuPAGE MOPS 1x running buffer (Invitrogen, U.K.) 
containing 0.25 % NuPAGE antioxidant (Invitrogen, U.K.). The remainder of the gel tank 
was filled with 1x MOPS running buffer containing antioxidant. The gels were run at 200 
V for 60 minutes or until the gel front was close to the base of the gel. 
2.2.3.2  2D Western Blotting techniques 
Gel loading 
The protein mixtures were initially separated for their charge using isoelectric focusing on 
Amersham’s Ettan
TM IPGphor
 TM system. Samples were run on 7 cm non linear 3-10 
immobilised pH gradient (IPG) Dry Strip gels, using the rehydration method (Rabilloud et 
al, 1994). For rehydration loading, 75 µg protein was added to a total volume of 
rehydration buffer (8 M urea, 2% ASB14, 5 mg/ml DTT, 0.5% IPG buffer) to a total 
volume of 125 µl. Dithiothreitol (DTT) and non-linear pH 3-10 IPG buffer were added 
fresh to the rehydration buffer prior to the 1
st dimension run.  
1
st Dimension run  
This mixture was spread evenly along the base of a 7 cm ceramic IPG strip holder and the 
strip was placed gel side down onto the sample mixture. The strip was placed ensuring that 
no bubbles were present between the strip and the coffin, with the anodic end of the strip 
placed towards the pointed end. 300 µl of silicone oil (Dry strip cover fluid, Amersham 
Biosciences, U.K.) was pipetted over the top of the IPG strip and the coffin lid replaced, to 
prevent the strip from drying out. The IPG strip was positioned to ensure that both the 
electrodes in the holder were touching the strip, and the holder itself made contact with the 
anode and cathode of the IPG-phor. Samples were run using a pre-set 7 cm program: John Broad, 2009    Chapter 2 46 
Step 1    Step and hold    30 V    14 h or 420 VHrs  
Step 2    Step and hold    500 V    1 h or 500 VHrs 
Step 3    Step and hold    1000 V    1 h or 1000 VHrs 
Step 5    Step and hold    5000 V    4 h or 20000 Vhrs 
at 20°C and 50 mA per gel.  
Successful 1
st dimension runs were considered to be runs in which the total volt hours 
exceeded 20000 Vh on the IPG-phor reader. The strips could then be used immediately or 
stored at -80°C for up to 3 months.  
2
nd Dimension- Equilibration and run  
The strips were used immediately after the 1
st dimension run or used straight from -80°C 
freezer, to prevent migration of the proteins. Strips were placed in plastic falcon tube 
containing 4 ml of equilibration buffer 1 (containing DTT) for 13 minutes and shook 
gently at room temperature. The buffer was removed and immediately replaced with 4 ml 
of equilibration buffer 2 (containing iodoacetamide), and the strips were again gently 
shook for 13 minutes at room temperature. Buffer 1 preserved the fully reduced state of the 
proteins, whereas buffer 2 prevented reoxidation of the thiol groups by alkylation, and thus 
preventing gel distortion. Equilibrated IPG strips were then run on pre-cast 12 % single 
well sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gels 
(Invitrogen, U.K.) to separate the proteins by charge. The gels were placed in gel tanks and 
the covered in NuPAGE MOPS 1x running buffer (Invitrogen, U.K.) containing 0.25 % 
NuPAGE antioxidant (Invitrogen, U.K.). The remainder of the gel tank was filled with 1x 
MOPS running buffer containing no antioxidant. The strips were placed with the 
(anode/cathode) to the left-hand side of the gel, ensuring there were no air gaps between 
the strip and the gels. 0.5 ml of agarose sealant solution was then pipetted over the length 
of the strip to ensure contact was maintained with the SDS-PAGE gel. The gels were run at 
200 V for 60 minutes. 
2.2.3.3  Gel Transfer 
The proteins from the gels were immediately transferred onto a 0.45  m pore size PVDF 
membrane. The components for the membrane transfer were all soaked in NuPAGE John Broad, 2009    Chapter 2 47 
transfer buffer containing 10 % Methanol, for 10 minutes prior to use. The PVDF 
membrane was initially soaked in pure methanol to enhance hydrophobic protein transfer. 
The NuPAGE transfer cassette (Invitrogen, U.K.) was assembled as the manufacturer’s 
instructions. The gel was removed from its casing and placed onto a piece of buffer-soaked 
filter paper, on top of several blotting sponges inside the cassette. The PVDF membrane 
was then placed on top of the gel followed by another piece of filter paper and several 
blotting sponges. The blot cassette was filled with clean transfer buffer containing 0.1 % 
antioxidant and the rest of the module was filled with water. The transfer was run at 30 V 
for 1 h and at room temperature.  
2.2.3.4  Blocking 
The PVDF membrane was removed from the blot cassette and washed briefly in distilled 
water. The membrane was then placed in ~10 ml 3% milk TBST solution for 2-3 h at room 
temperature. The membrane was placed on a plate shaker to gently wash the membrane. 
Blocking times were increased for antibodies that gave high background staining 
(indicated in figures).  
2.2.3.5  Primary antibody incubation 
Following blocking, the membranes were transferred to a plastic wallet containing 2 ml of 
the primary antibody at the correct dilution, diluted in 1 % milk TBST solution. The wallet 
was sealed, ensuring there were no air bubbles, and the wallet was placed onto a vibrating 
shaker overnight (~14 h) at 4°C. The following morning the membrane was removed from 
the wallet and washed 4x for 10 minutes in TBST.  
2.2.3.6    Secondary antibody incubation 
The membrane was then transferred to a second plastic wallet, containing 2 ml of the 
relevant secondary antibody conjugated to horseradish peroxidase enzyme (HRP) at a 
concentration of 1:1000. The antibody was diluted in 1% milk TBST solution. The wallet 
was again sealed and placed on a vibrating shaker at room temperature for 1 h. After this 
the membrane was removed from the wallet and washed 4x in TBST for 10 minutes before 
being revealed.  John Broad, 2009    Chapter 2 48 
2.2.3.7  Protein detection using enzyme chemi-luminescence (ECL) 
Following the final TBST wash, the membrane was blotted to remove excess moisture. 5 
ml of a 40:1 mix of Amersham ECL Westen Blotting Detection System (Amersham, U.K.) 
buffers A and B was then placed over the membrane, and the membrane was shook gently 
for 5 minutes. Excess buffer was blotted off the end of the membrane, and the membrane 
was then placed into a clear plastic envelope and inside a dark box (Amersham, U.K.).  
2.2.3.8  X-ray film development 
The membrane inside the development box was then taken to a dark room to reveal the 
location and intensity of the protein of interest. Amersham Hyperfilm (Amersham, U.K.) 
was placed over the membrane and the box closed. The film was left in the box for 
between 10 s and 5 minutes depending on the strength of the signal, and the film was then 
developed using a Kodak X-OMAT 1000 machine (Kodak, U.K.).  
2.2.3.9  Analysis 
As several protein spots were revealed on each membrane, some due to none specific 
antibody staining, there was a need to ensure the protein spot identified was the protein of 
interest. The protein spots were initially compared to known protein band sizes to observe 
the size migration of the protein. For the 2D western blots the proteins were then checked 
to establish whether the spots were at the correct pH position in the 1
st dimension. The 1D 
western blots were scanned with a Canon LiDE scanner and band intensity quantified 
using a 1D gel analysis programme within the Totallab v2003 image analysis software 
package (Nonlinear Dynamics Ltd, Newcastle upon Tyne). Data were analysed using 
Student’s T test and refutation of the null hypothesis taken as p < 0.05.   
2.3 Compounds 
All drugs were purchased from Sigma, (4-aminopyridine, oxotremorine-M, 2-AP5, 
CX546), Tocris Bioscience (bicuculline methochloride, kainate, NBQX, atropine) or were 
kind donations from GlaxoSmithKline (77-LH-281, CX691, MT-7). All drugs were stored 
as 10 mM stock solutions in H2O or DMSO at -20 C and dissolved on day of use.  49 
3  The effect of slice orientation on emergent 
oscillations John Broad, 2008     Chapter 3 50 
3.1  Introduction 
The emergent network properties of neuronal networks will depend upon many factors but 
one of the principal factors amongst these is the underlying circuitry that is present in the 
network. Although hippocampal slices retain much of the network within the slice 
differences in the circuitry of a particular slice will be apparent depending on the 
orientation in which the slice is made. As such different slices may show different 
preferences for particular emergent activities.   
In this chapter the effect of the orientation of the hippocampal slice on patterns of 
displayed oscillatory activity is investigated. Two orientations were investigated; the 
sagittal orientation, in which slices were made parallel to the midline of the brain; or the 
coronal orientation, in which slices were made along the long axis of the hippocampus.  
There are several types of oscillation that were obtained during the data collection for this 
thesis, both physiological oscillations and pathophysiological oscillations (see fig 3.1.A). 
Gamma oscillations (Traub et al., 1998) are thought to occur during the processing of 
incoming sensory signals (Gray and Singer, 1989) and were manifest as continuous low 
amplitude oscillatory activity in hippocampal slices. Beta frequency oscillations (13-29 
Hz) were also characterised by continuous oscillatory activity and also occur during mental 
activity. These fast oscillations are thought to be responsible for the binding of different 
sub-regions of the brain together (Engel et al., 1991). Theta frequency oscillations are 
involved in exploratory behaviour in vivo (Buzsaki, 2002; Vanderwolf, 1969), and these 
oscillations observed in the EEG are mimicked in hippocampal slices by the application of, 
amongst other things, carbachol (Williams and Kauer, 1997). Slower, continuous 
oscillations, of a frequency of <4 Hz were also observed on occasion. These oscillations 
were designated delta frequency oscillations and were identified as a sinusoidal waveform, 
as for the oscillatory activity detailed above.   
The other oscillations observed throughout this thesis were likely to be indicative of 
pathophysiological states in slices. The ictal activity observed in slices (see fig 3.1 B) is 
characterised by several seconds of oscillatory activity followed by periods of quiescence 
and are reminiscent of EEG recordings and field recordings that are made in vivo during 
seizure activity. Inter-ictal events, characterised by large positive and negative field 
deflections in vitro (Rutecki et al., 1987), are reminiscent of the events observed between 
seizures in EEG recordings from epileptic patients. These events, with a frequency of John Broad, 2008     Chapter 3 51 
occurrence of <2 Hz, differed from the ‘delta’ oscillations as they were independent events 
as opposed to a sinusoidal oscillation.          
As the hippocampus is arranged in an orthogonal fashion, the connectivity and the 
morphology of the slice differs depending on the orientation in which the slice is made. As 
oscillations depend upon the underlying synaptic connectivity and morphological 
processes of the cells that generate the oscillations, different slice orientations display 
differing oscillation frequency preferences (Gloveli et al., 2005). This chapter investigates 
some of the oscillations generated by the application of kainate and mAChR agonists in 
coronal and parasagittal hippocampal slices.     
Aims 
The aims of this chapter are: 
1.  To investigate the emergent network activities in parasagittal and coronal slices 
induced by application of kainate. 
2.  To compare differences between slice orientations in oscillations induced by 
oxotremorine-M. 
3.  To investigate the effect of applying 77-LH-281, a novel M1 subtype selective mAChR 
agonist, to parasagittal and coronal slices. 
Extracellular field recordings were performed to observe the emergent network oscillatory 
activity induced by the application of the above drugs.  
3.2 Results 
A range of oscillatory activities (examples of which can be seen in figure 3.1) were 
observed in hippocampal slices of either the coronal or parasagittal slices response to the 
application of kainate and the mAChR agonists. The major results are summarised in the 
other three following figures.  John Broad, 2008     Chapter 3 52 
 
Fig 3.1 Trace examples of oscillations in the hippocampus
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examples showing (i) ictal-like epileptiform activity and (ii) inter-ictal like events.
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3.2.1 Kainate-induced oscillations 
Application of the glutamate receptor agonist kainate to hippocampal slices led to different 
modes of oscillatory electrical activity depending on the orientation of the hippocampal 
slice. Application of 400 nM kainate to hippocampal slices prepared in the sagittal 
orientation led to the emergence of a regular inter-ictal-like bursting activity in the 
majority of slices tested (67%, n = 29/43 of slices, mean burst frequency = 1.91  ± 0.12 Hz 
[S.E.M.]).  
Whilst inter-ictal-like bursting represented the predominant form of activity, other less 
common modes of oscillatory activity were observed including rhythmical field potential 
oscillations in the gamma (mean frequency = 31.6 ±1.3 Hz, 26 %, n = 11 of 43 slices) and 
theta (mean frequency = 7.4 ± 1.6 Hz, 7%, n =3 of 43 slices) frequency ranges. This 
distribution of oscillatory responses is summarised in figure 3.2.1 D 
In comparison to responses seen in parasagittal slices, application of 400 nM kainate to 
hippocampal slices prepared in the coronal orientation led to emergent network oscillatory 
activity mainly in the gamma frequency range (71%, n = 27/38 of slices; mean frequency = 
31.46 ± 1.15 Hz). In addition to gamma frequency oscillations, 400 nM kainate was less 
commonly found to generate a range of other oscillatory activities including an inter-ictal-
like response (21%, 8/38 of slices; mean frequency = 2.0 ± 0.3 Hz), theta frequency 
network oscillatory activity (5%, 2/38 of slices; mean frequency = 6.3 ± 2.4 Hz) and beta 
frequency activity (2.5%, 1/38 of slices; frequency = 17.5 Hz) as indicated in figure 
3.2.1.D. 
3.2.2 Oxotremorine-M induced oscillatory activity  
Application of the mAChR agonist oxotremorine-M (10 µM) to slices prepared in the 
sagittal orientation led to the emergence of inter-ictal-like oscillatory events in the majority 
of slices tested (62.5%, 10/16 of slices; mean frequency = 0.396 ± 0.086 Hz; figure 3.2.2 
A).  Ictal-like events were observed in a subset (37.5%, 6/16) of slices. Both ictal-like and 
inter-ictal-like activities were sensitive to subsequent application of the specific mAChR 
antagonist atropine (10 µM) confirming the role of mAChRs in this activity.   John Broad, 2008     Chapter 3 54 
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A. Representative extracellular field recording trace showing (i) the naïve parasaggital hippocampal slice and (ii) 
inter-ictal-like events following the application of 400 nM kainate to the naïve hippocampal slice (inset- expanded 
interictal event). Note there is no emergence of network gamma oscillatory activity. B. Representative field 
recordings showing the (i) the naïve coronal hippocampal slice and (ii) subsequent application of 400 nM kainate. 
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shows the frequency of the oscillation to be at 37 Hz, within the gamma range. D. Bar chart showing the relative 
prevalence of oscillations induced by application of agonists to each slice orientation. Inter-ictal-like events were 
more predominant than gamma frequency oscillations in parasagittal slices, whereas the reverse is true in slices 
prepared in the coronal orientation (n shown in brackets above).
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Fig 3.2.2 Characterisation of the activity induced by the application of 10 µM 
oxotremorine-M to naïve hippocampal slices prepared in the parasagittal and 
coronal orientations
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B
A. Representative extracellular recording trace examples showing (i) the naïve hippocampal parasagittal slice, (ii) 
interictal-like network activity induced by the application of 10 µM oxotremorine-M (inset- expanded interictal event) 
B. Representative trace examples showing (i) naïve slices (ii) ictal-like activity following application of 10 µM 
Oxotremorine-M (inset- expanded trace) C. Bar chart showing the relative distribution of emergent network activity 
following application of 10 µM oxotremorine to slices prepared in parasagittal and coronal orientations. Inter-ictal-like 
activity was the dominant emergent oscillatory activity in parasagittal slices, whereas a wide range of oscillations 
occurred following application of oxotremorine in coronal slices. 
Control + 10 µM Oxotremorine
1 mV
30 s
(i) (ii)
C
Parasagittal
Coronal
0
20
40
60
80
100
Gamma
Beta
Ictal
Inter-ictal
(16) (20)
%
 
o
f
 
s
l
i
c
e
s
Fig 3.2.2 Characterisation of the activity induced by the application of 10 µM 
oxotremorine-M to naïve hippocampal slices prepared in the parasagittal and 
coronal orientations
Control + 10 µM Oxotremorine
0.25mV
5 s
0.25mV
0.5 s
(i) (ii)
(iii)
A
B
A. Representative extracellular recording trace examples showing (i) the naïve hippocampal parasagittal slice, (ii) 
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In contrast oxotremorine-M more regularly induced ictal-like activity in slices made in the 
coronal orientation than in the parasagittal orientation. The most common types of 
oscillatory activity observed in slices made in the coronal orientation following application 
of 10 µM oxotremorine-M were ictal-like activity (55%, 11/20 of slices, 10.6 ± 1.0 Hz) 
and inter-ictal-like activity (30%, 6/20 of slices, 1.14 ± 0.43 Hz). Subsequent application of 
10 µM atropine or the AMPA/kainate receptor antagonist NBQX (2 µM) or led to an 
attenuation of the ictal-like and inter-ictal-like activity induced by oxotremorine-M. 
Interestingly, in the presence of the M1 mAChR irreversible antagonist MT-7, application 
of oxotremorine-M led to the emergence of ictal-like activity in the majority (66 %, 4/6) of 
slices tested. This indicates the M1 mAChR is not necessary for the emergence of 
oxotremorine-induced oscillations.    
3.2.3 The effect of 77-LH-281 on naïve hippocampal slices 
The specific M1 mAChR agonist 77-LH-281 induced gamma frequency network activity in 
the majority (64%, 7/11) of coronal hippocampal slices but had no effect in parasagittal 
hippocampal slices (see fig 3.2.3). The mean frequency of the observed gamma oscillations 
was 36.6 ± 1.9 Hz following application of 77-LH-281. These oscillations were abolished 
in the majority (73%, 8/11) of slices by the subsequent application of 2 µM NBQX. No 
gamma frequency activity was observed in all (12/12) slices made in the parasagittal 
orientation following application of 10-100 µM 77-LH-281. Subsequent application of 10 
µM oxotremorine-M induced either inter-ictal or ictal-like activity in all 12 parasagittal 
slices tested.  
3.3 Discussion  
The main findings of this chapter are as follows: 
1.  Both kainate and mAChR agonists display differential oscillations depending on 
slice orientation. 
2.  Kainate and oxotremorine-M can induce pathophysiological epileptiform-like 
oscillatory activity, whereas the selective M1 mAChR agonist only induces 
physiological activities.  
3.  Slices prepared in the coronal orientation are more prone to display activity within 
the theta, beta and gamma ranges than slices prepared in the parasagittal 
orientation.John Broad, 2008     Chapter 3 57 
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It is likely that the difference in cellular and network connectivity between coronal and 
parasagittal slices underlies the difference in oscillatory activity initiated by drug 
application to these slices. 
Kainate 
Initially the differing effect of nanomolar concentrations of kainate upon hippocampal 
slices prepared in the coronal and parasagittal orientations was investigated. Kainic acid is 
a highly potent agonist at GluR 5-7 and KA1 and 2 receptors (Dingledine et al., 1999).  
Activation of kainate receptors leads to EPSCs in both pyramidal cells (Castillo et al., 
1997) and interneurones (Frerking et al., 1998) and can pre-synaptically reduce the release 
of GABA from interneurones (Rodriguez-Moreno et al., 1997). In coronal slices 
application of kainate leads to gamma frequency oscillatory activity (Fisahn et al. 2004; 
Fisahn 2005) in both the entorhinal cortex (Cunningham et al., 2003) and the hippocampal 
formation (Mann and Paulsen, 2005). The oscillation is maintained in the presence of 
AMPA receptor antagonists but abolished following application of the GABAA receptor 
antagonist bicuculline (Fisahn 2005).  
 
Basket cell interneurones innervate the somatic regions of pyramidal cells and other basket 
cells (Cobb et al., 1997). These interneurones can pace gamma frequency oscillations due 
to the existence of mutual fast synaptic inhibition between basket cells (Bartos et al., 2002; 
Mann et al., 2005). The interneurone network is well placed to regulate oscillatory activity 
as the extensive axonal arborisation of basket cells can provide large numbers of principal 
cells with synchronous inhibition at the frequency within the gamma range (Penttonen et 
al., 1998). The gamma frequency oscillations that are observed in the coronal sections are 
likely to be controlled by the perisomatic targeting interneurones like the basket cells, as 
they have extensive arborisations within the transverse plane (Gloveli et al., 2005). The 
absence of an extensive O-LM interneurone axonal arborisation in the transverse plane 
allows the oscillation frequency to be controlled by the basket cells.  
In a small proportion of coronal slices gamma frequency oscillatory activity could be 
observed on occasion in the absence of applied compounds. This occurred only 1-1½ hours 
following the preparation of slices. As such, it is likely that glutamate released during the 
slicing process is able to initiate these oscillations. This type of oscillation has been shown 
to be mediated by a mechanism that is distinct from the kainate-induced oscillation John Broad, 2008     Chapter 3 59 
(Pietersen et al, 2009), calling into question which oscillation best represents the in vivo 
situation.  
In parasagittal slices, application of kainate does not induce gamma frequency network 
oscillations in the majority of slices. The principal emergent oscillatory activity is inter-
ictal-like activity, with a mean frequency of ~2 Hz. This activity is clearly different from 
the gamma frequency oscillatory activity observed following application of kainate to 
coronal slices. An extensive OLM interneurone arborisation is present in slices prepared in 
the parasagittal direction (Gloveli et al., 2005). The OLM interneurones display a distinct 
frequency preference for rhythmic slow oscillations (Pike et al., 2000).  Thus, the larger 
arborisations of OLM cells that are present in parasagittal slices as opposed to coronal 
slices means that the parasagittal slices display slow ictal-like activity preferentially to 
gamma frequency oscillatory activity. Comparison of intracellular recordings from basket 
cell and OLM interneurones in both orientations may provide a clearer indication of the 
role of these interneurones in the inter-ictal-like and gamma frequency oscillations that 
emerge following the application of kainate. Pairing these recordings with recordings from 
pyramidal cells would allow further insight into role interneurones play in pacing 
oscillation frequency.    
Acetylcholine  
Acetylcholine receptors, comprising nicotinic and muscarinic receptors, are widely 
expressed within the hippocampus (Fabian-Fine et al., 2001; Levey et al., 1995). The 
network activity that emerged from the slices following application of muscarinic agonists 
was dependent on both the mAChRs activated by the agonists and the orientation of the 
slice used.  
Oxotremorine-M shows little functional selectivity between the 5 subtypes of muscarinic 
receptors (Birdsall et al., 1978; Kukkonen et al., 1996). In coronal slices application of 
oxotremorine-M mainly led to the emergence of ictal-like activity, whereas in parasagittal 
slices inter-ictal activity is the dominant oscillation. Ictal-like oscillatory activity is well 
described in the hippocampus both in vivo (Colom et al., 1991) and in vitro (Fellous and 
Sejnowski, 2000; Fischer et al., 1999; Traub et al., 1992). 
Ictal activity is characterised by periods of oscillatory activity followed by quiescence. 
During ictal events, pyramidal cells discharge strongly and GABAergic inhibition from 
interneurones is reduced, either through the depolarisation block of the interneurones John Broad, 2008     Chapter 3 60 
(Ziburkus et al., 2006), or by depolarising GABAergic synaptic transmission following a 
reversal of the chloride gradient (Isomura et al., 2003). The afterdischarge potential which 
occurs following tetanic stimulation is used as one model of ictal events. In this model 
GABAergic synaptic transmission becomes excitatory, and the depolarising GABAergic 
EPSPs are synchronised with pyramidal cell discharge (Fujiwara-Tsukamoto et al., 2003). 
In contrast, in a model of drug induced ictal events, depolarisation block of interneurones 
occurs throughout the ictal-like episodes, with a return of interneurone activity implicated 
in the termination of the ictal-like event (Ziburkus et al., 2006).  
mAChR agonists display a differential effect on the hippocampal pyramidal cells and 
interneuronal subtypes, which allows the emergence of ictal-like activity. Hippocampal 
pyramidal cells are depolarised to threshold by the application of mAChR agonists (Cole 
and Nicoll, 1984a),  following which they undergo a cycle of depolarisation and 
hyperpolarisation (Williams and Kauer, 1997). Lacunosum moleculare interneurones are 
directly depolarised by mAChR activation, which also induces voltage dependent 
oscillations in these neurones (Chapman and Lacaille, 1999). Other interneurones, 
including basket cells, can be depolarised, hyperpolarised, or unresponsive following 
mAChR activation (Widmer et al., 2006)    
For a difference in the propensity of different oscillations to emergence occur between 
slice orientations, there must be an underlying difference in the neurones that pace the 
oscillatory activity. As described previously, the OLM interneurones are the primary 
pacemaker neurone of the parasagittal slices, whereas the basket cell interneurones are the 
dominant pacemaker cell of the coronal slices (Gloveli et al., 2005). Following tetanic 
stimulation OLM interneurones hardly discharge during the afterdischarge potential, 
whereas fast spiking cells, including basket cells and chandelier cells, show spiking that is 
synchronous with pyramidal cell firing (Fujiwara-Tsukamoto et al., 2004). This 
mechanism could readily explain the different propensities of the emergence of ictal-like 
events for each slice orientation.   
However, the ictal like activity that emerges following application of mAChR agonists is 
likely to differ from that which emerges following tetanic stimulation. In a contrasting 
model of ictal events, following application of 4-AP profound depolarisation block of 
interneurones is observed during ictal episodes (Ziburkus et al., 2006). As the majority of 
interneurones recorded in this study were OLM interneurones, this finding does not 
directly contradict the above hypothesis. It is possible that fast spiking interneurones do not 
undergo depolarisation block to the same extent as OLM interneurones, allowing the John Broad, 2008     Chapter 3 61 
basket cells to continue to set the dominant oscillatory frequency. It is also possible that 
basket cells (amongst other interneurones) are required only for the initiation of ictal 
events. Thus in coronal slices the extensive arborisations of basket cells can initiate ictal 
events prior to undergoing depolarisation block, whereas in the parasagittal slices the 
decreased abundance of basket cell arborisations decreases the likelihood of ictal episodes. 
Paired recordings of basket cells and pyramidal cells during ictal and inter-ictal events in 
each plane would provide further insight into the cellular mechanisms of this activity.   
The ictal-like oscillation occurs predominantly within the theta frequency range, and this 
frequency is likely to be predominantly dependent on the intrinsic membrane properties of 
the pyramidal cells. This contrasts the classical theta model (Buzsaki 2002) in which 
phasic cholinergic excitatory and GABAergic inhibitory projections from the medial 
septum-diagonal band of broca (MS/DBB) control the output of basket cell interneurones, 
leading to phasic inhibition of pyramidal cells. This combined with the depolarisation of 
pyramidal cell dendrites by mAChRs and excitatory drive from the perforant path leads to 
the emergence of theta frequency oscillations. Interneuronal inhibition is removed by either 
the depolarisation block of interneurones during ictal events, or the reversal of the chloride 
gradient. The emergence of theta frequency oscillatory activity must arise from the 
intrinsic pyramidal cell properties or possibly from depolarising GABAergic events. 
Indeed, pyramidal cells display a resonant frequency within the theta frequency range 
(Pike et al., 2000).   
The M1 mAChR induced gamma frequency rhythm is similar in frequency to the kainate-
induced rhythm. However, in the majority of slices the cholinergic induced gamma 
frequency rhythm is dependent upon both fast phasic excitation and phasic inhibition, and 
can be stopped by the blockade AMPA/kainate receptors (Mann et al., 2005). Kainate 
induced oscillatory activity has previously been shown to be independent of fast 
glutamatergic transmission (Bartos et al., 2007; Fisahn et al., 2004). In the CA3 region, 
kainate receptors are expressed on interneurones (Fisahn 2005), and depolarisation of these 
interneurones following application of nanomolar concentrations of kainate leads to the 
emergence of the mutual basket cell-basket cell interactions that underlie gamma 
frequency oscillatory activity (Hajos et al., 2004). In contrast, the cholinergically initiated 
gamma frequency oscillation is dependent on phasic excitatory drive as the M1 mAChRs 
are primarily located upon pyramidal cells (Rouse et al., 1999). Therefore fast excitatory 
transmission from the pyramidal cell network appears to be required to drive the 
oscillation. However, in a minority of slices, gamma frequency oscillatory activity 
occurred following application of AMPA/kainate receptor antagonists. It is possible that John Broad, 2008     Chapter 3 62 
once AMPA/kainate receptors have initiated the oscillation, recurrent inhibition is able to 
carry the oscillation. However, in a highly active network a large amount glutamate release 
occurs (Szerb, 1984). In this case a competitive antagonist (like NBQX used in this study) 
may be overcome by increased amount of glutamate. In this case an increased 
concentration may have completely abolished gamma frequency oscillations. 
Application of the M1 mAChR specific agonist 77-LH-281 leads to gamma frequency 
oscillatory activity in coronal hippocampal slices but not in parasagittal slices. The slice 
orientation determines the predominant interneurone axonal arborisation. The arborisation 
of the basket cells in the coronal slices are ideally suited to pace gamma frequency 
oscillatory activity, whereas the predominant interneurones in the parasagittal slices are the 
OLM cells and these have a frequency preference of low theta frequency ranges (Pike et 
al., 2000). Thus selective M1 agonists may not produce oscillatory activity in parasagittal 
slices due to the absence of enough basket cell-basket cell recurrent synaptic connections 
to allow the emergence of gamma frequency activity.  
3.4 Conclusion 
In this chapter an attempt was made to investigate the effect of application of a range of 
compounds in both parasagittal and coronal hippocampal slices. The orientation of the 
slice had profound effects on the emergent activity that arose from the networks within the 
slices. It is likely that the different arborisations within the interneurone networks in the 
different slices underpin this change in network activity. Coronal slices are more 
conducive in allowing the emergence of network oscillatory activity in the theta, beta and 
gamma frequency ranges, whereas parasagittal slices tend to display slower oscillations. 
As the coronal slices displayed a higher propensity to display oscillatory activities, this 
orientation was used for the remainder of this thesis.  
Also, in comparison with oxotremorine-M, application of the M1 mAChR agonist 77-LH-
281 does not promote pathophysiological oscillatory activity in naïve hippocampal slices 
of either orientation, but rather promotes gamma frequency oscillations. Gamma frequency 
oscillations are thought to be important in cognitive function (Slobounov et al., 2000; 
Tallon-Baudry and Bertrand, 1999; Tallon et al., 1995), and therefore compounds like 77-
LH-281 that promote gamma frequency oscillations have the potential to enhance 
cognition.       63 
4  The effect of mAChR agonists on 
hippocampal neurophysiology
 John Broad, 2009     Chapter 4, 64 
4.1 Introduction  
In this chapter, two mAChR agonists are investigated in a range mechanistically 
distinct epileptiform models. These agonists are oxotremorine-M, a non-subtype 
selective mAChR agonist, and 77-LH-281, an M1 mAChR selective agonist. The 
effect of these agonists on different models allows the evaluation and comparison of 
the pro-epileptiform potential of these agonists, as well as mechanistic insight into the 
mode of action of oscillations induced by mAChR agonists. 
Compounds that promote cholinergic signalling are of interest in potential cognitive 
enhancement strategies for several reasons. The cholinergic system can enhance 
learning and memory within the hippocampus mostly through the activation of 
mAChRs (Bartus et al., 1982; Fibiger, 1991; Nilsson et al., 1992). Conversely, 
mAChR antagonists like scopolamine and atropine can disrupt hippocampal 
mnemonic processes (Grauer and Kapon, 1996; von Linstow Roloff et al., 2007). 
Enhancing cholinergic signalling is used clinically as prolonging ACh action at the 
synapse through the use of acetylcholinesterase inhibitors (such as rivastigmine or 
donepazil) improves cognitive performance in Alzhiemer’s disease (Perry et al., 
1985).  An approach to ameliorate the cognitive impaiment associated with 
schizophrenia using mAChR agonists has also been proposed (Friedman, 2004).  
It has been suggested that the M1 mAChR is primarily involved in mediating 
alterations in learning and memory (Hunter and Roberts, 1988; Messer et al., 1990). 
Studies have also shown the application of a functionally selective M1 mAChR 
receptor agonist, sabcomeline, significantly improved reversal learning in marmosets 
(Harries et al., 1998). As such, enhancement of mAChR activity though specific M1 
mAChR receptor agonism is a potential therapeutic strategy to develop novel 
nootropic drugs.   
Activation of cholinergic projections from the medial septum/diagonal band of Broca 
initiates oscillatory activity in the hippocampus (Brazhnik and Fox, 1999) which can 
be mimicked by application of cholinergic agonists like carbachol directly to the 
hippocampal formation. Application of carbachol promotes theta frequency 
oscillatory activity in vivo (Bland et al., 1994) and in vitro (Chapman and Lacaille, John Broad, 2009     Chapter 4, 65 
1999; Williams and Kauer, 1997), which enhances synaptic plasticity in CA1 
pyramidal neurones (Huerta and Lisman, 1993). Theta frequency oscillatory activity 
occurs during exploratory states in rodents (Vanderwolf, 1969) and hippocampal 
place cells (which encode spatial memory) discharge in relation to an underlying theta 
frequency oscillation (O'Keefe and Recce, 1993).  
Aside from the pro-cognitive potential of mAChR agonists, activation of mAChRs is  
pro-epileptogenic (Cobb et al., 1999; MacVicar and Tse, 1989; Williams and Kauer, 
1997). Application of pilocarpine, a mAChR agonist, can cause seizure activity in 
vivo (Cavalheiro et al., 1991). Epileptiform activity can be induced in hippocampal 
slices following the application of mAChR agonists (Egorov et al., 2003; Nagao et al., 
1996) and disinhibition-induced epileptiform activity is enhanced by the 
acetylcholinesterase inhibitor physostigmine (Gruslin et al., 1999). Epileptiform 
activity can be induced in hippocampal slices through the blockade of the mAChR 
sensitive K
+ current (IM) in hippocampal slices (Pena and Alavez-Perez, 2006). It is 
therefore important to investigate the pro-epileptogenic potential of the novel specific 
M1 mAChR subtype selective agonist 77-LH-281 (Langmead et al., 2008).      
The major aim of this chapter is to investigate the effect of application of 
oxotremorine-M and 77-LH-281 on four mechanistically distinct models of 
epileptiform activity. The effect of application of oxotremorine-M and 77-LH-281 on 
the intrinsic electrical properties of CA1 pyramidal cells and excitatory synaptic 
transmission will also be investigated. The effect of oxotremorine-M and 77-LH-281 
on naïve slices is shown in the preceding chapter.  
Extracellular and intracellular electrophysiological recordings from coronal 
hippocampal slices are performed to determine the pro-epileptiform potential of M1 
selective and non-subtype selective mAChR agonists, and allow insight into the 
oscillations induced by mAChR agonists.    John Broad, 2009     Chapter 4, 66 
4.2 Emergent network activity in the hippocampus 
and its modulation by mAChR agonists 
The effects of the mAChR agonists oxotremorine-M and 77-LH-281 on experimental 
models of epileptiform activity were investigated. Four different epileptiform models 
were used: a 4-AP-induced block of K
+ currents; a bicuculline-induced block of the 
GABAA receptor, alongside a raised extracellular [K
+]o to 5 mM; the removal of Mg
2+ 
ions from the extracellular medium, ACSF, to remove the voltage-dependent 
magnesium site block of the NMDA receptor channel; and the combined use of 4-AP 
to activate the network and NBQX to reduce AMPA/kainate mediated ionotropic 
glutamatergic synaptic transmission.  
4.2.1 The 4-AP-induced network activity model 
Application of 20 µM 4-AP led to inter-ictal-like epileptiform activity in coronal 
hippocampal slices (Fig 4.2.1). Inter-ictal-like events started to appear with a latency 
of 8.0 ± 1.8 minutes (mean ± S.E.M., n = 11) after the initial application of 4-AP. 
Following the initial inter-ictal-like event, there was a gradual increase in the inter-
ictal-like event frequency, as shown by fig 4.2.1 B.  The frequency of inter-ictal 
events stabilised approximately 30-40 minutes after application of 20 µM 4-AP, with 
a mean event frequency of 1.02 ± 0.02 Hz (n = 12) 40 minutes after 4-AP application. 
The rate of change in frequency after 40 minutes does not differ significantly from 
zero (P = 0.95, r
2 = 0.00007).  
4.2.2 Oxotremorine-M is pro-epileptogenic in the 4-AP 
epileptiform model 
Application of 10 µM oxotremorine-M to 20 µM 4-AP-induced inter-ictal-like events 
led to the emergence of ictal-like bursting events in the majority (80%, 8/10) of slices 
with a mean occurrence frequency of 0.17 ± 0.06 Hz.  John Broad, 2009     Chapter 4, 67 
Fig 4.2.1 The response of naïve coronal hippocampal slices to the application of 4-
amino pyridine (4-AP)
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A. Representative trace example showing the emergence of regular inter-ictal-like activity 5-10 minutes after application 
of 20 µM 4AP to coronal hippocampal slices. This oscillation persists regularly for over 90 minutes. Expanded trace- it 
can be seen that in this example the rate of inter-ictal-like activity is approximately 0.5 Hz. Inset- an example of a 4AP-
induced inter-ictal-like event. B. Pooled frequency data from 12 hippocampal slices. It can be seen that the frequency of 
inter-ictal-like events stabilises 30-50 minutes after application of 20 µM 4-AP.  
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Fig 4.2.2 Investigation into the effect of the application of 10 µM oxotremorine-M 
on 4-AP-induced inter-ictal-like activity
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A. Representative trace example showing (i) inter-ictal-like activity induced by the application of 20 µM 4-AP, (ii) 
subsequent application of 10 µM oxotremorine-M and (iii) wash out of the 10 µM oxotremorine-M. Regular inter-ictal-like 
activity (~0.5 Hz (i)) is converted into ictal-like events, with an intra-burst oscillation frequency of 11 Hz, following the 
application of oxotremorine-M. B. Summary histogram showing oxotremorine-M induces a significant increase in inter-
ictal-like frequency before the activity changes to ictal-like activity. C. Trend chart showing the effect of 10 µM 
oxotremorine-M application on 20 µM 4AP-induced activity. As can be seen, of the 10 slices displaying inter-ictal-like 
activity, the majority (8) display ictal-like activity following oxotremorine-M application.  
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Prior to the change in mode of activity induced by oxotremorine-M application, the 
agonist initially caused a significant (P = 0.039) increase (0.56 ± 0.10 to 0.92 ± 0.20 
Hz, n = 8) in the inter-ictal-like event frequency (fig 4.2.2 B) before the activity 
changed to ictal-like activity. The oscillatory frequency within the episodes lies within 
the theta frequency range (9.54 ± 0.70 Hz). 
4.2.3 77-LH-281 has no effect on 4-AP-induced network 
activity 
Next the effect of the M1 mAChR selective agonist 77-LH-281 on 4-AP induced 
activity was investigated in order to elucidate the role of the M1 receptor in the 
mAChR-induced ictal-like activity. In contrast to the effect of 10 µM oxotremorine-
M, application of 77-LH-281 (10 µM) did not change the mode, or frequency, of 4-
AP-induced epileptiform activity. The summary histogram in fig 4.2.3 B shows 
application of 10 µM 77-LH-281 did not cause a significant change (P = 0.17) in the 
frequency of inter-ictal-like events induced by the application of 20 µM 4-AP (0.62 ± 
0.08 to 0.72 ± 0.10 Hz, n = 11). The trend chart (fig 4.2.3 C) shows the majority 
(93%, 14/15) of slices do not display a change in the mode of activity following 
application of 10 µM 77-LH-281. 100 µM 77-LH-281 also did not change the mode 
or frequency of the observed network activity. Mechanistically distinct models of 
epileptiform activity were used to investigate further the oscillations induced by 
mAChR agonists.  
4.2.4 Bicuculline-induced network activity 
Figure 4.2.4 shows the effect of 20 µM bicuculline on coronal hippocampal slices. 
The inter-ictal-like activity induced by application of bicuculline, a GABAA receptor 
antagonist, had a much lower frequency than the frequency of inter-ictal-like activity 
induced by the application of 20 µM 4-AP. A raised [K
+]o (5 mM) in the circulating 
ACSF was used to increase the frequency of inter-ictal-like events towards the 
frequency of inter-ictal-like events induced by application of 20 µM 4-AP.  John Broad, 2009     Chapter 4, 70 
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A. Representative trace showing (i) inter-ictal-like bursting induced by 20 µM 4-AP (inset- single inter-ictal-like 
burst) (ii) the effect of subsequent application of the M1 mAChR agonist 77-LH-281 (10 µM) on this activity 
(inset- single inter-ictal-like burst) and (iii) wash out of 77-LH-281. B. Summary histogram showing there is no 
significant change in inter-ictal-like event frequency. No overt change in oscillatory activity from inter-ictal-like 
activity is observed, as shown in the trend chart (C) in which only 1 of the 15 slices displaying inter-ictal-like 
activity display ictal-like activity following application of 10 µM 77-LH-281. 
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Fig 4.2.4 The effect of application of 20 µM bicuculline (+ 5 mM K+) to naïve 
hippocampal slices
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A. Representative trace example showing the effect of 20 µM bicuculline (+5 mM K+) on naïve hippocampal slices. 
10-15 minutes after 20 µM bicuculline (+5 mM K+) application inter-ictal-like activity appears. The frequency of 
inter-ictal-like events increases with time. Expanded trace (ii)- in this example it can be seen that the event 
frequency is approximately 0.3-0.4 Hz. Inset (iii)- note the change in the inter-ictal-like event from the 4-AP 
induced event (see fig 4.2.1). B. Time-frequency plot showing the mean (± S.E.M.) inter-ictal-like activity (n = 9) 
increases in frequency until it stabilises between 30-40 mins post bicuculline application.
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Despite the increased [K
+]o the inter-ictal-like event frequency induced by 20 µM 
bicuculline is lower than the inter-ictal frequency induced by 20 µM 4-AP. Inter-ictal-
like events started to appear with a mean latency of 8.4 ± 1.6 minutes (n = 9) 
following bicuculline application, with characteristic positive and negative voltage 
deflections (fig 4.2.4 A). The time frequency plot illustrated in fig 4.2.4 B shows the 
mean oscillatory frequency as bicuculline washed into the slice. There was a sharp 
increase in inter-ictal-like event frequency over the initial 10-20 minutes following 
bicuculline application, before the frequency of events stabilised after 40 minutes 
(0.23 ± 0.01 Hz, n = 9) with no significant change in the frequency of inter-ictal-like 
events after this rime point (P = 0.70, r
2 = 0.004). 
4.2.5 Oxotremorine-M is pro-epileptogenic in the bicuculline 
epileptiform model 
Application of 10 µM oxotremorine-M to hippocampal slices displaying bicuculline-
induced inter-ictal-like activity changed the mode of activity from inter-ictal-like 
activity to ictal-like activity in the majority of slices tested (83%, 5/6 slices) with a 
mean occurrence frequency of 0.12 ± 0.03 Hz. The frequency of the oscillation within 
the ictal-like event was predominantly within the theta frequency range (mean = 12.65 
± 0.44 Hz). There was a significant (P = 0.0078) increase in the inter-ictal-like event 
frequency following addition of 10 µM oxotremorine-M (0.22 ± 0.06 to 0.69 ± 0.19 
Hz, n = 9) (see fig 4.2.5.B), prior to the emergence of ictal-like activity. Inter-ictal-
like activity re-emerged upon wash out of oxotremorine-M. 
4.2.6 77-LH-281 increases bicuculline-induced inter-ictal-like 
event frequency 
The effect of the application of the M1 mAChR subtype selective agonist 77-LH-281 
on bicuculline induced inter-ictal-like activity was then investigated to allow the 
elucidation of the role of the M1 mAChR subtype in the mAChR induced ictal-like 
activity. Application of 10 µM 77-LH-281 to bicuculline induced inter-ictal-like 
events caused a significant (P = 0.027) increase in the frequency (0.16 ± 0.02 to 0.27 
± 0.03 Hz, n = 18) of inter-ictal-like events. This effect was not reversible upon wash 
out of 10 µM 77-LH-281 (0.24 ± 0.03 to 0.26 ± 0.03 Hz, n = 10, fig 4.2.6.B).  John Broad, 2009     Chapter 4, 73 
Fig 4.2.5 Investigation into the effect of application of 10 µM oxotremorine-M on 
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A. Representative trace showing (i) inter-ictal-like activity induced by 20 µM bicuculline (+ 5 mM K+) (inset-inter-
ictal-like event), (ii) the effect of the application of 10 µM oxotremorine-M on bicuculline-induced inter-ictal-like 
activity (inset- ictal-like event) and (iii) wash out of oxotremorine-M (inset-inter-ictal-like event). B. Summary 
histogram showing a significant increase in the frequency of inter-ictal-like events in response to the application of 
10 µM oxotremorine-M prior to changing the mode of activity to ictal-like activity. C. Trend chart showing the 
effect of 10 µM oxotremorine-M on inter-ictal-like activity induced by 20 µM bicuculline (+ 5 mM K+). 5 of 6 
slices displaying inter-ictal-like activity displayed ictal-like activity following application of 10  M oxotremorine-
M.   
Fig 4.2.5 Investigation into the effect of application of 10 µM oxotremorine-M on 
inter-ictal-like activity induced by 20 µM bicuculline (+ 5 mM K+)
A
B C
Ictal
Inter-ictal-like
Ictal
Inter-ictal-like
10  M Oxotremorine-M
1
5
+ 10 µM Oxotremorine-M 20 µM Bicuculline (+ 5 mM K+) wash out
1 mV
0.1 s
2mV
10s
1 mV
2 s
20 mM Bicuculline
+ 10 mM Oxo-M
0.00
0.25
0.50
0.75
1.00 *
n = 9
F
r
e
q
u
e
n
c
y
 
(
H
z
)
(i) (ii) (iii)
1 mV
0.1 s
A. Representative trace showing (i) inter-ictal-like activity induced by 20 µM bicuculline (+ 5 mM K+) (inset-inter-
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Fig 4.2.6. Investigation into the effect of application of 10 µM 77-LH-281 on 
20 µM bicuculline (+5 mM K+)-induced inter-ictal-like activity
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A. Representative trace showing (i) 20 µM bicuculline (+5 mM K+)-induced oscillatory activity (inset- single inter-
ictal-like event), (ii) the effect of subsequent application of the M1 specific agonist 77-LH-281 (10 µM) on 20 µM 
bicuculline (+5 mM K+)-induced inter-ictal-like activity (inset- single inter-ictal-like event) and (iii) wash out of 77-
LH-281 (inset- inter-ictal-like event). B & C. Summary histograms showing the effect the effect of the application 
of 10 µM 77LH281 on bicuculline (+5 mM K+)-induced interictal-like activity. There is a significant increase in the 
frequency of interictal-like activity induced by the application of 10 µM 77-LH-281 Note this effect is not 
reversible upon wash out of 77-LH-281 (B), or when all mAChRs are blocked by the mAChR antagonist atropine 
(C). D. Trend chart showing application of 10 µM 77-LH-281 to 20 µM bicuculline (+5 mM K+)- induced inter-
ictal-like activity did not change the mode of activity into ictal-like activity in 20 of 22 slices.
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A. Representative trace showing (i) 20 µM bicuculline (+5 mM K+)-induced oscillatory activity (inset- single inter-
ictal-like event), (ii) the effect of subsequent application of the M1 specific agonist 77-LH-281 (10 µM) on 20 µM 
bicuculline (+5 mM K+)-induced inter-ictal-like activity (inset- single inter-ictal-like event) and (iii) wash out of 77-
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of 10 µM 77LH281 on bicuculline (+5 mM K+)-induced interictal-like activity. There is a significant increase in the 
frequency of interictal-like activity induced by the application of 10 µM 77-LH-281 Note this effect is not 
reversible upon wash out of 77-LH-281 (B), or when all mAChRs are blocked by the mAChR antagonist atropine 
(C). D. Trend chart showing application of 10 µM 77-LH-281 to 20 µM bicuculline (+5 mM K+)- induced inter-
ictal-like activity did not change the mode of activity into ictal-like activity in 20 of 22 slices.John Broad, 2009     Chapter 4, 75 
Only a small subset (8.3%, 2/24) of slices displayed ictal-like activity following 
addition of 10 µM 77-LH-281. In order to investigate further the irreversibility of 10 
µM 77-LH-281 induced frequency potentiation upon wash out, 10 µM atropine (a 
non-selective mAChR antagonist) was subsequently applied to slices (fig 4.2.6.C). 
Atropine did not significantly reverse (0.31 ± 0.05 to 0.29 ± 0.10 Hz, P = 0.46, n = 8) 
the increase in inter-ictal-like event frequency induced by application of 10 µM 77-
LH-281 suggesting M1 mAChR activation leads to a potentiation of inter-ictal-like 
event frequency that is not dependent on continuous M1 mAChR activation.  
4.2.7 Low extracellular magnesium-induced network activity  
The effect of removing Mg
2+ ions from the extracellular bathing medium was to 
induce inter-ictal-like events (fig 4.2.7) as previously reported (Tancredi et al., 1990; 
Traub et al., 1994). Removal of Mg
2+ ions relieves the voltage-dependent block of the 
NMDA receptor, which leads to an increase in excitability of the network. The inter-
ictal-like events appeared after 13.0 ± 2.6 minutes (n = 8) and there was no 
statistically significant change the frequency of the events after 40 minutes (fig 
4.2.7.B, P = 0.62, r
2 = 0.007). The mean frequency following this point was 0.18 ± 
0.01 Hz, indicating the frequency of the events is slower than both the 4-AP and 
bicuculline induced events. As inter-ictal-like events in the low extracellular 
magnesium took on average longer to appear and stabilise than the 4-AP and 
bicuculline-induced events, at least 60 minutes following removal of Mg
2+ from the 
ACSF were allowed to elapse before further pharmacological experimentation was 
carried out.  
4.2.8 Oxotremorine-M is pro-epileptogenic in the low 
extracellular magnesium epileptiform model 
Application of 10 µM oxotremorine-M to both of the previously studied epileptiform 
models and naïve hippocampal coronal sections predominantly led to ictal-like 
activity. Likewise, application of 10 µM oxotremorine-M to low extracellular 
magnesium-induced inter-ictal-like activity led to a change in the mode of oscillatory 
activity from inter-ictal-like to ictal-like events (11/13 slices tested, fig 4.2.8.C).  John Broad, 2009     Chapter 4, 76 
Fig 4.2.7 Investigation into the effect of low Mg2+ ACSF on naïve hippocampal slices.
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A. Representative trace showing the gradual emergence of inter-ictal-like events 30-40 minutes following the removal of 
Mg2+ ions from the extracellular bathing medium to give a nominally zero extracellular [Mg2+].  Expanded trace- the rate 
of inter-ictal-like activity is approximately 0.2 Hz in this example. Inset- the inter-ictal-like burst event. B Time-frequency 
plot of the mean (± S.E.M.) inter-ictal-like activity (n = 7) following the removal of Mg2+ ions from the extracellular 
bathing medium. Note the stability of the frequency of inter-ictal-like events after 40-50 minutes.
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Fig 4.2.8 Investigation into the effect of the application of 10 µM oxotremorine-M 
on inter-ictal-like activity induced by the removal of Mg2+ from the extracellular 
bathing medium.
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A. Representative trace showing (i) inter-ictal-like activity from hippocampal slices in which extracellular [Mg2+] is 
nominally zero (inset- inter-ictal-like event), (ii) the effect of 10 µM oxotremorine on this inter-ictal-like activity (inset-
ictal-like event), and (iii) wash out of oxotremorine-M (inset- inter-ictal-like event). B. Summary histogram showing a 
significant increase in inter-ictal-like event frequency before the mode of activity changes from inter-ictal-like activity 
to ictal-like activity. C. Trend chart showing the effect of application of 10 µM oxotremorine on inter-ictal-like activity 
induced by low extracellular Mg2+. The majority (11/13) of slices change from inter-ictal-like activity to ictal-like 
activity.  
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on inter-ictal-like activity induced by the removal of Mg2+ from the extracellular 
bathing medium.
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activity.  John Broad, 2009     Chapter 4, 78 
The ictal-like events occurred at a frequency of 0.30 ± 0.08 Hz, and the frequency of 
the oscillatory activity within the ictal-like discharges (mean = 9.44 ± 0.71 Hz) was 
within the theta frequency range. This change from inter-ictal-like to ictal-like events 
was reversed by subsequent wash out of oxotremorine-M or by subsequent 
application of atropine (10 µM). Prior to the occurrence of ictal-like events, the inter-
ictal-like event frequency (fig 4.2.8.B) significantly (P = 0.032) increased (0.61 ± 0.19 
to 0.82 ± 0.22 Hz, n = 11) as 10 µM oxotremorine-M washed into the slice.  
4.2.9 77-LH-281 does not effect low extracellular magnesium-
induced network activity  
The effect of the 77-LH-281 was then investigated in the low magnesium model. 
Unlike the effect of 10 µM oxotremorine-M on low magnesium-induced inter-ictal-
like activity, application of 10 µM 77-LH-281 did not induce ictal-like activity in the 
majority (10/12, see fig 4.2.9 C) of slices tested. Furthermore, application of 10 µM 
77-LH-281 to inter-ictal-like activity induced by low-magnesium conditions did not 
lead to a significant (P = 0.22) change (0.21 ± 0.05 to 0.24 ± 0.05 Hz, n = 8) in the 
frequency of inter-ictal-like activity. Subsequent application of atropine (10 µM) 
reversed the increase (0.24 ± 0.05 to 0.20 ± 0.04, n = 8) in frequency of oscillatory 
activity.  
4.2.10  The 4-AP/NBQX- induced slow inter-ictal-like 
activity model  
In order to investigate further the role of mAChR acetylcholine receptors in the 
physiology of oscillatory network activity, it was decided to investigate the role of 
mAChR activation in a model of reduced excitatory drive. This was achieved by the 
initial application of 4-AP, as for the epileptiform activity model described 
previously, and the subsequent application of the AMPA/kainate receptor antagonist 
NBQX to block AMPA/kainate receptor mediated synaptic transmission in the 
hippocampal slice. Application of 2 µM NBQX caused a significant (P = 0.039) 
decrease in the rate of 50 µM 4-AP-induced inter-ictal-like activity (from 0.43 ± 0.07 
to 0.15 ± 0.04 Hz, n = 8, see fig 4.2.10.B). These events are similar in appearance to 
inter-ictal like events, but occur much less frequently, and are designated slow inter-
ictal-like events henceforth.  John Broad, 2009     Chapter 4, 79 
Fig 4.2.9. Investigation into the effect of the application of 10 µM 77-LH-281 on 
low extracellular Mg2+-induced inter-ictal-like activity
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A. Representative trace examples showing (i) low-extracellular Mg2+ induced inter-ictal-like activity (inset- interictal-
like event) (ii) the effect of the application of 10 µM 77-LH-281 on low-extracellular Mg2+ induced inter-ictal-like 
activity and (iii) the effect of the subsequent application of the mAChR antagonist atropine (10 µM) (inset- interictal-
like event).  B. Summary histogram showing there is no change in inter-ictal-like event frequency upon application of 
10 µM 77-LH-281. C. Trend chart showing the effect of application of 10 µM 77-LH-281 on low-Mg2+-induced 
oscillatory activity. Only 2/12 slices change the mode of activity following application of 10 µM 77-LH-281.  
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A. Representative extracellular trace showing intermittent burst discharges in response to application of 50 mM 4-AP (i). 
Subsequent co-application of the AMPA receptor antagonist NBQX (2 mM) results in a slowing and smoothing of the 
field potential events (ii). Such events were subsequently abolished by application of the GABAA receptor antagonist 
bicuculline in 4/8 slices (iii, 20 mM) suggesting that GABAA mediated synaptic transmission is implicated the events. In 
a number of slices tested (4 of 8) infrequent episodes of field events were noticed (iv) but which occurred at very low 
frequency (every 243 to 746 s, mean 495 s) and were abolished by NMDA receptor antagonist 2-AP5 (v, 50 mM). B. 
Summary histogram and (C), time course scatter plot showing effect of cumulative AMPA, GABAA and NMDA 
receptor blockade on the frequency of 4-AP-induced hippocampal field events. D. Trend chart showing switches in 4-
AP/NBQX network activity upon application of bicuculline. Note that the predominant response is a suppression of the 
slow inter-ictal-like events and the emergence of ictal-like discharges. 
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A. Representative extracellular trace showing intermittent burst discharges in response to application of 50 mM 4-AP (i). 
Subsequent co-application of the AMPA receptor antagonist NBQX (2 mM) results in a slowing and smoothing of the 
field potential events (ii). Such events were subsequently abolished by application of the GABAA receptor antagonist 
bicuculline in 4/8 slices (iii, 20 mM) suggesting that GABAA mediated synaptic transmission is implicated the events. In 
a number of slices tested (4 of 8) infrequent episodes of field events were noticed (iv) but which occurred at very low 
frequency (every 243 to 746 s, mean 495 s) and were abolished by NMDA receptor antagonist 2-AP5 (v, 50 mM). B. 
Summary histogram and (C), time course scatter plot showing effect of cumulative AMPA, GABAA and NMDA 
receptor blockade on the frequency of 4-AP-induced hippocampal field events. D. Trend chart showing switches in 4-
AP/NBQX network activity upon application of bicuculline. Note that the predominant response is a suppression of the 
slow inter-ictal-like events and the emergence of ictal-like discharges. John Broad, 2009     Chapter 4, 81 
Application of 20 µM bicuculline abolished the slow inter-ictal-like events in 4 slices 
and led to the emegence of very slow and infrequent ictal-like events in the other 4 of 
the slices (0.002 Hz ± 0.001 Hz, n = 4). Application of 50 µM 2-AP5 caused near 
abolition of all remaining activity, with very infrequent field events remaining in 2 
slices (0.02 ± 0.01 Hz). This is also displayed in the time-frequency scatter plot (fig 
4.2.10.C), in which the sequential addition of the above compounds leads to a 
decrease in field event frequency following each addition. The trend chart (fig 
4.2.10.D) shows that application of 20 µM bicuculline abolished the slow inter-ictal-
like events in all slices, with 4/8 slices displaying slow ictal-like activity (see fig 
4.2.10.A (iv)), and one slice displayed gamma frequency oscillatory activity.  
4.2.11  Oxotremorine-M induces beta frequency 
oscillations in the 4-AP/NBQX epileptiform model 
The effect of mAChR agonists on a model of reduced excitatory drive was then 
investigated. As seen above it is possible to isolate slow inter-ictal like events by co-
application of 4-AP and NBQX (see fig 4.2.10). Subsequent application of 
oxotremorine-M allowed insights into the effect of mAChR activation on the 
interneuronal network. Application of 10 µM oxotremorine-M to 50 µM 4-AP/2 µM 
NBQX-induced slow inter-ictal like events caused a significant (P = 0.0012) mean 
attenuation (from 0.30 ± 0.11 to 0.024 ± 0.004 Hz, n = 16) in slow inter-ictal like 
event frequency and an initiation of a beta frequency oscillatory activity in the 
majority of (9/16) slices (figs 4.2.11.C and G). The decrease in the slow inter-ictal 
like event frequency was very partially reversible upon wash out of 10 µM 
oxotremorine-M (the mean event frequency increased from 0.024 ± 0.04 to 0.029 ± 
0.003 Hz). 
 The majority of the network oscillatory activity induced by the application of 10 µM 
oxotremorine-M (mean = 17.88 ± 1.9 Hz, n = 16) occurred within the beta frequency 
range. Both the slow inter-ictal like events and the beta frequency oscillatory activity 
could be observed concurrently in 50% (13/26) of slices. Network oscillatory activity 
remained in a subset of (3/9, 33%) slices for at least 30 minutes after washout of 
oxotremorine-M. John Broad, 2009     Chapter 4, 82 
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Application of the mAChR antagonist atropine (10 µM) to the co-applied 50 µM 4-
AP/ 2 µM NBQX and 10 µM oxotremorine induced network activity (fig 4.2.11.D) 
caused an increase in slow inter-ictal like event frequency (0.015 ± 0.003 to 0.028 ± 
0.008 Hz, n = 9). In other experiments, prior application of 10 µM atropine prevented 
attenuation of the 4-AP/NBQX slow ictal-like event frequency by 10 µM 
oxotremorine-M (fig 4.2.11.E) indicating that these effects were mediated by 
mAChRs. There was a significant (P = 0.031) increase in the mean slow inter-ictal 
like event frequency (from 0.031 ± 0.011 to 0.050 ± 0.016 Hz, n = 6) following 
application of 10 µM oxotremorine-M (fig 4.2.11.E), possibly through nAChR 
activation. Network oscillatory activity was also prevented by the prior application of 
10 µM atropine (n = 6). Application of the GABAA receptor antagonist bicuculline 
(20 µM) abolished the predominant beta frequency network oscillatory activity 
induced by oxotremorine-M in all slices tested (8/8). The slow inter-ictal like events 
that were not attenuated by oxotremorine-M were almost abolished (from 0.02 ± 
0.006 to 0.004 ± 0.002 Hz, n = 10) by subsequent application of 20 µM bicuculline 
(fig 4.5.1.F), and the events that remained were small in amplitude and sporadic in 
occurrence.   
4.2.12  The M1 mAChR does not mediate the oxotremorine-
M -induced oscillations in the 4-AP/NBQX epileptiform 
model  
Activation of mAChRs changes the mode of activity from 4-AP/NBQX induced slow 
inter-ictal like events (fig 4.2.10) to beta frequency oscillatory network activity (fig 
4.2.11). As selective tools were available to study the M1 mAChR the role of this 
receptor in the suppression of 4-AP/NBQX events and induction of beta frequency 
oscillations was investigated.  
Application of 77-LH-281 (10 µM) to 4-AP/NBQX induced slow inter-ictal-like 
events did not lead to significant (P = 0.36) attenuation (from 0.11 ± 0.06 to 0.06 ± 
0.04 Hz, n = 9) of the frequency of the slow inter-ictal-like events (fig 4.2.12.1.B) and 
did not change the mode of events in any of the slices tested (10/10 slices, fig 
4.2.12.1.D).  Even at a concentration of 100 µM (fig 4.2.12.1.C), 77-LH-281 did not 
significantly (P = 0.73) change the slow inter-ictal-like event frequency (from 0.026 ± 
0.004 to 0.023 ± 0.003 Hz, n = 9). John Broad, 2009     Chapter 4, 84 
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At this concentration some theta frequency network oscillatory activity (9.43 ± 1.93 
Hz, n = 3) was observed in only a minority (33 %, 3/9) of slices. 
The M1 mAChR subtype specific irreversible antagonist MT-7 was used to block the 
M1 mAChR receptor. Slices were pre-incubated for >2 hours with 100 nM MT-7 prior 
to the initiation of 4-AP/NBQX-induced slow inter-ictal like events. In naïve slices 
this was able to prevent initiation of gamma frequency oscillatory activity (see fig 
3.2.3) by the subsequent application of 10 µM 77-LH-281, but not the emergence of 
ictal like events following application of 10 µM oxotremorine-M (n = 6, data not 
shown). Application of 10 µM oxotremorine-M significantly (P = 0.0005) attenuated 
slow inter-ictal-like event frequency (from 0.10 ± 0.04 to 0.02 ± 0.003 Hz, n = 15) 
and induced oscillatory network activity (fig 4.2.12.2.A) in 55 % (10/18) slices (mean 
frequency = 14.29 ± 1.9 Hz, n = 10). The decrease in slow inter-ictal-like event 
frequency was partially, but not significantly (P = 0.44) reversed following wash out 
of oxotremorine-M (0.03 ± 0.004 Hz on washout).  
4.3 The modulation of cellular properties of 
hippocampal pyramidal cells by mAChR agonists 
The activation of mAChRs alters the intracellular excitability of neurones (Cole and 
Nicoll, 1983; , 1984a). This section concerns the effect of the non-selective mAChR 
agonist oxotremorine-M and the M1 mAChR subtype specific agonist 77-LH-281 on 
the intracellular properties of CA1 pyramidal cells.  
Comparison of the effects of application of oxotremorine-M and 77-LH-281 on the 
intracellular properties of CA1 pyramidal cells 
Transient application of a bolus of 10 µM oxotremorine-M for 60 s caused a 
depolarisation of pyramidal cells and action potential firing (fig 4.3.A). Application of 
a 60 s bolus of the M1 mAChR agonist 77-LH-281 (30 µM) also led to action 
potential firing and membrane depolarisation (fig 4.3.B). The membrane potential 
depolarisations induced by both 10 µM oxotremorine (from -59.1 ± 3.8 to – 47.5 ± 3.3 
mV, n = 8) and by 30 µM 77-LH-281 (-60.0 ± 1.8 to 52.5 ± 2.6 mV, n = 10) (fig 
4.3.C) were statistically significant (P < 0.001).  John Broad, 2009     Chapter 4, 87 
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A. Representative current clamp recording from a CA1 pyramidal neurone showing (i) the response of the cell to a 60 s 
application of 10 µM Oxotremorine-M (ii) expanded trace showing action potential firing (inset- power spectrum 
showing theta frequency sub-threshold membrane potential oscillation). Note the strong suprathreshold depolarising 
response. B. Representative current clamp recording from a CA1 pyramidal cell showing (i) the response of the cell to a 
60 s application of 30 µM 77-LH-281 (ii) expanded trace showing action potential firing. Hyperpolarising membrane 
deflections in response to 0.1 nA current injections can be observed in both A and B. C. Box plots showing the significant 
depolarisation of the pyramidal cell induced by the application of (i) 10 µM Oxotremorine-M and (ii) 30 µM 77-LH-281. 
D Summary histograms showing (i) the significant increase in input resistance with application of 10 µM Oxotremorine-
M (P < 0.01) and (ii) no change in input resistance following the application of 30 µM 77-LH-281. 
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A. Representative current clamp recording from a CA1 pyramidal neurone showing (i) the response of the cell to a 60 s 
application of 10 µM Oxotremorine-M (ii) expanded trace showing action potential firing (inset- power spectrum 
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response. B. Representative current clamp recording from a CA1 pyramidal cell showing (i) the response of the cell to a 
60 s application of 30 µM 77-LH-281 (ii) expanded trace showing action potential firing. Hyperpolarising membrane 
deflections in response to 0.1 nA current injections can be observed in both A and B. C. Box plots showing the significant 
depolarisation of the pyramidal cell induced by the application of (i) 10 µM Oxotremorine-M and (ii) 30 µM 77-LH-281. 
D Summary histograms showing (i) the significant increase in input resistance with application of 10 µM Oxotremorine-
M (P < 0.01) and (ii) no change in input resistance following the application of 30 µM 77-LH-281. 
(ii)John Broad, 2009     Chapter 4, 88 
The mean input resistance of the pyramidal cells significantly (P = 0.0078) increased 
from 57.3 ± 5.0 to 80.8 ± 8.7 M  in response to application of 10 µM oxotremorine-
M whereas there was no significant change in the input resistance (from 60.6 ± 6.0 to 
65.7 ± 5.1 M , P = 0.28, n = 8) following application of 30 µM 77-LH-281 (fig 
4.3.D).  
4.4 The modulation of synaptic properties of the 
hippocampus by mAChR agonists  
The effect of the application of mAChR agonists on the synaptic properties of the 
hippocampus can be investigated by stimulating the Schaffer collaterals in the stratum 
radiatum and recording the field excitatory post-synaptic potential (fEPSP) in the 
same lamina of the CA1 region. Parameters of the fEPSP, including the amplitude, 
can be modulated by compounds that affect synaptic transmission at the Schaffer 
collateral to CA1 pyramidal cell synapse.    
Comparison of the effects of oxotremorine-M and 77-LH-281 on the field excitatory 
post-synaptic potential 
Application of 10 µM oxotremorine-M significantly (P = 0.031) reduced the mean (n 
= 6) amplitude of the fEPSP (from 0.89 ± 0.13 mV to 0.35 ± 0.11 mV) (mean ± 
S.E.M.). In contrast the mean (n = 12) amplitude of the fEPSP was not significantly 
altered (1.04 ± 0.11 mV to 0.95 ± 0.11 mV, n = 12, P = 0.47) by 10 µM 77-LH-281 
(fig 4.4.C). Application of 100 µM 77-LH-281 also did not have a significant effect 
on the amplitude of the fEPSP. The mean (n = 6) amplitude of the fEPSP was 
significantly reduced 6 minutes after application of 10 µM oxotremorine-M (all P < 
0.05 following this time point) whereas application of 10 µM 77-LH-281 produced no 
significant change in the mean (n = 12) amplitude of the fEPSP at any time point (fig 
4.4.D).  John Broad, 2009     Chapter 4, 89 
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A. Representative trace examples showing (i) the field excitatory post-synaptic potential (fEPSP), (ii) the effect of 
application of 10 µM oxotremorine-M on the fEPSP and (iii) washout of oxotremorine-M. Triangle shows the 
point of stimulus. B. Representative trace examples showing (i) fEPSP, (ii) the effect of application of 10 µM 77-
LH-281 on the fEPSP and (iii) wash out of 77-LH-281. C. Summary histograms showing the amplitude of the 
fEPSP as measured 30 minutes after application of 10 µM oxotremorine-M compared to 5 minutes before 
oxotremorine application. Application of 10 µM oxotremorine-M leads to a significant decrease in the amplitude 
of the fEPSP whereas application of 10 µM 77-LH-281 has no effect on the amplitude of the fEPSP. D. Time 
course showing the significant decrease of the amplitude of the fEPSP in response to application of 10 µM 
oxotremorine-M (i) and no significant change in the amplitude of the fEPSP in response to application of 10 µM
77-LH-281 (ii). 
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4.5 Discussion 
This chapter investigates the effect of mAChR agonists upon network oscillatory 
activity within the hippocampus. In the previous chapter oxotremorine-M induced 
ictal-like events whilst the M1 mAChR selective agonist 77-LH-281 led to persistent 
gamma frequency network oscillatory activity. In order to gain mechanistic insight 
into the different oscillations that were displayed, and to evaluate whether M1 
mAChR selective agonists display a similar pro-epileptogenic potential to non-
subtype selective agonists, 77-LH-281 and oxotremorine-M were applied to four 
mechanistically distinct models of epileptiform activity. The cellular and synaptic 
effects of 77-LH-281 were also investigated and compared with oxotremorine-M. A 
summary of activities induced by mAChR agonists in hippocampal slices is displayed 
in table 2 below. 
Table 2- Summary of effects of mAChR agonists in naïve coronal hippocampal 
slices and hippocampal slices displaying oscillatory activities 
 
Drug  Naïve slices  4-AP-
induced 
events 
Bicuculline-
induced 
events 
Low Mg
2+- 
induced 
events 
4-AP/NBQX- 
induced 
events 
Control conditions 
(vehicle) 
No activity  Inter-ictal  Inter-ictal  Inter-ictal  Slow inter-
ictal 
Oxotremorine-M  Theta 
oscillations 
Ictal Events  Ictal events  Ictal events  Beta 
oscillations 
77-LH-281  Gamma 
oscillations 
No effect  Increase in 
inter-ictal-
like event 
frequency 
No effect  No effect 
 
4-AP-induced events 
The mAChR agonists were initially applied to 4-AP-induced inter-ictal type network 
activity. 4-AP blocks K
+ channels that mediate, including others, the ID current, a 
slowly inactivating K
+ current (Storm, 1988) and the IA current, a transient outward 
K
+ current (Huguenard et al. 1991).  As 4-AP washes into the hippocampal slice, the John Broad, 2009     Chapter 4, 91 
blockade of these K
+ currents leads to paroxysmal depolarising shifts within the 
pyramidal cells of the CA3 region (Perreault and Avoli, 1991). The synchronised 
activity of large numbers of pyramidal cells, specifically currents within the dendrites 
of pyramidal cells, produces the potential difference measured in hippocampal 
extracellular recordings. The depolarising shifts are likely to arise from the synaptic 
activation of a large number of cells (Gutnick et al., 1982). This is measured as the 
characteristic inter-ictal-like event as shown in figure 4.2.1., which can be abolished 
by bicuculline (Avoli et al., 1996), and reduced in frequency by NBQX (see fig 
4.2.10; (Perreault and Avoli, 1992). Thus both glutamatergic and GABAergic 
networks are activated following application of 4-AP (Rutecki et al., 1987).  
Application of oxotremorine-M produced an initial increase in inter-ictal event 
frequency, followed by the eventual emergence of ictal-like activity. As was 
mentioned in the previous chapter, application of oxotremorine can activate all 
subtypes of mAChRs (Birdsall et al., 1978; Kukkonen et al., 1996). The M1 or M3 
mAChRs are located principally on pyramidal cells (Levey et al., 1995; Rouse et al., 
1999) and they couple through Gαq G-proteins. Activation of these receptors 
depolarises pyramidal cells, as shown in figure 4.3. The paroxysmal depolarising shift 
frequency is independent of the membrane potential of individual pyramidal cells, but 
is dependent on [K
+]o (Rutecki et al., 1985). As depolarisation of pyramidal cells and 
consequent action potential firing of pyramidal cells can cause activity dependent 
increases in [K
+]o (Poolos et al., 1987), this is one possible mechanism for the 
increase in frequency of inter-ictal-like events. This is clearly related to the level of 
depolarisation in each pyramidal cell, but the effect is observed at the level of the 
network. It is likely that the number of action potentials within the network, which is 
proportional to the level of depolarisation of the pyramidal cells within the network, 
regulates the frequency of paroxysmal depolarisation shifts within pyramidal cells. In 
short, a depolarisation of pyramidal cells will act to increase the frequency of inter-
ictal-like events.       
Oxotremorine-M also activates the inhibitory M2 and M4 mAChRs. The majority of 
these receptors are located on pre-synaptic interneurones (Kitaichi et al., 1999; Rouse 
et al., 1999). They act to decrease GABAA mediated inhibition to pyramidal cells by John Broad, 2009     Chapter 4, 92 
disrupting the release of GABA where M2/4 mAChRs are expressed. As observed in 
the bicuculline model, reducing GABAA mediated inhibition is pro-epileptogenic. 
They also act to decrease GABAB activation through reduced GABA release. Both 
agonists of GABAB, through the activation of pre-synaptic GABAB receptors and 
inhibition of GABA release (Motalli et al., 1999), and antagonists, through the block 
of post-synaptic GABAB mediated inhibition of pyramidal cells (Motalli et al., 2002), 
have been shown to be pro-convulsant in models of epileptiform activity. This 
indicates that the effects of presynaptic disruption of GABA release and consequent 
removal of GABAB activation by M2/4 mAChR activation are complex. Pre-synaptic 
GABAB activation leads to inhibition of transmitter release by a reduction in Ca
2+ 
entry (Huang et al., 2006), whereas post-synaptic GABAB activation acts to 
hyperpolarise pyramidal cells through the action of inwardly rectifying potassium 
channels (Andrade et al., 1986; Pham and Lacaille, 1996).   
In the main this increase in inter-ictal-like event frequency caused by oxotremorine-M 
is superseded by the emergence of ictal-like events. As mentioned in the previous 
chapter, ictal-like events emerge following a reduction of inhibition from 
interneurones either by depolarising block of the interneurones (Ziburkus et al., 2006), 
or by a reversal of the chloride gradient allowing GABAA activation to become 
excitatory (Isomura et al., 2003). To induce ictal activity in the network 
oxotremorine-M must also remove inhibition from interneurones. This may be 
through a direct inhibition of GABA release through M2/4 mAChRs as described 
above. It is also possible that an increased excitatory drive to the pyramidal cells leads 
to either a feed-forward depolarisation block of interneurones, or an activity 
dependent reversal of the chloride gradient (Fischer et al., 1999).     
77-LH-281 did not have an effect on the network activity that emerged from 
hippocampal slices in which inter-ictal-like events were ongoing following the 
application of 4-AP. The M1 mAChR induced depolarisation of pyramidal cells, 
which should increase the probability of, and therefore frequency of, paroxysmal 
depolarising shifts, did not lead to a subsequent significant increase in frequency of 
inter-ictal-like events. It is possible that increased pyramidal cell activity led to a 
consequent increase in inhibitory feedback from the interneurones in the network. 
Without the reduction in inhibition following M2/4 mAChR activation, the inter-ictal-John Broad, 2009     Chapter 4, 93 
like event frequency remained constant. It is also possible that M3 mAChRs, located 
on the pyramidal cells, are required in combination with M1 mAChRs to increase the 
frequency of inter-ictal-like events.  
Following application of the M1 specific mAChR agonist 77-LH-281 ictal events are 
not observed. This indicates that the removal of GABAergic inhibition that occurs 
during ictal-like events does not occur following activation of the M1 mAChR alone. 
This could be due to the absence of M2/4 mAChR mediated inhibition of 
interneurones. As M1 mAChRs do not increase the rate of inter-ictal-like events it is 
also possible feed-forward depolarisation block of interneurones, or an activity 
dependent change in the equilibrium potential of GABA, does not occur. As there are 
a range of possible mechanisms for the absence of ictal-like events following 
application of 77-LH-281, mechanistically distinct epileptiform models were used to 
investigate the differences between M1-selective and non subtype selective mAChR 
agonists.  
Bicuculline-induced events 
Bicuculline is an antagonist of GABAA receptors, which are the most widely 
expressed ligand gated anion channels in the central nervous system. Blockade of 
these channels leads to a removal of fast GABAA mediated potentials in the 
hippocampus. The emergence of epileptiform phenomena is dependent upon the 
balance of excitation and inhibition (Bernard, 2005). Removal of GABAA mediated 
synaptic transmission leads to the gradual emergence of inter-ictal-like events through 
the removal of IPSPs, and consequent increased summation of EPSPs within each 
pyramidal cell (Pouille and Scanziani, 2001), leading to more supra-threshold action 
potential firing. This is manifest as paroxysmal depolarising shifts within pyramidal 
cells and inter-ictal-like events throughout the network.  
Activation of M1-5 mAChRs by oxotremorine-M leads to an increase in inter-ictal-like 
event frequency and the emergence of ictal-like events. This indicates that a reduction 
in GABAA mediated synaptic transmission is not the sole driving force behind a 
mAChR-induced increase in inter-ictal-like event frequency or the emergence of ictal-
like activity. As for the 4-AP model described above, a depolarisation of pyramidal John Broad, 2009     Chapter 4, 94 
cells through M1 and M3 mAChR activation would lead to an activity dependent 
increase in the frequency of paroxysmal depolarisation shifts within pyramidal cells. 
Through the action of M2 and M4 mAChRs pre-synaptic disruption of GABA release 
occurs. However, as GABAA receptors are blocked in this model, any change in the 
level of inhibition will be mediated by the reduction in pre-synaptic and post-synaptic 
GABAB activation.  
In the presence of bicuculline, activation of M1-5 mAChRs often leads to the 
emergence of ictal-like activity. As mentioned above, there are two hypotheses 
concerning the emergence of ictal-like activity in hippocampal slices. In the first, a 
depolarising block of interneurones contributes to the removal of inhibition from the 
network (Ziburkus et al., 2006); in the second a reversal of the chloride gradient 
allows GABAA-mediated synaptic transmission to become depolarising (Isomura et 
al., 2003). In the presence of bicuculline, a removal of inhibition, rather than 
depolarising GABA transmission, is likely to contribute to ictal-like activity. As ictal-
like events are not induced by bicuculline, other reductions in inhibitory drive must 
occur, most likely through the modulation of GABAB.  
Pyramidal cells display a long sustained depolarisation during an ictal-like event 
(Ziburkus et al., 2006). These transient depolarisations are correlated with the 
depolarisation block of interneurones. It is possible that postsynaptic GABAB 
mediated potentials tonically prevent the emergence of ictal-like events within 
pyramidal cells, and the disruption of these by a reduction in GABA release by M2/4 
mAChRs may allow ictal-like events to occur (Kitaichi et al., 1999; Levey et al., 
1995; Rouse et al., 1999).  
The depolarisation block of interneurones is possible contributor to the removal of 
GABAB mediated inhibition. This could arise following direct activation of mAChRs 
on interneurones (Chapman and Lacaille, 1999), or increased feed-forward activation 
of interneurones following increased pyramidal cell activity due to actions of mAChR 
agonists.        
Further evidence for the key role interneurones (and therefore GABAB receptors) play 
in mediating ictal-like events is the absence of ictal-like events in the bicuculline John Broad, 2009     Chapter 4, 95 
model following selective M1 mAChR activation by 77-LH-281. The predominant 
pyramidal cell expression of M1 mAChRs means subtype-selective activation of the 
M1 mAChR would not disrupt GABA release from interneurones.  
In the presence of bicuculline application of the M1 mAChR agonist 77-LH-281 
causes a significant increase in the frequency of inter-ictal-like events. In the presence 
of GABAA mediated synaptic inhibition, M1 mAChR activation does not increase the 
frequency of inter-ictal-like events. The depolarisation of pyramidal cells caused by 
M1 mAChR activation, in combination with the removal of feedforward inhibition 
allows an increase in the frequency of paroxysmal depolarising shifts.      
Zero Mg
2+-induced events 
The removal of Mg
2+ ions from the extracellular bathing solution surrounding the 
hippocampal slice removes the Mg
2+ block of NMDA receptors, which leads to inter-
ictal-like network activity emerging from the CA3 region (Tancredi et al., 1988). The 
NMDA receptors are located on the dendrites of pyramidal cells and are normally 
quiescent at polarised potentials following glutamate release due to the Mg
2+ block. 
However, strong activation of AMPA/kainate receptors leads to a removal of the 
Mg
2+ block by depolarisation, which opens the NMDA receptor channel to allow  Na
+ 
and Ca
2+ entry and further depolarisation (Dingledine et al., 1999). In low-Mg
2+ 
bathing solution, the level of basal NMDA receptor-mediated transmission is enough 
to induce synchronous activity in the hippocampus (Traub et al., 1994). This 
depolarisation of the pyramidal cell decreases the seizure threshold (Tancredi et al., 
1990) and leads to the emergence of inter-ictal-like events.    
As in the previous models, oxotremorine-M initially increases the frequency of inter-
ictal-like events and eventually induces ictal-like activity in the low Mg
2+ model. The 
increase in inter-ictal like event frequency is likely to be due to an increase in the 
probability of action potential firing following depolarisation of pyramidal cells, in 
combination with a reduction of GABAergic inhibition through the action of M2/4 
mAChRs. Similarly, ictal-like events emerge during a transient further reduction of 
(potentially GABAB) mediated inhibition. The mAChRs associated with the increase 
in inter-ictal-like event frequency and induction of ictal events exerts their effects John Broad, 2009     Chapter 4, 96 
through mechanisms distinct from the modulation of the voltage dependency of the 
NMDA receptor. 
In contrast to the bicuculline-induced model of epileptiform activity, application of 
the M1 mAChR agonist 77-LH-281 does not increase the frequency of inter-ictal-like 
events induced by the removal of extracellular Mg
2+ ions. M1 mAChR activation has 
been shown to regulate NMDA receptor function, including increasing NMDA 
receptor mediated LTP (Marino et al., 1998; Shinoe et al., 2005). As the M1 mAChR 
agonist has no effect in this model, it is possible the effects of the M1 mAChR 
activation are occluded by the removal of the Mg
2+ block of the NMDA receptor. If 
this is the case then the M1 mAChR may have little or no role in the induction of ictal-
like events caused by oxotremorine-M, as robust ictal-like events are induced even 
whilst the M1 mAChR is functionally occluded. Further evidence for this is the ability 
of oxotremorine-M to initiate ictal events in the presence of MT-7.  
Application of nicotinic acetylcholine receptor (nAChR) agonists has previously been 
demonstrated to enhance the frequency of inter-ictal-like events in the three 
epileptiform models investigated above (Roshan-Milani et al., 2003). Oxotremorine-
M enhances the 4-AP-induced events by 80 ± 34%, the bicuculline induced events by 
270 ± 112%, and the low-Mg
2+ induced events by 105 ± 79%. This corresponds to the 
enhancement of 4-AP-induced events by approximately 50%, the bicuculline induced 
events by 220%, and the low-Mg
2+ induced events by 100% by nAChR agonists. The 
similarity in the ratios of enhancement in the three models may be due to convergence 
of the mechanisms of frequency potentiation by the acetylcholine receptor agonists in 
the individual models. Also, the maximum possible degree of frequency potentiation, 
and the initial frequency of the oscillatory activity, is dependent on the paradigm used 
to induce the inter-ictal-like activity.   
4-AP/NBQX induced events 
Application of NBQX to 4-AP-induced events leads to the abolition of the majority of 
AMPA/kainate mediated synaptic transmission within the hippocampus. All inter-
ictal-like activity, which is underpinned by paroxysmal depolarising shifts, is not 
abolished by glutamate receptor block. EPSPs received from other pyramidal cells John Broad, 2009     Chapter 4, 97 
through AMPA/kainate receptors are significant contributors to paroxysmal 
depolarisation shifts within pyramidal cells (Chamberlin et al., 1990). The slow inter-
ictal-like activity that occurs in the presence of NBQX indicates that other 
mechanisms must be able to initiate paroxysmal depolarisations. It is possible that the 
competitive block of AMPA/kainate receptors is overcome due to increased glutamate 
release in an active network (Hamberger et al., 1979), or another mechanism, such as 
depolarising GABAergic potentials from interneurones (Perreault and Avoli, 1992), 
synchronously activates the pyramidal cell network. The remaining slow inter-ictal-
like events are abolished by bicuculline, indicating that the GABAA receptor mediated 
signalling is critically important for the slow inter-ictal-like events. NMDA receptors 
are functional in this model as well, as the GABAA antagonsim reveals very 
infrequent 2-AP5 sensitive ictal-like-events in 50% of the slices. NMDA antagonists 
were not routinely used in as subsequent addition of NMDA antagonists does not 
affect inter-ictal-like event frequency in the presence of AMPA/kainate antagonists 
(Perreault and Avoli, 1992). It is possible therefore, that the effect of the NMDA 
receptor is only revealed following removal of the dominant GABAA component of 
the oscillatory activity.  
The strident differences between the effect of oxotremorine-M in this and the 4-AP 
model indicate NBQX is effective in reducing AMPA/kainate glutamatergic synaptic 
transmission. In hindsight, if a dose response relationship between inter-ictal-like 
event frequency and NBQX concentration was constructed, a concentration that had 
more evidence for the complete block of AMPA/kainate receptors could have been 
chosen.      
Application of the mAChR agonist oxotremorine-M significantly decreases the 
frequency of slow inter-ictal-like events and predominantly induces beta frequency 
network oscillations. The oscillation and the slow inter-ictal-like events are not 
mutually exclusive, as in up to 50% of slices both occurred simultaneously. The 
suppression of the slow inter-ictal-like events and the beta frequency oscillation in the 
presence of NBQX are clearly dissimilar to the increase in inter-ictal-like event 
frequency and ictal-like events induced by oxotremorine-M and 4-AP alone. In the 
absence of AMPA/kainate receptor blockade mAChR agonists increase the frequency 
of inter-ictal-like events due to the depolarisation of pyramidal cells and a decrease of John Broad, 2009     Chapter 4, 98 
GABAergic inhibition (see above). In the presence of AMPA/kainate receptor 
antagonists, mAChR agonists decrease the frequency of slow inter-ictal-like events. 
The decrease in slow inter-ictal-like event frequency is possibly due to a change in the 
[K
+]o, which could be investigated using ionic electrodes. It is more likely to be due to 
a change in the network connections involved in the initiation of the slow inter-ictal-
like events. One way this decrease in frequency could occur would be to decrease 
GABA release from interneurones (Behrends and ten Bruggencate, 1993). Inter-ictal-
like events are correlated with an increase in EPSPs within pyramidal cells. If these 
EPSPs are received through depolarising GABAA potentials (as suggested by the 
Avoli group) a mAChR mediated decrease in GABA release would act to decrease the 
frequency of inter-ictal-like events. Another would be to activate different classes of 
interneurones directly, or through the modulation of NMDA receptor mediated 
transmission, to initiate other forms of synchronous activity within pyramidal cells. It 
is unlikely that these changes in oscillation mode and frequency are direct effects of 
mAChR activation on pyramidal cells, as M1 mAChR activation does not replicate the 
decrease in slow inter-ictal-like event frequency.    
Rather than the induction of ictal-like events, oxotremorine-M induced beta frequency 
oscillatory activity. This oscillation was sensitive to the subsequent application of 
bicuculline, indicating that the oscillation was dependent upon GABAA receptors, and 
thus interneurones play a continuous role in the oscillation. A feature of ictal-like 
events is the depolarisation block of interneurones, or a shift in the chloride reversal 
potential so that GABA becomes excitatory. Stratum oriens-lacunosum moleculare 
interneurones undergo depolarisation block during ictal-like events (Ziburkus et al., 
2006), whereas fast spiking and non-fast spiking perisomatic-targeting interneurones 
are able to continue to fire action potentials (Fujiwara-Tsukamoto et al., 2004). These 
are likely to be the dominant class of interneurone in the coronal slices, are 
depolarised by the action of mAChR s and therefore potentially able to pace beta 
frequency oscillatory activity (McMahon et al., 1998).  
Given the requirement of GABAA receptors signalling, and the absence of 
AMPA/kainate mediated EPSPs, an attractive mechanism for the generation of the 
beta frequency oscillation is a depolarising GABAA signal, with GABAergic IPSPs at John Broad, 2009     Chapter 4, 99 
beta frequencies acting as the pacemaker. Another possible component of the 
oscillation is the depolarising block of interneurones removing GABAB mediated 
inhibition and allowing the emergence of the beta frequency oscillatory activity.  
In order to confirm this, intracellular recordings from pyramidal cells and perisomatic 
targeting interneurones would need to be performed, alongside labelling the 
interneurones to assess their morphology. This experiment would give great insight 
into the mechanism of the network shift from slow inter-ictal-like events into beta 
frequency oscillatory activity. It would be interesting to investigate the role of NMDA 
receptors in the oscillation, as it is possible these receptors are revealed by a change in 
the GABA mediated synaptic transmission following activation of mAChRs. 
Beta oscillations have previously been reported in the hippocampus following 
application of carbachol (Arai and Natsume, 2006; Shimono et al., 2000), 
metabotropic glutamate receptor agonists (Boddeke et al., 1997), and tetanic 
stimulation (Traub et al., 1999). In all of the models the oscillation is insensitive to 
block of fast glutamatergic synaptic transmission and sensitive to block of synaptic 
inhibition, indicating that the beta oscillation that occurs in the presence of 4-
AP/NBQX/oxotremorine-M has a similar pharmacological profile as previously 
reported beta frequency oscillations.  
Activation of the M1 mAChR has no effect on the slow inter-ictal-like event 
frequency and does not induce beta frequency oscillatory activity. This suggests that 
the M2-5 mAChRs mediate the induction of the beta frequency oscillation and the 
suppression of slow inter-ictal-like event frequency. This is expected with the 
majority of M1 mAChRs being expressed on pyramidal cells (Rouse et al., 1999). The 
absence of effect of 77-LH-281 in this model is consistent with the reported absence 
of effect of NMDA antagonists, as M1 mAChRs modulate NMDA receptors (Shinoe 
et al., 2005; Perreault and Avoli, 1992). 
The effect of mAChR agonists on pyramidal cells 
Application of mAChR agonists to CA1 hippocampal pyramidal cells leads to a 
depolarisation of pyramidal cells by approximately 8 mV and action potential firing, John Broad, 2009     Chapter 4, 100 
which corresponds to previous studies (Cole and Nicoll, 1984a; Williams and Kauer, 
1997). There is an increase in input resistance within pyramidal cells following 
application of oxotremorine-M, which is not apparent following application of 77-
LH-281. Activating M1 mAChR alone can depolarise pyramidal cells. The selective 
activation of the M1 mAChR activates the hyperpolarisation activated current, Ih, and 
the non-specific cation conductance, Icat (Fisahn et al., 2002). Opening these channels 
would, if anything, decrease input resistance. The depolarisation that occurs following 
M1 mAChR activation is likely to be mediated by both of these mixed cation currents, 
as the reversal potential of Ih is around -17 mV and the reversal potential of Icat is 
around -20 mV (Colino and Halliwell, 1993; Maccaferri et al., 1993).   
The increase in input resistance that occurs following application of oxotremorine-M 
is due to the action of the M2-5 mAChRs on of a range of conductances. Non subtype 
selective mAChR agonists modulate a range of conductances including the activation 
of the Ih and Icat, as mentioned above, and the suppression of a slow Ca
2+- activated 
K
+ current IAHP, the voltage and time dependent K
+ current IM, and the voltage and 
time independent Ileak (Cole and Nicoll, 1984a; Colino and Halliwell, 1993; Halliwell 
and Adams, 1982). Previous reports suggest the increase in input resistance is mainly 
from the suppression of the IAHP and the IM and the closing of the channels associated 
with these conductances (Cole and Nicoll, 1984a). There is no significant change in 
input resistance following the selective activation of the M1 mAChR by 77-LH-281, 
as selective activation of the M1 mAChR does not affect these currents. The absence 
of activation of IM by M1 mAChR selective agonists is another possible contributing 
factor in the lack of epileptogenic effects of these agonists, as activation of IM has 
been shown to be pro-epileptogenic (Pena and Alavez-Perez, 2006).     
The effect of mAChR agonists on evoked potentials   
The fEPSP experiments were conducted at the Schaffer collateral to CA1 pyramidal 
cell synapse. Application of oxotremorine-M leads to a significant decrease in the 
amplitude and the slope of the fEPSP, whereas application of 77-LH-281 has no 
significant effect on the fEPSP. This strongly supports the suggestion that the 
decrease of the amplitude and the slope of the fEPSP induced by mAChRs is not 
mediated by the M1 mAChR subtype. Previous studies have shown that synaptic John Broad, 2009     Chapter 4, 101 
transmission at the Schaffer collateral-CA1 pyramidal cell synapse is reduced in 
amplitude by mAChR activation by approximately 40% in the stratum radiatum (SR), 
whereas in the stratum lacunosum-moleculare (SLM) synaptic transmission is reduced 
by up to 90% (Hasselmo and Schnell, 1994). As wide low resistance electrodes were 
utilised in these experiments it is possible that both the SR and SLM were recorded 
from, as demonstrated by the approximately 60% reduction in fEPSP amplitude by 
oxotremorine-M.  
It is likely that the fEPSP is decreased by the action of the M2 and/or M4 receptors, as 
they are located presynaptically (Levey et al., 1995) and are linked to a decrease in 
Ca
2+ entry into the neurone through N-type Ca
2+ channels, a process vital for synaptic 
vesicle release (Caulfield and Birdsall, 1998). Paired pulse experiments have shown 
that the mAChR effect on the Schaffer collateral-CA1 synapse is a presynaptic effect 
(de Sevilla et al., 2002; Kuhnt and Voronin, 1994).    
4.6 Conclusion 
In this chapter the networks that underlie cholinergic induction of oscillatory activity 
in the hippocampus was investigated. The M1 subtype selective mAChR agonist 77-
LH-281 does not induce ictal-like activity in a range of models of epileptiform 
activity in the hippocampus, whereas application of the mAChR agonist 
oxotremorine-M leads to ictal-like activity.  
As well as this, insight into the mechanisms that underlie the ictal events observed in 
the hippocampus can be gained. Fast glutamatergic transmission is required for both 
the M1-induced gamma frequency oscillation and ictal-like activity (see chapter 3), 
but fast GABAA mediated transmission is not required for ictal-like events.  
Only in the presence of bicuculline does selective activation of the M1 mAChR lead to 
an increase in the frequency of inter-ictal-like events. M1 mAChR agonists acting 
through the activation of Icat depolarise pyramidal cells, leading to an increased 
probability of action potential firing. In the bicuculline model as there would be no 
increase in IPSPs on pyramidal cells as interneurones are activated, the frequency of 
paroxysmal depolarisations increases. In the absence of fast glutamatergic John Broad, 2009     Chapter 4, 102 
transmission activation of the M1 mAChR receptor has no effect on the network 
activity. Therefore the M1 mAChR is almost certainly acting predominantly through 
pyramidal cells of the CA3 region. 
The above chapter indicates that M1 subtype selective mAChR agonists display many 
of the desirable characteristics required for a nootropic compound. These include the 
potential to initiate gamma frequency oscillations, and a lower potential than classical 
mAChR agonists to promote epileptiform activity. Although many further safety and 
efficacy studies would need to be performed to confirm both the safety profile and 
potential of this compound to be pro-cognitive, these studies indicate that M1 subtype 
selective mAChR agonists are a safer class of compound to use than non-subtype 
selective mAChR agonists as cognitive enhancing drugs. 103 
5  The effect of ampakines on hippocampal 
neurophysiology  John Broad, 2009     Chapter 5 104 
5.1 Introduction 
This chapter investigates the effect of ampakines on hippocampal slices. Ampakines are 
positive allosteric modulators of AMPA-type glutamate receptors, which are the most 
highly expressed receptor in the central nervous system (Dingledine et al., 1999). AMPA 
receptors are ionotropic glutamate receptors and mediate fast excitatory synaptic 
transmission. Ampakines positively modulate AMPA receptors by (i) increasing the 
conductance of the AMPA receptor, (ii) increasing the time to channel deactivation, or (iii) 
preventing desensitisation of the AMPA receptor (Lynch, 2004).  
Ampakines are known to be pro-cognitive in rats (Lockhart et al., 2007), and humans 
(Ingvar et al., 1997). Ampakines enhance LTP in vitro (Arai et al., 2004) and in vivo 
(Staubli et al., 1994), a change in synaptic function thought to underpin learning and 
memory (Kandel, 1997), and cause the release of BDNF (Lockhart et al., 2007), a pro-
cognitive gene regulator which enhances LTP (Kang et al., 1997). Ampakines increase 
synaptic transmission at the excitatory synapses in the hippocampus and increase 
depolarisation by increasing EPSCs (Lynch and Gall, 2006). This increase in the post-
synaptic depolarisation and enhancement of synaptic transmission underlies the nootropic 
properties of ampakines (Lynch, 2004). 
However, by increasing post-synaptic depolarisation it has been suggested that ampakines 
could be pro-epileptogenic as well as pro-cognitive. Cyclothiazide, an ampakine that 
prevents desensitisation of AMPA receptors, is pro-epileptogenic in vivo (Qi et al., 2006) 
and in vitro (Lasztoczi and Kardos, 2006). In this chapter, the effect of two recently 
developed ampakines, CX546 and CX691, will be investigated in a series of models to 
evaluate their pro-epileptic potential. CX546 is a first generation type 1 ampakine that 
causes increases in the hippocampal EPSC duration (Xia and Arai, 2005). CX691 is a 
second-generation ampakine that increases the amplitude of the EPSC.  
As such, the aims of this chapter are as follows; 
1.  To evaluate the effect of application of the ampakines CX546 and CX691 on evoked 
field excitatory post-synaptic potentials.  
2.  To investigate the potential of CX546 and CX691 to initiate emergent oscillatory 
activity in naïve hippocampal slices. John Broad, 2009     Chapter 5 105 
3.  To investigate the effect of application of CX546 and CX691 on hippocampal slices in 
which epileptiform-like activity has been initiated. 
This will allow an investigation into the effect of CX546 and CX691 on physiological 
synaptic and network activity, and the potential pro-epileptogenic nature of these 
ampakines.      
5.2 The effects of ampakines on field excitatory post-
synaptic potentials 
The modulation of the biophysical properties of AMPA receptors by ampakines is likely to 
affect Schaffer collateral-CA1 pyramidal cell synaptic transmission as the synapse is 
glutamatergic (Hollmann and Heinemann, 1994). A change in the properties of synaptic 
transmission by modulation of AMPA glutamate receptors will be manifest in a change in 
the magnitude of the field excitatory post-synaptic potential (fEPSP) measured from the 
CA1 region of the hippocampus.     
5.2.1 The effect of CX546 on fEPSP 
Application of 100 µM CX546 to hippocampal slices caused an increase in the amplitude 
of the fEPSP (fig 5.2.1.A). The mean (n = 7) amplitude of the fEPSP was significantly (P = 
0.031) increased (1.13 ± 0.32 to 1.28 ± 0.34 mV) by the application of 100 µM CX546. 
This effect was reversible upon wash out (1.11 ± 0.33 mV, fig 5.2.1.B). There was no 
change in the paired pulse ratio of the amplitude at all time points tested following 
application of 100 µM CX546 (fig 5.2.1.C). These data suggest that the facilitation of the 
fEPSP by CX546 occurred at a postsynaptic locus consistent with the proposed action of 
ampakines.  John Broad, 2009     Chapter 5 106 
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and absence of CX546 (100 µM). 
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5.2.2 The effect of CX691 on fEPSP 
The mean amplitude of the fEPSP was significantly (P = 0.027) increased (from 0.79 ± 
0.19 to 0.81 ± 0.22 mV, n = 12) by 10 µM CX691; subsequent application of 100 µM 
CX691 further increased the amplitude (to 0.88 ± 0.23 mV) of the fEPSP (fig 5.2.2.B). 
Wash out of 100 µM CX691 decreased the amplitude of the fEPSP to 0.77 ± 0.22 mV. 100 
µM CX691 induced no changes in the paired pulse ratio of the amplitude of fEPSP at all 
time points tested (fig 5.2.2.C). This indicates the increase in the magnitude of the fEPSP 
by CX691 occurred at a postsynaptic locus.   
5.3 Ampakines and emergent network activities  
As ampakines positively modulate synaptic transmission, it is important to evaluate the 
pro-epileptogenic potential of these compounds at the level of the network. In order to 
characterise the effects of ampakines on network activity, the ampakines CX546 and 
CX691 were applied to coronal hippocampal slices displaying either no network activity 
(fig 5.3), or four mechanistically distinct models of epileptiform activity (fig 5.3.1-8).  
Initially the ability of ampakines to induce oscillatory network activity was investigated. 
The ampakines CX546 and CX691 were applied to naïve hippocampal coronal slices and  
emergent network activity was monitored. 
The effect of application of CX546 on naïve slices 
Application of 100 µM CX546 to naïve hippocampal slices did not produce any detectable 
field events or oscillatory activity in all slices tested (8/8, see fig 5.3.B). In fig 5.3.A the 
expanded trace shows there was no change from the background signal following addition 
of 100 µM CX546.  John Broad, 2009     Chapter 5 108 
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CX546 does not induce or lead to a change in network activity. C. Representative trace examples showing 
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on the hippocampal slice and (iii) subsequent application of 2 µM NBQX. D and E. Trend charts showing no 
change in oscillatory activity following application of 100 µM CX691 to naïve hippocampal slices in (D) normal 
ACSF and only 1/9 slices change in (E) elevated extracellular [K+] ACSF.  
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The effect of application of CX691 on naïve slices 
Application of 100 µM CX691 to naïve hippocampal slices also did not induce oscillatory 
activity (fig 5.3.C). The trend diagram (fig 5.3.D) shows that no activity was observed in 
all (7/7) slices tested following application of 100 µM CX691. Even in the presence of a 
raised extracellular [K
+]o of 5 mM, to increase neuronal excitability by depolarising 
neurones (Traub and Dingledine, 1990), only 11% (1/9) of slices displayed oscillatory 
activity in response to application of 100 µM CX691. This activity was in the form of 
inter-ictal-like events.     
5.3.1 The effect of application of CX546 on 4-AP-induced inter-
ictal-like activity 
As observed above ampakines are not overtly oscillogenic in naïve slices. However, in 
naïve slices basal glutamate and GABA release are likely to be low, which may not best 
represent the in vivo situation. To truly assess the potential pro-epileptogenic nature of 
ampakines in hippocampal slices ongoing AMPA receptor activation is required. 
Ampakines affect glutamatergic synaptic transmission through positive modulation of 
AMPA receptors (Ito et al., 1990) and it has therefore been postulated that ampakines may 
be pro-epileptogenic (Qi et al., 2006). Thus, the ampakines CX546 and CX691 were 
applied to 4-AP, bicuculline, low extracellular Mg
2+ and a 4-AP/NBQX slow inter-ictal-
like event models to investigate their effect on established epileptiform activity.     
Blockade of the potassium currents ID and IA by 4-AP induces inter-ictal-like events (see 
fig 4.2.1). 4-AP activates pyramidal cells to increase glutamate release in the hippocampus 
(Buzsaki and Draguhn, 2004). Application of 100 µM CX546 to slices exhibiting ongoing 
4-AP-induced inter-ictal-like activity increased the frequency of inter-ictal-like activity and 
often led to a change in the mode of activity (fig 5.3.1). The inter-ictal-like events induced 
by application of 20 µM 4-AP were converted into ictal-like events (37.5%, 6/16 slices) 
following application 100 µM CX546, as shown in fig 5.3.1.C. Also on occasion delta 
frequency oscillatory network activity was observed in a small subset (12.5%, 2/16) of 
slices.  John Broad, 2009     Chapter 5 111 
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Application of 100 µM CX546 significantly (P = 0.0006) the frequency of 20 µM 4-AP-
induced inter-ictal-like events increased (from 0.14 ± 0.07 to 0.24 ± 0.09 Hz, n = 14) (fig 
5.3.1.B). This effect was not reversible upon wash out of CX546 (0.26 ± 0.10 Hz, n = 13). 
5.3.2 The effect of application of CX691 on 4-AP-induced inter-
ictal-like activity 
Application of CX691 to 4-AP-induced inter-ictal-like activity led to an increase in inter-
ictal-like event frequency, but did not lead to a change in the mode of oscillatory activity 
(fig 5.3.2.). Application of 10 µM CX691 to 20 µM 4-AP induced inter-ictal-like activity 
led to a significant (P = 0.016) increase (from 0.28 ± 0.11 to 0.46 ± 0.13 Hz, n = 7) in the 
mean frequency of 4-AP-induced inter-ictal-like events (fig 5.3.2.B). This increase was not 
reversible upon wash out (0.55 ± 0.16 Hz, n = 7). In order to investigate the mechanism of 
the irreversible nature of the CX691-induced increase in inter-ictal-like frequency, the 
NMDA receptor antagonist 2-AP5 (50 µM) was applied before CX691 to prevent NMDA 
mediated network plasticity. Application of 2-AP5 itself significantly (P = 0.009) increased 
(from 0.34 ± 0.12 Hz to 0.94 ± 0.21 Hz, n = 7) the frequency of 4-AP induced inter-ictal-
like events. In the presence of the NMDA receptor antagonist 50 µM 2-AP5, 10 mM 
CX691 caused a significant increase in inter-ictal-like event frequency (from 0.94 ± 0.21 to 
1.05 ± 0.23 Hz, n = 7, P = 0.016), which was partially reversible (to 1.01 ± 0.20 Hz) (fig 
5.3.2.C).  
Following application of 10 µM CX691 to 20 µM 4-AP-induced inter-ictal-like activity the 
majority (69%, 9/13) of slices continued to display inter-ictal-like activity (fig 5.3.2.D) and 
only 15% displayed ictal-like activity. Again in a small subset (15%, 2/13) of slices delta 
frequency oscillatory network activity was observed. 
5.3.3 The effect of application of CX546 on bicuculline-induced 
inter-ictal-like activity 
Bicuculline induces oscillatory network activity through the blockade of GABAA 
receptors, allowing summation of EPSPs throughout the network, and the development of 
paroxysmal depolarising shifts within pyramidal cells (see chapter 4).  John Broad, 2009     Chapter 5 113 
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Fig 5.3.3 Investigation into the effect of CX546 on the frequency of inter-ictal-like 
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Application of 100 µM CX546 to 20 µM bicuculline (+5 mM [K
+])-induced inter-ictal-like 
activity led to a significant (P = 0.002) increase (from 0.39 ± 0.13 to 0.50 ± 0.13 Hz, n = 
11) in the frequency of inter-ictal-like activity (fig 5.3.3.B). The increase was not 
reversible upon wash out of CX546 (0.49 ± 0.12 Hz). Of the slices displaying inter-ictal-
like activity in response to application of 20 µM bicuculline (+5 mM [K
+]), 78% (7/9) of 
slices continued to display inter-ictal-like activity in the presence of 100 µM CX546, 
whilst ictal-like activity emerged in 22% of slices. 
5.3.4 The effect of application of CX691 on bicuculline-induced 
inter-ictal-like activity 
The frequency of 20 µM bicuculline (+5 mM [K
+])-induced inter-ictal-like activity was 
similarly increased in response to the application of 10 µM CX691. However CX691 did 
not induce ictal-like activity (fig 5.3.4). Application of 10 µM CX691 led to a significant 
(P = 0.0006) increase (from 0.26 ± 0.05 to 0.35 ± 0.07 Hz, n = 21) in the mean inter-ictal-
like event frequency (fig 5.3.4.B), which was again not reversible upon wash out of 10 µM 
CX691 (frequency = 0.37 ± 0.08). Prior application of 50 µM 2-AP5 increased the 
frequency of inter-ictal-like events (0.15 ± 0.03 to 0.34 ± 0.06 Hz, n = 8) and did not 
prevent the 10 µM CX691-induced significant (P = 0.047) increase (0.34 ± 0.06 to 0.38 ± 
0.06 Hz, n = 8) in mean inter-ictal-like activity (fig 5.3.4.C). Wash out of 10 µM CX691 in 
the same experiment did not result in a decrease in event frequency (0.41 ± 0.07 Hz, n = 8).  
Application of 10 µM CX691 to bicuculline -induced inter-ictal-like events did not change 
the mode of activity in 96% (22/23) of slices tested (fig 5.3.4.D), and 88% (7/8) slices 
continued to display inter-ictal-like activity following application of 100 µM CX691. In 
the presence of 50 µM 2-AP5 88% (8/9) of slices did not change the mode of activity in 
response to the application of 10 µM CX691 (fig 5.3.4.E).   
5.3.5 The effect of the application of CX546 on low extracellular 
magnesium-induced inter-ictal-like activity 
Removal of extracellular magnesium leads to emergent inter-ictal-like network activity 
through the removal of the voltage dependent magnesium block of the NMDA receptor 
(Traub et al., 1994).John Broad, 2009     Chapter 5 116 
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Fig 5.3.5 Investigation into the effect of CX546 on low Mg2+ induced inter-ictal-
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10 slices changes the mode of activity from inter-ictal-like activity to ictal-like activity following the application of 
100  M CX546.      
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The gradual emergence of these inter-ictal-like events is described in the previous chapter 
(fig 4.2.7).  
Application of 100 µM CX546 increased the frequency of low magnesium induced inter-
ictal-like activity but did not change the mode of activity in the majority of slices. 
Application of 100 µM CX546 caused a significant (P = 0.0020) increase (from 0.34 ± 
0.11 to 0.48 ± 0.15 Hz, n = 10) in the low-magnesium-induced inter-ictal-like activity 
frequency (fig 5.3.5.B) that was reversible on wash out of 100 µM CX546 (frequency = 
0.38 ± 0.11 Hz, n = 10).  Application of 100 µM CX546 did not change the mode of 
activity in 90% (9/10) of slices tested, with the exception of one slice in which ictal-like 
events were observed following its application. 
5.3.6 The effect of the application of CX691 on low extracellular 
magnesium-induced inter-ictal-like activity 
Application of 10 µM CX691 led to a significant (P = 0.014) increase in the frequency 
(0.49 ± 0.22 to 0.67 ± 0.27 Hz, n = 12) of low extracellular magnesium-induced inter-ictal-
like events (fig 5.3.6.B) that was reversed by the subsequent application of the 
AMPA/kainate antagonist NBQX (0.37 ± 0.11 Hz). Application of 100 µM CX691 also 
led to a significant (P = 0.020) increase (from 0.48 ± 0.13 to 0.73 ± 0.19 Hz, n = 7, not 
shown) in the frequency of the low extracellular magnesium-induced inter-ictal-like 
activity that was reversible upon subsequent application of 2 µM NBQX (0.53 ± 0.08 Hz, n 
= 7). Application of 2 µM NBQX prior to the addition of 10 µM CX691 prevented (0.30 ± 
0.12 to 0.33 ± 0.11 Hz, n = 8) the increase (P = 0.15) in low extracellular magnesium-
induced inter-ictal-like event frequency induced by CX691 (fig 5.3.6.C).  
Application of 50 µM 2-AP5 caused a significant (P = 0.005) decrease in the inter-ictal-
like event frequency (from 0.22 ± 0.03 Hz to 0.08 ± 0.03 Hz, n = 9).  In the presence of 50 
µM 2-AP5, 10 µM CX691 caused a significant (P = 0.03) increase (to 0.13 ± 0.04 Hz, n = 
9) in low extracellular magnesium-induced inter-ictal-like event frequency. This increase 
was not reversible upon wash out of the CX691 in the presence of 50 µM 2-AP5 (0.17 ± 
0.06 Hz, n = 9). John Broad, 2009     Chapter 5 119 
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reversible upon addition of 2 µM NBQX or wash out of the ampakine (data not shown). C. This increase is abolished 
by the addition of 2 µM NBQX prior to the application of 10 µM CX691. D. The significant increase in inter-ictal-like 
event frequency is not abolished by the addition of the NMDA receptor antagonist 50 µM AP5 before application of 
the ampakine CX691 (10 µM). E. Trend charts showing the effect of application of the ampakine CX691 on low 
Mg2+-induced inter-ictal-like activity. The majority of slices (11/13) do not change the mode of activity in response to 
the application of 10 µM CX691. 
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The majority (85%, 11/13) of slices did not change in the mode of activity from low 
extracellular magnesium-induced inter-ictal-like activity following application of 10 µM 
CX691 (fig 5.3.6.E). All slices (9/9) continued to display low extracellular magnesium-
induced inter-ictal-like activity following application of 100 µM CX691. In the presence of 
2 µM NBQX or 50 µM 2-AP5, subsequent application of 10 µM CX691 did not change 
the mode of activity from low extracellular magnesium-induced inter-ictal-like activity in 
all slices tested (8/8 and 9/9 slices respectively).   
5.3.7 The effect of CX546 on 4-AP/NBQX-induced slow inter-ictal-
like events 
In order to ensure that the ampakines investigated acted through the modulation of AMPA 
receptors, ampakines were applied the 4-AP/NBQX induced slow inter-ictal-like event 
model. Application of ampakines to this model should not alter the mode or frequency of 
emergent network activity, as the antagonist NBQX blocks all AMPA/kainate receptors. If 
the ampakines are acting through other receptor systems to increase the frequency of 4-AP-
induced oscillations in the absence of NBQX (figs 5.3.1 and 5.3.2), then an increase in 
frequency would be expected to occur in the presence of NBQX.      
The frequency of 20 µM 4-AP/2µM NBQX induced slow inter-ictal-like events was not 
altered by application of 100 µM CX546 (fig 5.3.7). There was no significant change (P = 
0.50, from 0.033 ± 0.013 to 0.031 ± 0.013 Hz, n = 5) in the mean slow inter-ictal-like event 
frequency (fig 5.3.7.B), which again did not alter upon wash out (0.032 ± 0.013 Hz, n = 5). 
In all slices (6/6) displaying 4-AP/NBQX induced slow inter-ictal-like events the slices 
continued to show this mode of activity following addition of 100 µM CX546 (fig 
5.3.7.C).  
5.3.8 The effect of application of CX691 on 4-AP/NBQX-induced 
slow inter-ictal like events 
The frequency of 20 µM 4-AP/2µM NBQX induced slow inter-ictal-like events was not 
altered by 10 µM CX691 (fig 5.3.8).  John Broad, 2009     Chapter 5 121 
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application of 100 µM CX546. C. Trend chart showing there is no change in the mode of activity following 
application of 100 µM CX546 (n = 6).     
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Fig 5.3.8 CX691 does not alter the frequency of  4-AP/NBQX induced slow 
inter-ictal-like events
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out of the ampakine CX691. B. Summary histogram showing there is no significant change in the frequency 
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There was a slight non-significant (P = 0.69) decrease (from 0.030 ± 0.014 to 0.024 ± 
0.005 Hz, n = 6) in the mean slow inter-ictal-like event frequency following application of 
10 µM CX691 (fig 5.3.8.B), which decreased further upon wash out (0.017 ± 0.003 Hz, n = 
6). In all slices (5/5) displaying 4-AP/NBQX induced slow inter-ictal-like events the slices 
continued to show this mode of activity following addition of 10 µM CX691 (fig 5.3.8.C). John Broad, 2009     Chapter 5 124 
5.4 Discussion 
In this chapter the effect of two ampakines on hippocampal networks was investigated. 
CX546 is an ampakine that causes a significant increase in the open time of AMPA 
receptors, increasing the width of the EPSC. CX691 is a 20-50 times more potent analogue 
of the ampakine CX516, which significantly increases the current flow through the AMPA 
receptor by increasing the amplitude of the EPSC (Arai et al., 2004). The main findings of 
this chapter are as follows; 
1.  Ampakines promote synaptic transmission at the Schaffer collateral-CA1 synapse. 
2.  Ampakines do not induce emergent oscillatory activity when applied to naïve 
hippocampal slices. 
3.  Ampakines increase the frequency of inter-ictal-like events in three mechanistically 
distinct models of epileptiform activity. 
4.  The ampakine CX546 also promotes ictal-like activity in hippocampal slices 
displaying 4-AP-induced inter-ictal-like activity. 
5.  Ampakines have no effect on the mode or frequency of the slow inter-ictal-like 
events induced by co-application of 4-AP and NBQX.  
Ampakines are of interest as the facilitation of fast glutamatergic transmission is known to 
improve cognitive function in many disparate tasks and species (Ingvar et al., 1997; 
Hampson et al., 1999; Jones et al., 2005), but the potential of these drugs to be used as 
nootropic agents is hindered by the fact they may possibly induce seizures.  
The older generation ampakine, CX546, and the newer ampakine, CX691, facilitate 
glutamatergic transmission at the Schaffer collateral-CA1 synapse as shown in section 5.2. 
The facilitation of glutamatergic transmission is thought to underlie the pro-cognitive 
action of ampakines (Black, 2005).  
Although the effect of CX546 is to increase the deactivation time of the AMPA receptor 
(Arai et al., 2004), this is manifest as an increase in the amplitude of the fEPSP. The fEPSP 
is predominantly made up of current flow into pyramidal cell dendrites, and is proportional 
to the excitability of pyramidal cells (Balestrino et al., 1986). It is possible that an increase 
in the temporal summation of EPSPs from Schaffer collaterals can occur in the presence of John Broad, 2009     Chapter 5 125 
CX546. Temporal summation occurs when membrane depolarisations occur within 
dendrites within a short amount of time (Rall, 1964; Sjostrom et al., 2008). This increases 
the excitability of pyramidal cells and probability of action potential firing, increasing the 
amplitude of the fEPSP. CX691 does not change the temporal component of the EPSC, but 
rather increases the amplitude of the EPSC (Arai et al., 2004). The increased amplitude of 
the EPSC leads to a greater depolarisation of the CA3 pyramidal cells in the network for 
each EPSP, increasing the probability of suprathreshold potentials in pyramidal cells in the 
presence of CX691.  
CX546 and CX691 appear to exert the majority of their effect on normal synaptic 
transmission at the post-synaptic locus as they do not change the paired pulse ratio. The 
paired pulse ratio is a measure of the change in the amplitude of the EPSP that occurs in 
response to a second stimulus due to a raised residual [Ca
2+] in the pre-synaptic bouton 
following the initial stimulus (Schulz et al., 1994). Thus if the paired pulse ratio changes 
following an experimental intervention, then the locus of that effect is pre-synaptic.  
AMPA receptor activation is crucial in the electrophysiological phenomenon that is 
thought to represent memory formation, long term potentiation (LTP) (Malinow and 
Malenka, 2002; Sprengel, 2006) which is a long-term increase in the glutamatergic 
synaptic strength. Ampakines have been shown to increase the amplitude of LTP at the 
Schaffer collateral-CA1 synapse (Arai et al., 2004). Both pre- and post-synaptic loci have 
been implicated in the molecular changes that occur in LTP, but the changes that occur in 
the presence of the ampakines above would be likely to be at a postsynaptic locus.  
Application of either of the ampakines, CX546 and CX691, did not induce any detectable 
oscillatory network activity in naïve hippocampal slices. As ampakines are positive 
allosteric modulators of AMPA receptors (Ito et al., 1990), they do not directly activate 
AMPA receptors. Ampakines require AMPA receptor activation by endogenous or 
exogenous AMPA receptor agonists, like glutamate, to have an effect. Neuronal activity 
underlies both glutamate release (Hamberger et al., 1979) and oscillatory network activity 
(Traub et al., 2004). Therefore ongoing neuronal activity is required for ampakines to exert 
their effect, and in slices in which no detectable oscillatory activity is observed it is likely 
that the majority of neurones are quiescent (Connors et al., 1982). The absence of network 
oscillatory activity following application of ampakines to quiescent slices was therefore 
expected. Even following the increase of [K
+]o up to 5 mM, which increases the probability 
of neuronal activity by depolarising neurones closer to action potential firing threshold 
(Kaila et al. 1997), the ampakines largely did not promote network oscillatory activity.  John Broad, 2009     Chapter 5 126 
In the slices that were not quiescent in either normal ACSF or raised extracellular [K
+]o, 
the ampakines CX546 and CX691 were able potentiate oscillatory activity. The activities 
induced were highly variable and relatively rare, so no quantifiable measure of the 
facilitation of these activities by the ampakines was possible. However, the facilitation of 
both the physiological and pathophysiological oscillatory network activities in these slices 
was expected as the ongoing activity indicates glutamate was being released and AMPA 
receptors activated (Whittington et al., 1997).       
The effect of these ampakines on four different models of epileptiform activity was then 
investigated. Both of the ampakines caused a significant increase in the frequency of inter-
ictal-like activity in three of the epileptiform models tested. The 4-AP model induces 
epileptiform activity in hippocampal networks through the generation of paroxysmal 
depolarising shifts within principal cells (Perreault and Avoli, 1991). Paroxysmal 
depolarising shifts are initiated by the summation of glutamate mediated EPSPs within the 
network. As CX546 increases the width of the AMPA-mediated EPSC (Arai et al., 2004), 
an increase in the temporal summation of EPSPs increases the probability, and thus the 
frequency, of action potential firing. As action potential firing increases the frequency of 
paroxysmal depolarising shifts (see chapter 4), the inter-ictal-like event frequency 
increases in the presence of CX546. As mentioned above, an increase in the amplitude of 
the EPSC leads to greater action potential firing in the presence of CX691. This property 
also increases the frequency of paroxysmal depolarisation shifts, and as such inter-ictal-
like events within the network.  
This increase in the decay time of EPSCs following application of CX546 displayed a 
tendency to induce a change from inter-ictal-like events to ictal-like events in the 4-AP 
model of epileptiform activity. For ictal-like events to be manifest, a transient decrease in 
GABAergic inhibition from interneurones is required, either through depolarisation block 
of interneurones, or a reversal in the chloride gradient making GABAA potentials 
excitatory (Isomura et al., 2003; Fujiwara-Tsukamoto et al., 2004; Ziburkus et al., 2006). 
AMPA receptors are located on interneurones and display shorter rise and decay times than 
AMPA receptors in pyramidal cells (Geiger et al., 1997; Povysheva et al., 2006). CX546 
would lengthen the temporal component of AMPA receptor mediated EPSCs on 
interneurones, and the temporal summation of EPSPs within interneurones may lead to 
depolarisation block of OLM interneurones, to a sufficient degree that ictal-like events 
could occur as in the Ziburkus model detailed in the previous chapters. It is also possible 
that increased neuronal activity reverses the chloride gradient so that GABAA receptor 
mediated potentials are excitatory, as in the Fujiwara-Tsukamoto model. Ictal-like activity John Broad, 2009     Chapter 5 127 
would not be induced by CX546 in the bicuculline model as depolarising GABA potentials 
are blocked in this model.   
The increase in inter-ictal-like event frequency following the application of CX691 was not 
reversible upon wash out of the ampakine. It was postulated that this irreversibility may 
have been due to some plasticity associated with enhanced network activity, perhaps due to 
the recruitment of NMDA receptor mediated potentiation. To investigate this further the 
NMDA receptor antagonist 2-AP5 was used to block the NMDA receptor prior to the 
ampakine application. Application of 2-AP5 did allow a partial reversal of the inter-ictal-
like event frequency following wash out of CX691, suggesting that the irreversible nature 
of the increase in event frequency on washout of CX691 is at least partially mediated by 
the NMDA receptor. NMDA receptor mediated plasticity is involved in LTP in which 
strong depolarisations in the postsynaptic membrane lead to increases in synaptic strength 
(Bliss and Collingridge 1993). As CX691 allows greater post-synaptic potentials by 
increasing the amplitude of the EPSC than in normal conditions, some plasticity of this 
fashion would be expected.  
Interestingly there was a significant increase in inter-ictal-like event frequency following 
application of 2-AP5. As this is a glutamate receptor antagonist, application of 2-AP5 may 
be expected, if anything, to decrease the frequency of inter-ictal-like events. Indeed other 
studies have shown that NMDA antagonists are anticonvulsant (Aram et al., 1989), but 
some have shown NMDA antagonists to be pro-convulsant (Stafstrom et al., 1997). It is 
likely the NMDA receptors are activated following 4-AP application (Perreault and Avoli 
1992). Thus it appears that the activation of NMDA receptor negatively regulates inter-
ictal-like event frequency. Two possible mechanistic explanations of this effect include: 
1.  Ca
2+ activated K
+ channels are activated in the network by NMDA receptor activity as 
open NMDA receptors are permeable to Ca
2+ (Faber et al., 2005; Faber and Sah 2007). 
This allows K
+ ions to flow out of pyramidal cells through SK channels, which 
mediates the medium after-hyperpolarisation potential (mAHP) (Sah and Faber 2002). 
Blockade of the NMDA receptor mediated Ca
2+ entry by 2-AP5 may stop the 
activation of this channel and allow depolarisation of pyramidal cells.  
2.  NMDA receptors, which are expressed in interneurones (Standaert et al., 1996), may 
be involved in feed forward inhibition of pyramidal cells. Block of these NMDA 
receptors decreases interneurone excitation by pyramidal cells and subsequent GABA 
mediated inhibition of pyramidal cells.     John Broad, 2009     Chapter 5 128 
In order to gain further mechanistic insight into the physiological networks that underlie 
the increase in inter-ictal-like event frequency induced by ampakines and the NMDA 
antagonist 2-AP5, these compounds were applied to a range of mechanistically distinct 
models of epileptiform activity.  
Inter-ictal-like events are also induced by application of the GABAA receptor antagonist 
bicuculline. Bicuculline abolishes fast GABAA mediated synaptic inhibition leading to the 
gradual emergence of inter-ictal-like events in vivo (Campbell and Holmes 1984) and in 
vitro (Hwa et al., 1991). These inter-ictal-like events are mediated through fast 
glutamatergic transmission (Hwa and Avoli 1991), and so ampakines are well positioned to 
modulate the events induced by application of bicuculline. Application of both CX546 and 
CX691 lead to significant increases in the frequency of the inter-ictal-events induced by 
bicuculline. As for the 4-AP model of epileptiform activity, application of ampakines 
increases the frequency of the inter-ictal events by increasing the magnitude of EPSPs, 
following the increase in open time (for CX546) or current flux (for CX691) of the AMPA 
receptor in the presence of the ampakines (Arai et al., 2004).  
In contrast to the 4-AP model, application of CX546 does not show a tendency to induce 
ictal-like activity in the bicuculline induced inter-ictal-like event model. Application of 
CX691 also does not induce ictal-like activity in the majority of slices tested. A 
straightforward explanation for this could be the absence of depolarising GABAA mediated 
potentials within this model (Isomura et al., 2003). It is also possible that the lower inter-
ictal-like event frequency in the bicuculline model means that the effect of the increased 
open time of the AMPA receptor in the presence of CX546 is negated. With a lower 
frequency the potential for temporal summation, and subsequent depolarisation block, is 
decreased.   
As in the 4-AP induced inter-ictal-like event model, the increase in inter-ictal-like event 
frequency was not reversed upon wash out of the ampakine, indicating some longer term 
changes in synaptic strength may have occurred. Unlike the 4-AP-induced inter-ictal-like 
event model, the frequency of the bicuculline-induced events did not reverse upon washout 
of the ampakine in the presence of the NMDA receptor antagonist 2-AP5. Therefore these 
changes were not totally mediated by the NMDA receptor, so NMDA receptor independent 
plasticity changes must have occurred. Ca
2+ entry into pyramidal cells via voltage-gated 
Ca
2+ channels (Johnston et al., 1992) or Ca
2+ permeable AMPA receptors (receptors that 
lack  the GluR2 subunit) have been reported to lead to NMDA receptor independent 
plasticity (Jia et al., 1996). Application of ampakines would enhance the current flow John Broad, 2009     Chapter 5 129 
through GluR2 containing AMPA receptors, possibly increasing the degree of NMDA 
receptor independent plasticity by increasing Ca
2+ entry via the AMPA receptor route. 
Also, as ampakines act to depolarise pyramidal cells by increasing AMPA receptor 
mediated EPSCs, application of the ampakines would increase the levels of activation of 
voltage gated Ca
2+ channels. As this NMDA independent plasticity occurred only in the 
bicuculline model, it is possible that the NMDA-dependent plasticity observed in other 
models occurs through the interneurones, and the NMDA-independent plasticity occurs 
through direct effects on pyramidal cells or through modulation of GABAB receptor 
function.  
As in the 4-AP model, application of 2-AP5 caused a significant increase in the frequency 
of the inter-ictal-like events in the bicuculline model. The direct effects on pyramidal cells 
would remain in place in this model. It is possible that although GABAA mediated 
signalling from interneurones is removed; post-synaptic GABAB-mediated inhibition may 
still regulate inter-ictal-like event frequency. The removal of GABAB mediated inhibition, 
by reducing the excitability of interneurones through NMDA receptor block, may allow the 
increase in inter-ictal-event frequency observed in the bicuculline model following 
application of 2-AP5. The role of GABAB could be further elucidated using specific 
antagonists such as CGP55845 (Davies et al., 1993). 
As shown in the previous chapter, removal of Mg
2+ ions from the extracellular medium 
leads to the gradual emergence of inter-ictal-like events within hippocampal slices 
(Tancredi et al., 1990). Subsequent application of both CX546 and CX691 lead to a further 
increase in the inter-ictal-like event frequency. The low-Mg
2+ induced events occur 
following the removal of the Mg
2+ block of the NMDA receptor channel. This is confirmed 
by the significant reduction in inter-ictal-like event frequency following application of the 
NMDA receptor antagonist 2-AP5. Paroxysmal depolarising shifts in pyramidal cells 
within the CA3 subfield of the hippocampus leads to the formation of inter-ictal-like 
events. Although these events are initiated by the opening of the NMDA receptor, the 
recurrent synaptic connections and EPSPs that make up paroxysmal depolarisation shifts 
are largely mediated through AMPA/kainate receptors, as indicated by the significant 
reduction in event frequency following application of NBQX.  
CX546 increases the open time of the AMPA receptor, allowing increased temporal 
summation of EPSPs and action potential firing within pyramidal cells. CX691 increases 
the amplitude of the AMPA mediated EPSC, which causes an increased magnitude of each 
EPSP. This increased action potential firing increases the frequency of inter-ictal-like John Broad, 2009     Chapter 5 130 
events as noted above. There is not a dependency on NMDA receptor activation to increase 
the frequency of the low Mg
2+-induced inter-ictal-like events following application of the 
ampakines, as NMDA receptor activation is ongoing in this model (Tancredi et al., 1988). 
Indeed, CX691 increased the frequency of inter-ictal-like events in the presence of 2-AP5.  
In the low Mg
2+ model, application of 2-AP5 caused a significant decrease in the 
frequency of inter-ictal-like events. This is expected as the major effect on pyramidal cells 
by removing Mg
2+ is the activation of the NMDA receptor (Tancredi et al., 1990). 
However, IPSPs that are present in this model are also blocked by 2-AP5, indicating the 
role of NMDA activation in the recruitment of interneurones. This adds evidence to the 
putative NMDA mediated interneurone recruitment as a possible mechanism for the 
increase in inter-ictal-like events following 2-AP5 application in the other epileptiform 
models described above.   
The combination of 4-AP and NBQX induces slow inter-ictal-like events in the 
hippocampus. This model was predominantly used to check the functional specificity of 
the ampakines for AMPA receptors at the level of the network, using a competitive 
antagonist of AMPA receptors. These events rely on GABAA mediated transmission and 
are depolarising at the intracellular level (Perreault and Avoli, 1992). Subsequent 
application of CX546 and CX691 did not lead to a significant change in the frequency or 
mode of the slow inter-ictal-like events, indicating that the ampakines are functionally 
selective for AMPA/kainate receptors in hippocampal network oscillatory models.  
5.5 Conclusion  
The main conclusion from the experiments in this chapter is that ampakines increase the 
frequency of inter-ictal-like activity in a range of models of epileptiform activity. The 
ampakines investigated increase the amplitude of the fEPSP through their actions on 
postsynaptic glutamate receptors. They do not induce emergent network activity in 
quiescent hippocampal slices. CX691 is likely to be more useful than CX546 as a putative 
nootropic drug as CX691 does not robustly induce ictal-like activity in any of the models 
investigated, and is therefore likely to be less pro-convulsant than CX546.   
Ampakines are potentially useful clinical drugs as they have been shown to significantly 
improve cognitive function. In the in vitro slice preparation, application of the ampakine 
CX546 often changed the mode of activity from inter-ictal- to ictal-like activity, and in the 
rest of the models some of the slices displayed ictal-like events following application of the John Broad, 2009     Chapter 5 131 
both ampakines. In individuals who do not display seizures but who are pre-disposed to 
epilepsy, ampakine treatment may tip the balance of excitation too far and these 
individuals may then develop epilepsy. If these individuals are representative of the range 
of susceptibilities of a population to epilepsy, a large proportion of the more vulnerable 
may suffer seizures following ampakine treatment.       132 
6  Changes in protein expression following 
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6.1 Introduction  
As discussed in the previous chapters, treatment with nootropic drugs is an approach to 
enhance cognitive performance. However, other approaches have been shown to improve 
performance in cognitive tasks, including exposure to an enriched environment for a period 
of time (Hebb, 1949). In this protocol, animals are either kept in an environment 
containing ladders, running wheels and tubing, which is moved on a regular basis, or 
alternatively in a sparse environment containing only minimal shelter and stimulation (see 
methods chapter). Changes in spine density, dendritic length and behaviour can be 
observed between the two groups (Varty et al., 2000) and subsequent biochemical analysis 
shows changes in gene expression (Huang et al., 2006).  
Changes in protein expression also occur following exposure to an enriched environment. 
In McNair et al (2007), differential in-gel electrophoresis (DiGE) along with matrix 
assisted laser desorbsion-ionisation time of flight (MALDI-ToF) and Q-STAR mass 
spectrometry allowed the identification of hippocampal proteins that significantly change 
in expression in response to exposure to an enriched environment.  Subsequent database 
searching and gene ontology analysis revealed the majority (>70%) of proteins regulated 
were involved in energy metabolism, cytoplasmic organisation/biogenesis, and signal 
transduction.   
The focus of this chapter is the initial confirmation of some of the protein changes that 
occur in response to the enrichment protocol using a 2-dimensional western blot technique. 
This allows antibodies raised against the protein of interest to identify changes in the 
charge or size of the protein. The expression of a further protein, MeCP2, a histone 
modification protein, will be compared between the animals exposed to the enriched 
environment and the poor environment using a conventional 1D western blot. This protein 
is involved in the epigenetic regulation of gene expression and deficits in this protein are 
known to induce developmental deficits (Amir et al., 1999).  
The aims of this chapter were to  
1.  Confirm the observations from the DiGE experiment identifying several proteins that 
significantly changed in expression in response to an enriched environment 
2.  Quantify the expression of MeCP2 in response to an enriched environment John Broad, 2009     Chapter 6 134 
The possible implications of the changes that occur at the proteomic level, with respect to 
the cognitive enhancement that occurs following exposure to this model, will be discussed.  
6.2 Effect of a model of environmental enrichment on 
global hippocampal protein expression  
Figure 6.2 is reproduced here from McNair et al (2007) with permission. Upon initiation of 
the enrichment protocol, animals were housed in an open field (fig 6.2.A.i) or an enriched 
environment (fig 6.2.A.ii), containing many objects that were moved on a regular basis. 
This enhances spatial re-mapping ability and improves cognitive performance (Duffy et al., 
2001; Escorihuela et al., 1994; Escorihuela et al., 1995), and promotes synaptic plasticity 
(Duffy et al. 2001). Following a six week enrichment regime, the hippocampi were rapidly 
removed and chilled (see methods). The somatic and dendritic layers of the hippocampus 
were separated to isolate the predominantly principal cell soma from the dendritic field 
neuropil.   
The entire proteome was then labelled for DiGE to allow quantification of individual 
protein spot abundance levels in control and enriched animals. The scatter plot (fig 6.2.C) 
shows the change in the log abundance of proteins from the somatic layer following the 
environmental enrichment protocol, in which only 137 of 2469 protein spots displayed a 
change in abundance greater than 1.5 fold. Using biological variance analysis it was 
revealed that only 71 of the proteins significantly (P < 0.05) changed in abundance 
following the environmental enrichment protocol (see fig 6.2.D), with slightly fewer 
somatic proteins changing expression (32) than dendritic proteins (42). Only 2 proteins 
significantly changed in abundance in both the somatic and dendritic regions. Following 
MALDI-ToF/Q-STAR mass spectrometry several of these proteins were identified and 
displayed in tables 1 and 2 in the appendix.  
The schematic representation of the DiGE gel shows the approximate locations of where a 
significant (P < 0.05) change in the expression of β-Actin, Rho A, and hnRNP K occurs, as 
identified by the MALDI-ToF/Q-STAR mass spectrometry (see appendix). These locations 
correspond to the locations on the 2D western blots where protein changes were observed. John Broad, 2009     Chapter 6 135 
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Fig 6.2 The effect of an environmental enrichment protocol on the global 
protein expression of the hippocampus
A. These pictures show the environmental conditions for the animals exposed to an open field (i) or an  enriched (ii) 
environment for a total period of 6 weeks. B. Hippocampal tissue was then isolated from either predominantly dendritic or 
somatic regions (shaded areas). C. Total protein extracts from area CA1 stratum pyramidale of the enriched animals show 
a number of proteins change in abundance relative to the control animals. The scatter plot shows the log abundance ratio of 
individual sample spot pairs against the maximum protein spot abundance. Individual protein spots show decreased (￿), 
unaltered (￿) and increased (￿) log abundance ratios. The vertical lines indicate 1.5 fold change in abundance. The red 
curve shows the frequency distribution of the log abundance ratios, and the blue curve shows the normalised modal 
frequency fitted to a modal peak of zero. Note that the majority of protein spots remain unaltered by the enrichment 
protocol. D. The gel image indicates that the environmental enrichment protocol induced significant (P < 0.05) changes in 
protein abundance in 71 proteins revealed by biological variance analysis. Of these proteins 42 displayed differential 
abundance only in the somatic layer (open squares), whilst 32 showed significantly altered abundance in the somatic layer 
(black squares), and only 2 proteins significantly changed abundance in both the somatic and dendritic layers (grey 
squares). E. Schematic of a DiGE gel showing the approximate locations of the proteins β-Actin, Rho A, and hnRNP K, as 
identified by MALDI-ToF mass spectrometry. The indicated location of β-Actin, which can be observed in several 
locations throughout the gel, is the one identified as significantly changing in the DiGE analysis. 
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6.3 The change in expression of the proteins β-Actin, 
Rho A, and hnRNP K following exposure to a model 
of environmental enrichment 
The DiGE analysis revealed the altered expression of a number of hippocampal proteins 
following environmental enrichment. To confirm and validate the findings of the DiGE 
experiment using a different experimental approach, representative proteins were selected 
from the DiGE study. Commercial antibodies selective for these proteins were then used to 
identify these proteins.     
In order to confirm the changes in expression of these proteins, 2 dimensional western 
blots were performed for β-Actin, Rho A, and hnRNP K. β-Actin, the cell structural 
protein, increases in expression at the locus identified following the enrichment protocol 
(fig 6.2.1.B). Three extra protein spots can be observed following the enrichment protocol 
as opposed to the control showing the change in the pattern of expression of β-Actin. The 
enrichment protocol causes a decrease in the expression of the cell signalling protein Rho 
A. Rho A displays a weaker but more disparate protein spot in the tissue taken from the 
hippocampus of the animals exposed to an enriched environment than the poor 
environment. Similarly, hnRNP K decreased in expression in response to exposure to the 
enriched environment, as shown by the expanded gel image, which validates the findings 
of the DiGE experiment.  
6.4 The change in expression of MeCP2 in response to a 
model of environmental enrichment 
To assess the effect of environmental enrichment on the DNA methyl binding protein 
MeCP2, 1D western blot experiments were performed using a commercially available anti-
MeCP2 antibody. The representative bands from the 1 dimensional western blot (fig 6.4) 
show that the enrichment protocol increases the expression of MeCP2. The theoretical size 
from the amino acid sequence of MeCP2 is 52 kDa but the band migrates to around 73 kDa 
(Myaki and Nagai 2006). The summary histogram (fig 6.4.B) shows that there is a 
significant (P = 0.04) increase in the mean (n = 6) expression of MeCP2 in the 
hippocampus of animals exposed to an enriched environment as opposed to a poor 
environment. This is reflected in the increase in the optical density in the bands 
corresponding to MeCP2. John Broad, 2009     Chapter 6 137 
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enrichment protocol causes a decrease in the expression of Rho A at this locus. C. An decrease in the expression of 
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Fig 6.4 Quantification of expression change of MeCP2 in response to 
enriched environment
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A.  Representative 1 dimensional western blot showing the effect of an enrichment protocol on the expression 
of the histone modification protein MeCP2, taken from a combined sample of 3 animals. B. Summary 
histogram showing environmental enrichment causes a significant (P = 0.04) increase in the mean (n = 6) 
expression of MeCP2. Each individual experiment is taken from a combined protein sample of 3 animals, 
with 5 replicates per gel, across 6 gels. The pairing of the data approaches significance (P = 0.07). 
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6.5  Discussion 
As well as the electrophysiological approaches in the previous chapter, it is important to 
analyse the changes that occur at the proteomic level following cognitive enhancing 
strategies, allowing the isolation of cognition–related biomarkers and the identification of 
novel molecular entities involved in cognitive processes. The pharmaceutical industry is 
especially interested in the reversal of cognitive deficits that are associated with 
neurological conditions like Alzheimer’s Disease and schizophrenia (Buchanan et al., 
2007; Chamberlain et al., 2006).  
The cognitive enhancing strategy investigated in this chapter was environmental 
enrichment, which is reported to result in improvements in a range of cognitive tasks 
(Duffy et al., 2001). Regular changes in the features of the environment in which the 
rodents were housed ensured the rodents underwent spatial re-mapping (Jankowsky et al., 
2005), thought to be crucial in the enhancement of cognition that occurs in this 
environment. 
Previous studies showed that the expression of genes performing a range of different 
functions varied following an environmental enrichment regime (Rampon et al., 2000). Fig 
6.2 shows that the expression of proteins also changes following exposure to the six-week 
environmental enrichment protocol. The majority of the proteins that change are involved 
in signalling, metabolism, biogenesis and cytoplasmic organisation (see appendix). It is 
likely that as structural and metabolic proteins are more highly abundant than other classes 
of proteins, one may expect a higher proportion of proteins from these classes to be 
identified. In the dendritic sample, a substantially greater proportion of signalling proteins 
change in expression as compared to the somatic fraction (fig 3, appendix), perhaps due to 
the enhancement of synaptic transmission, and therefore synaptic remodelling, which 
occurs in the dendrites following the enrichment protocol (Duffy et al., 2001; Huang et al., 
2006). 
Three proteins that significantly changed in expression were selected for further analysis – 
the structural protein β-Actin, the signalling protein Rho A, and the heterogeneous nuclear 
ribonuclear protein complex K (hnRNP K). These proteins were chosen as representative 
examples of the proteins investigated as they perform different functions within neurones, 
and they are expressed in different compartments of the neurone. Also an important 
consideration for the 2D western analysis is the availability of an antibody for the John Broad, 2009     Chapter 6 140 
particular protein of interest. One of the proteins initially chosen, CRMP2, an important 
protein in axonal growth that promotes microtubule assembly (Fukata et al., 2002), was 
eventually rejected due to the unavailability of a specific CRMP2 antibody. These proteins 
were chosen to perform 2D western blot experiments as the location of the gel spot on the 
DiGE experiment could be related to the position of the spot identified by the specific 
antibody to the protein. Performing 2D (as opposed to 1D) western blots also allowed the 
change in charge of the protein to be identified. The activation state of proteins, which can 
be changed by processes such as phosphorlyation, can be differentiated even if the total 
expression level does not change. These proteins all changed spot density in the direction 
predicted by the DiGE experiment, confirming the validity of the conclusion that the 
proteins changed in expression following exposure to an enriched environment.  
The DiGE experiment highlighted the wide range of proteins that change in expression 
following an environmental enrichment protocol. These experiments showed that β-actin, a 
widely expressed protein and one often used as a protein loading control in western blots 
(Dennis-Sykes et al., 1985; Towbin et al., 1979), is dynamically regulated and can change 
in expression in response to environmental conditions. β-Actin is a cytoskeletal protein that 
regulates the leading edge of cell growth (Wallar and Alberts, 2003). A change in the total 
expression of β-Actin demonstrates that changes in the synaptic morphology may occur 
during the enrichment protocol. Indeed, spine formation and synapse re-modelling is 
important in the expression of long term potentiation (Popov et al., 2004), and actin 
polymerisation is implicated in LTP formation (Huntley et al., 2002; Krucker et al., 2000).    
Rho A is part of a family of Rho GTPases which are small proteins involved in the 
transduction of extracellular signals to the nucleus (Jaffe and Hall, 2005). Rho GTPases are 
known to play a role in hippocampal neuronal plasticity (O'Kane et al., 2003; O'Kane et al., 
2004). In particular, RhoA is known to be important in the maintenance of neuronal 
structures (Threadgill et al., 1997). RhoA was found to increase in expression following 
exposure to an enriched environment. Activated RhoGTPases, including RhoA, are 
involved in the enhancement of learning and memory in mice (Diana et al., 2007), 
suggesting that an increased level of RhoA would be beneficial to the processes that occur 
during spatial re-mapping. The conditional knockout or pharmacological inhibition of 
RhoA during the environmental enrichment protocol would lead to a greater understanding 
of the role RhoA plays in the enhancement of cognition.  
The protein kinase hnRNP K is involved in the control of transcription of a number of cell 
cycle regulators (Michelotti et al., 1996), and activation of hnRNP K involves an increase John Broad, 2009     Chapter 6 141 
in RNA synthesis of its target genes (Lee et al., 1996). Expression of hnRNP K is 
increased in the model of environmental enrichment, and thus the expression of the genes 
controlled by hnRNP K may be involved in the enhancement of cognition observed 
following the enrichment protocol. An increase in RNA synthesis is involved in the 
process of long term potentiation, and as such, activated hnRNP K may act to transcribe 
target genes in this process.  
However, activated hnRNP K can antagonise the effects of the neuronal nicotinic 
acetylcholine receptor promoter (Du et al., 1998), amongst other protein targets. Activation 
of the neuronal nicotinic acetylcholine receptor is widely reported to be pro-cognitive 
(Ferguson et al., 2007; Hodgkiss and Kelly, 2001; Timmermann et al., 2007). This 
suggests that if an increase in the expression of hnRNP K is mediating the enhancement of 
cognitive function, it must be pro-cognitive despite its detrimental effect upon nicotinic 
acetylcholine receptor expression.   
There are clearly several advantages and disadvantages to this method of investigating 
changes in protein expression. This approach allows an unbiased evaluation of the whole 
proteome, and all the proteins that do significantly change in expression can be identified 
following the DiGE experiment. This allows the identification of proteins previously not 
associated with the changes that occur following cognitive enhancing strategies. The 
confirmation of the change in protein expression by the 2D western blotting analysis 
provides an extra assurance of the veracity of the conclusions made following the DiGE 
experiments. However, conclusions obtained using a DiGE approach must include several 
caveats. With such a large data set generated, this consequently increases the chance of 
false positives and negatives being generated. Many proteins, especially membrane bound 
proteins, do not run onto the gels and therefore cannot be identified by the DiGE approach. 
Proteins with a low abundance are less likely to be identified by mass spectrometry than 
proteins with an abundant expression. As only one time point was chosen (6 weeks in this 
case) other proteins important in the development of cognitive enhancement may be 
missed. As such, further experiments investigating proteins that are identified by this 
approach should be carried out to evaluate the precise temporal and spatial expression and 
function of the proteins. This would allow further understanding of the roles of these 
proteins in cognitive enhancement.    
The second approach used to investigate changes in protein expression that occur 
following exposure to an enrichment environment was the use of a conventional 1D 
western blot. The protein chosen was methyl-CpG binding protein 2 (MeCP2), a protein John Broad, 2009     Chapter 6 142 
that is aberrantly expressed in the neurodevelopmental disorder known as Rett syndrome 
(Lewis et al., 1992; Meehan et al., 1992a; Meehan et al., 1992b). MeCP2 is an X-linked 
protein and binds to methylated CpG islands of DNA and suppresses gene transcription at 
these locations (Nan et al., 1998). The condition is X-linked (Amir et al., 1999) and female 
patients develop severe autistic-like and other symptoms after 6-18 months of apparently 
normal development (Chahrour and Zoghbi, 2007). Other autistic spectrum disorders are 
linked to mutations in the MECP2 gene in males (Jan et al., 1999; Moretti and Zoghbi, 
2006). MeCP2 is thought to play a role in neuronal maturation and plasticity through 
transcriptional repression (Nan et al., 1997) and modification of RNA splicing (Young et 
al., 2005).  
The main finding of this section was the demonstration that the expression of MeCP2 does 
significantly increase following exposure to an enriched environment. The enrichment 
protocol, through the regularly changing environment, causes spatial re-mapping in the 
hippocampus and therefore changes in the plasticity of the neurones must occur (Duffy et 
al., 2001). The upregulation of MeCP2 may therefore be required to allow these plasticity 
changes to occur. As MeCP2 is involved in neuronal maturation then an upregulation of 
MeCP2 may occur as neurogenesis increases in the hippocampus following environmental 
enrichment (Nilsson et al., 1999).  
The upregulation of MeCP2, a transcriptional repressor, fits with the fact that the majority 
of proteins identified as significantly changing expression decreased in expression 
following exposure to the model of environmental enrichment. It is possible that 
expression of MeCP2 is important in the subsequent down-regulation of many genes 
(Rampon et al., 2000) and proteins (see appendix) following the enrichment protocol. In 
contrast to the findings above, immunohistochemical studies (Zhou et al., 2006) have 
shown that total levels of MeCP2 expression do not change in response to environmental 
stimuli, but the level of phosphorylation of the protein is activity dependent. As the 
antibody used above was raised such that it was not selective between the phosphorylated 
and dephosphorylated states of MeCP2, the activation state of the protein could not be 
assessed following the enrichment regime. Interestingly, changes in either the gene or 
protein expression of MeCP2 were not identified by the microarray (Rampon et al., 2000) 
or DiGE (see appendix) studies.        
It is also tempting to speculate that the environmentally poor model is essentially a model 
of Rett syndrome, as there is a lower expression of this protein than in the enrichment 
model. MeCP2 deficient mice display altered social interactions (Moretti et al., 2005). John Broad, 2009     Chapter 6 143 
When compared to the enrichment model, there was a decreased expression of this protein, 
and a measurable cognitive impairment as in Rett syndrome. However, as introducing 
mutations into MeCP2 can produce further cognitive deficits, the environmentally poor 
environment is a model of a mild form of Rett syndrome at best. Cognitive impairment 
may occur through other mechanisms, and this model would have to be characterised 
further to evaluate its potential use as a model of mild Rett syndrome.    
An important proviso in interpreting the results from the environmental enrichment model 
is that the animals exposed to the enriched environment were likely to get more exercise 
that the animals exposed to the poor environment. Exercise can change protein expression 
(Ding et al., 2006; Ueda et al., 2003) and improve cognitive function (Hicks and Birren, 
1970; Radak et al., 2001). It is difficult to control for and separate these changes from the 
changes induced by the spatial re-mapping and exploratory behaviour.   
Both approaches, despite the fact that the somatic and dendritic regions were separated for 
the DiGE experiment, can not provide any information at the cellular or regional levels of 
protein expression. There are many distinct cell types within the hippocampus, including 
the pyramidal cells, the interneurons, the glial cells, the blood vessels etc. Important 
changes that occur in one region that do not occur in another may not be identified by the 
proteomic approaches used above. One way to overcome this problem is to identify the cell 
type using immunohistochemistry single cell RT-PCR. Another approach is to genetically 
label a sub-population of cells with fluorescent markers linked to markers of that cell type, 
and use fluorescence activated cell sorting (FACS) to separate this particular population of 
cells (Herzenberg et al., 2002). This would allow proteomics to be subsequently performed 
upon a particular cell type.    
The environmental enrichment model confirms that improvements in cognition do not 
necessarily cause epileptogenesis, as some of the approaches to enhancing cognition 
investigated in the previous chapters do. Environmental enrichment can actually decrease 
seizure susceptibility in rodents (Young et al., 1999), indicating an increase in cellular 
excitability to the point of increased seizure susceptibility is not required to improve 
cognitive function.     
6.6 Conclusion   
In this chapter a further strategy shown previously by several groups to enhance cognition, 
an environmental enrichment model, was investigated. A vast number of proteins in many John Broad, 2009     Chapter 6 144 
different classes, that perform many different functions, changed in expression following 
the enrichment protocol. An indication of the extremely large range of proteins that are 
modulated in expression following a cognitive enhancing strategy was gained from the 
DiGE experiment and the subsequent western blots. As MeCP2 was not identified as 
significantly changing in expression following exposure to the enriched environment in the 
proteomic analysis, but was in the 1D western blot approach, this indicates the proteomic 
approach cannot identify all of the relevant proteins at the same time. A combination of 
approaches using genetics, molecular biology, pharmacology, electrophysiology, and 
proteomics and is required to gain further insight into the processess that underlie cognitive 
enhancement.  143 
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7.1 Introduction 
The major focus of this thesis was the investigation of hippocampal physiology, 
pharmacology and protein expression with respect to cognitive enhancing strategies. Two 
approaches to cognitive enhancement, one using nootropic drugs to induce oscillations and 
another using an environmental enrichment, were investigated. Initially, potentially 
nootropic compounds were investigated to establish the propensity of these compounds to 
induce network oscillatory activity in hippocampal slices. Network oscillations are 
correlated with specific brain functions, and an enhancement of oscillatory activity has 
been proposed to rectify cognitive impairment in a number of different conditions (Cobb 
and Davies, 2005). Many compounds that can enhance cognitive function also show a 
tendency to be epileptogenic, and so the effects of these compounds were investigated in 
models of epileptiform activity. The hippocampus is an ideal brain region in which to 
study these processes, as the hippocampus is a region involved in mnemonic processes, but 
is also an area that is highly susceptible to the generation of seizures (Schwartzkroin, 
1993). The protein changes that occur following exposure to an enriched environment, an 
experimental paradigm which is known to improve cognitive function, were identified 
using a global proteomic approach, following which the changes in expression of selected 
proteins were confirmed by western blots. The findings of these experiments, and the 
potential implications for the development of cognitive enhancing strategies, are discussed 
below.     
7.2 The effect of mAChRs on hippocampal 
neurophysiology 
Application of mAChR agonists to hippocampal slices leads to the emergence of a range of 
oscillatory activities. Both physiological and pathophysiological oscillations induced by 
the application of mAChR agonists have long been identified within the hippocampus 
(Rutecki and Yang, 1998; Williams and Kauer, 1997). The selective M1 mAChR agonist 
77-LH-281 behaves very differently from non-M1 selective mAChR agonists in that it may 
possess desirable pro-oscillatory/cognitive properties whilst not producing unwanted 
pathophysiological oscillatory responses.  
In naïve hippocampal slices, application of a range of mAChR agonists, including 
carbachol, oxotremorine, and pilocarpine, have been shown to induce epileptiform-like 
activity. These agonists also induce seizures within laboratory animals (Turski et al., 
1989). As the mAChR agonists are also putatively pro-cognitive and promote synaptic John Broad, 2008     Chapter 7 147 
plasticity (Huerta and Lisman, 1993; Messer et al., 1990), an agonist that can promote 
mAChR-mediated transmission, but does not promote epileptiform activity, is a potentially 
useful therapeutic strategy to promote cognitive function. 77-LH-281, an allosteric M1 
mAChR agonist, promotes gamma frequency oscillations in hippocampal slices, which are 
associated with cognition (Tallon-Baudry and Bertrand, 1999). Promoting gamma activity 
is a potential therapeutic strategy in reversing the cognitive decline that is observed in 
schizophrenics, as a reduced power of gamma frequency oscillatory activity is observed in 
schizophrenic patients (Haig et al., 2000). In the majority of both naïve slices, and slices in 
which a range of mechanistically distinct epileptiform-like activities were induced, 77-LH-
281 did not promote pathophysiological epileptiform-like activity. This is in contrast to the 
non-subtype-selective mAChR agonist oxotremorine-M.  
Gamma frequency oscillations are also initiated by the application of kainate. However, 
application of kainate to laboratory animals leads to the eventual emergence of seizure-like 
activity (Ben-Ari et al., 1981). Thus further in vivo studies are required to evaluate the 
potential epileptogenic potential of 77-LH-281.  
Profound differences in the emergent network activities were observed depending on the 
orientation in which the slices are made. The main difference observed between the slices 
was a greater tendency for slices prepared in the coronal orientation to display gamma 
frequency oscillatory activity in response to kainate and 77-LH-281, whereas gamma 
frequency oscillations were absent in slices prepared in the parasagittal orientation. This is 
likely to be due to basket cells interneurone aborizations being predominant in the coronal 
sections, with stratum oriens-lacunosum moleculare being the predominant interneurone 
class within parasagittal slices (Gloveli et al., 2005).     
Previously, cholinergically induced gamma frequency oscillations have been shown to be 
sensitive to antagonists of both fast glutamatergic synaptic transmission and fast 
GABAergic synaptic transmission (Fisahn et al., 1998; Mann et al., 2005). Similarly, the 
gamma frequency oscillation induced by 77-LH-281 is also sensitive to antagonists of 
ionotropic glutamate and GABAA receptors.  
A range of mechanistically distinct models of epileptiform activity allowed both the 
potential pro-epileptogenic nature of mAChR agonists to be investigated, and insight into 
the network that underlies these oscillations. In the main, oxotremorine-M increased the 
frequency of inter-ictal-like events and induced ictal-like activity in three of the four 
epileptiform models studied. In contrast, 77-LH-281 did not induce ictal-like activity in John Broad, 2008     Chapter 7 148 
any of the models studied and only increased the frequency of inter-ictal-like events in the 
bicuculline model. This indicates that 77-LH-281 displays a lower potential to be 
epileptogenic than oxotremorine-M.   
Inter-ictal-like events are characterised by paroxysmal depolarising shifts within the 
pyramidal cells. The frequency of paroxysmal depolarisation shifts is increased with a 
greater excitability of the network; this in turn increases the frequency of inter-ictal-like 
events. Excitability is manifest as an increased pyramidal cell action potential firing within 
the hippocampus (Rutecki et al., 1985). mAChR agonists depolarise and cause action 
potentials within pyramidal cells partially through M1 mAChRs (Fisahn et al., 2002), so the 
absence of an increase in inter-ictal-like event frequency in both the 4-AP and low Mg
2+ 
modes following M1 mAChR activation is somewhat surprising. It is possible that an 
increased activation of interneurones occurs in these models leading to an increase in 
GABAA mediated IPSPs in pyramidal cells. In the bicuculline model this form of 
inhibition is removed allowing an increase in inter-ictal-like event frequency. As inter-
ictal-like event frequency has been correlated with [K
+]o it would be interesting to record 
the [K
+]o with ionic sensitive electrodes.    
The application of oxotremorine-M to hippocampal slices leads to pathophysiological ictal-
like activity in both quiescent hippocampal slices and slices in which inter-ictal-like events 
are ongoing. This ictal-like activity is dependent upon AMPA/kainate mediated glutamate 
signalling, and is not replicated by M1 mAChRs. Ictal-like events are characterised by a 
transient decrease in inhibition from interneurones, with GABAB prominent in the 
bicuculline model. Greater insight into the mechanism of ictal generation in hippocampal 
networks in a variety of these epileptiform models would be provided by intracellular 
recordings from pyramidal cells and morphologically distinct classes of interneurones in 
the hippocampus. In hindsight a more thorough investigation of the role of the GABAB 
receptor in these models would have been of interest.   
As a strategy to enhance cognition, the development of a specific M1 mAChR agonist 
appears to show a greater tendency to induce gamma oscillations, and less of a propensity 
to induce pathophysiological epileptiform-like activity, than non-subtype-selective 
mAChR agonists. 77-LH-281 therefore has a more favourable electrophysiological profile 
for use as a potential cognitive enhancer than non-subtype selective mAChR agonists.    John Broad, 2008     Chapter 7 149 
7.3 The effect of ampakines in hippocampal slices 
Another class of compounds that are potentially useful cognitive enhancing drugs are the 
ampakines. These are positive allosteric modulators of AMPA type glutamate receptors, 
and potentiate fast glutamatergic synaptic transmission. Compounds with this property 
have long been associated with cognitive enhancement (Ingvar et al., 1997; Ito et al., 
1990), but, like mAChR agonists, they have the potential to be pro-epileptogenic (Qi et al., 
2006). Here the effects of two ampakines were investigated, one that increases the 
amplitude of current flow through the AMPA receptor, and the other that increases the 
time the ion pore is open. The potential pro-epileptogenic effect of the ampakines was 
tested in the same models of epileptiform activity used in the investigations of 77-LH-281.   
In quiescent slices both ampakines did not induce any oscillatory activity. In the 
epileptiform models, both CX546 and CX691 significantly increased the frequency of 
inter-ictal-like events. This increase in the frequency of inter-ictal-like events corresponds 
to an increase in excitability in the network. CX546 showed a tendency to promote ictal-
like activity only the 4-AP model, possibly due to an increase in the window of temporal 
summation for EPSPs acting on interneurones to lead to an eventual depolarisation block 
of the interneurones. This may only happen in the 4-AP model as the frequency of inter-
ictal-like events, and paroxysmal depolarising shifts, is higher than in the other models 
investigated. It is also possible that an increased level of excitation reverses the chloride 
gradient to make GABAA mediated potentials excitatory.    
These experiments show that these ampakines are potentially pro-epileptogenic, as they 
increase the frequency of inter-ictal-like events in hippocampal slices. The ampakines only 
display a tendency to promote epileptiform activity in slices in which epileptiform activity 
was induced prior to the application of the ampakine: in less excitable physiological 
networks ampakines did not promote epileptiform-like activity. It is possible that in non-
epilieptics ampakines may have a wide enough therapeutic index to promote cognitive 
function without promoting pathological oscillations. The ampakines that enhance the 
single channel conductance of the AMPA receptor, like CX691, are more likely to be safer 
than ampakines that increase the open time of the ion channel, like CX546. Conversely, as 
oscillatory activity is associated with mnemonic function (Traub et al., 1998), it may be 
that ampakines in the same class as CX546, which promote oscillatory activity, are better 
cognitive enhancers. Further in vivo studies investigating the cognitive and pro-epilieptic 
potential of these ampakines could be performed to determine the potential use of these 
compounds as cognitive enhancers in the clinic.    John Broad, 2008     Chapter 7 150 
7.4 The environmental enrichment protocol  
The environmental enrichment protocol is a well-characterised method of improving the 
cognitive ability of rodents (Varty et al., 2000). Changes in protein expression that 
occurred following exposure to an enriched environment were investigated. Several of 
these proteins were identified using a non-biased proteomic approach, and one protein was 
selected due to the phenotype of severe cognitive impairment that occurs following 
disruption of this protein. These complementary approaches also allowed a comparison of 
the methods used to select these proteins.  
There were many proteins, of several functional classes, that changed in expression 
following exposure to the environmental enrichment protocol. Some or all of these may 
play a role in the cognitive enhancement that occurs following exposure to the enriched 
environment. The ones selected for confirmation of the change in expression by 2D 
western blot analysis were known to perform different roles within the neurones.  
These proteins significantly changed in expression and were identified using MALDI-ToF 
mass spectrometry. Database searches were then performed to identify these proteins, and 
antibodies for these proteins were then selected. All of these tasks have limitations. If the 
protein does not resolve on the gel the protein cannot be identified. This is a particular 
problem with hydrophobic proteins like neurotransmitter receptors. If the proteins are not 
picked up by the mass spectrometer or do not appear within the database they cannot be 
identified. 2D proteomics provides a greater weighting to the more abundantly expressed 
proteins, and as such the proteins that are present in small amounts within the cells are less 
likely to be identified as significantly changing. No emphasis is given to proteins that play 
a more prominent role in the changes that are observed between the two groups. A ‘single 
gene’ approach often provides more detailed insight into the key proteins that underlie 
changes that occur in following interventions like environmental enrichment, though an 
appreciation of the network that protein exists in in crucial to understanding these complex 
changes.  
MeCP2 is an important protein in the regulation of the expression of many genes (Nan et 
al., 1998). In the model of environmental enrichment many different genes are regulated 
(Rampon et al., 2000) and it is likely that epigenetic factors play a role in changes of 
expression of these genes. Recently environmental enrichment has been shown to help 
ameliorate the cognitive decline that occurs in Rett syndrome mice (Kondo et al., 2008; 
Nag et al., 2009). It was therefore decided to investigate the expression of MeCP2 in John Broad, 2008     Chapter 7 151 
environmentally enriched animals. MeCP2 is a protein that is known to be important in 
cognitive function, as disruption of MeCP2 leads to Rett syndrome (Amir et al., 1999). 
MeCP2 is significantly increased in expression in the enriched model, despite the fact that 
the DiGE approach did not identify MeCP2 as significantly changing in expression. A 
change in the expression of MeCP2 would have many downstream effects on the 
expression of many genes that are regulated by MeCP2, and these changes may partially 
underlie the changes in the global proteome that occur following exposure to an enriched 
environment. This emphasises some of the limitations of the 2D DiGE approach. Prior 
selection of protein targets that may be involved in cognitive enhancement would lead to 
important proteins in this process being missed. As such, combined proteomic approaches 
are required to investigate fully the changes in protein expression that underlie cognitive 
enhancement.      
7.5 Combination of approaches investigating cognitive 
enhancement 
In this thesis two experimental approaches to enhance cognition, the application of 
nootropic drugs, and exposure to an environment that improves cognitive function, were 
investigated. It would be interesting to combine both of these, and other, approaches to 
investigate further cognitive enhancement. Following the chronic or acute treatment of 
animals with putatively nootropic drugs, such as 77-LH-281 or ampakines, the 
behavioural, electrophysiological and proteomic changes that occur following drug 
application could be compared to the changes that occur in enriched animals. Also, it 
would be interesting to see if the deficits in cognitive function that occur in the poor 
environment can be reversed by treatment with cognitive enhancers. Protein changes that 
occur may provide a reliable biomarker for cognitive impairment, a useful way of 
identifying the effectiveness of future nootropic drugs, and even provide possible new 
targets for cognitive enhancement strategies.  
7.6 Conclusions  
This thesis has provided insight into both electrophysiological properties and protein 
expression within the hippocampus, and the relation of these to the field of cognitive 
enhancement. Mechanistic insight into the role of specific mAChR subtypes in oscillations, 
and the effect of nootropic compounds on emergent network activity has been gained. 
Importantly, the novel specific M1 mAChR 77-LH-281 has been shown to induce an 
oscillatory rhythm that is associated with cognition, and to not promote ictal-like John Broad, 2008     Chapter 7 152 
epileptiform activity. Ampakines show a tendency to promote some forms of 
pathophysiological activity. This thesis also showed the wide range of proteins that change 
in expression following exposure to an enriched environment, indicating the complex sub-
cellular response to this cognitive enhancing strategy. The studies performed in this thesis 
can hopefully underpin further research into cognitive enhancing strategies, and to help 
ameliorate cognitive decline in diseases such as Alzheimer’s disease and schizophrenia.    153 
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Abstract—Exposure to an enriched environment promotes
neurochemical, structural and neurophysiological changes
in the brain and is associated with enhanced synaptic plas-
ticity and improved hippocampal-dependent learning. Using
a global proteomics-based approach we have now been able
to reveal the altered expression of a diverse range of hip-
pocampal proteins following exposure to an enriched envi-
ronment. Male Hooded Lister rats (8 weeks) were subjected to
a 6-week regimen in which they were housed in either non-
enriched (open ﬁeld) or enriched conditions (toys, wheels
etc.). Whole protein extracts from stratum pyramidale and
stratum radiatum of area CA1 were then isolated and sub-
jected to differential gel electrophoresis [McNair K, Davies
CH, Cobb SR (2006) Plasticity-related regulation of the hip-
pocampal proteome. Eur J Neurosci 23(2):575–580]. Of the
2469 resolvable protein spots detected in this study, 42
spots (1.7% of the detectable proteome) derived from pre-
dominantly somatic fractions and 32 proteins spots from
dendritic fractions (1.3% of detectable proteome) were sig-
niﬁcantly altered in abundance following exposure to an
enriched environment (somatic: 14 increased/28 de-
creased abundance, range 21.5 to 11.4-fold change; den-
dritic: 16 increased, 16 decreased abundance, range 21.6
to 13.0-fold change). Following in-gel tryptic digestion and
Maldi-Tof/Q-star mass spectrometry, database searching
revealed the identity of 50 protein spots displaying envi-
ronmental enrichment-related modulation of expression.
Identiﬁed proteins belonged to a variety of functional
classes with gene ontology analysis revealing the majority
(>70%) of regulated proteins to be part of the energy me-
tabolism, cytoplasmic organization/biogenesis and signal
transduction processes. © 2006 IBRO. Published by
Elsevier Ltd. All rights reserved.
Key words: hippocampus, environmental enrichment, pro-
teomics, glutamate, plasticity, proteome.
An enriched environment where animals are introduced to
novel, complex and stimulating surroundings has long
been known to promote structural changes in the brain and
to enhance learning and memory performance in rodents
(Hebb, 1947). Indeed, more recent studies have con-
ﬁrmed exposure to an enriched environment to result in
altered expression of various neurochemical markers
(Huang et al., 2006; Naka et al., 2005) as well as neu-
rophysiological changes such as enhanced synaptic
plasticity (Irvine and Abraham, 2005). For instance, en-
vironmental enrichment is reported to modify the PKA-
dependence of long-term potentiation (LTP) as well as
improving hippocampal-dependent memory (Duffy et al.,
2001).
However, the exact cellular and molecular basis for
enrichment-induced structural or neurophysiological mod-
iﬁcations remains unknown. Altered intracellular signaling
and modiﬁed synaptic strength may support enrichment-
induced cognitive changes. Microarray studies following
short- and long-term environmental enrichment exposure
have identiﬁed genes involved in DNA/RNA synthesis,
neuronal signaling, neuronal growth/structure, cell death
and protein processing (Rampon et al., 2000) as possible
targets for neuronal adaptations in response to environ-
mental enrichment. However, a global assessment of al-
terations in expression at the protein level remains to be
undertaken. Therefore, to better understand the degree
and patterns of altered protein expression underlying
environmental enrichment, we have used difference gel
electrophoresis (DiGE) to analyze differential global pro-
tein expression in the rat hippocampus following several
weeks of exposure to a complex and stimulating envi-
ronment. DiGE permits pairwise comparison between
protein samples on a single gel by labeling each protein
sample with a distinct ﬂuor with the beneﬁcial incorpo-
ration of an internal standard (Unlu et al., 1997; Lilley
and Friedman, 2004).
The unique anatomical structure of the hippocampus
in which the overwhelming majority of principal cells are
co-aligned enables the separation of dendritic ﬁelds
from soma. In the current study we have taken advan-
tage of this feature to enable a simple form of tissue
pre-fractionation in which the somatic tissues are sepa-
rated from the synaptic transmission domain of the cell
to allow independent analysis of these two areas.
We report altered expression of a diverse range of
proteins isolated from somatic and dendritic hippocampal
regions in response to environmental enrichment. The re-
sults indicate that proteins involved in neuronal signaling,
structural alterations and protein metabolism, among oth-
ers, are altered following exposure of rats to a complex and
stimulating environment.
*Corresponding author. Tel: 144-0141-330-2914; fax: 144-0141-
330-2923.
E-mail address: s.cobb@bio.gla.ac.uk (S. Cobb).
Abbreviations: ACSF, artiﬁcial cerebrospinal ﬂuid; BVA, biological vari-
ance analysis; DiGE, difference gel electrophoresis; LTP, long-term
potentiation; PMF, peptide mass ﬁngerprint.
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413EXPERIMENTAL PROCEDURES
Animals
Hooded Lister rats (male, aged 8 weeks) were obtained from
Harlan (Bicester, UK) and initially housed in groups of ﬁve in
standard cages from 3 months prior to the beginning of the
study. They were given ad libitum access to food and water and
were kept on a 12-h light/dark cycle. Upon commencement of
the enrichment study the enriched group was placed in a black
Perspex box 100350 cm in size which contained a food corner,
suspended drinking bottle and sawdust base in addition to several
novel objects including tubes, running wheels, platforms, beams,
ladders etc. These enrichment objects were re-arranged and
some were removed and replaced by novel items on a weekly
basis. This ensured a degree of spatial novelty and learning about
objects and their relationships. Control groups were placed in the
same size and type of box, with a food corner, suspended drinking
bottle and sawdust base with no additional enrichment objects.
Both enriched and control groups were placed in their correspond-
ing environments overnight for 15 h, 5 days per week for a total
experimental period of 6 weeks.
Tissue harvest
At the end of the 6-week regimen, control and enriched rats were
killed with an overdose of intraperitoneally injected tribromoetha-
nol followed by cervical dislocation in accordance with local ethical
guidelines and UK legislation [Animals (Scientiﬁc Procedure) Act,
1986]. All efforts were made to minimize the suffering and number
of animals used in each experiment. Brains were rapidly trans-
ferred into ice cold (0–3 °C), oxygenated (95% O2, 5% CO2)
artiﬁcial cerebrospinal ﬂuid (ACSF) of the following composition
(mM): NaCl 124, KCl 3, NaHCO3 26, NaH2PO4 1.25, MgSO4 1,
D-glucose 10 and CaCl2 2. The hippocampi were dissected free
and transverse 500 mm thick slices cut using a McIlwain tissue
chopper (Camden Instruments, Loughborough, UK). In oxygen-
ated ice cold ACSF and under a dissection microscope, hip-
pocampal area CA1 was dissected free from surrounding regions
following which the stratum radiatum and stratum pyramidale were
collected separately and snap frozen in liquid nitrogen and stored
at 270 °C prior to proteomic analysis.
DIGE sample extraction and preparation
For each individual protein sample the CA1 region from three to
four hippocampal slices were pooled and lysed in 150 ml of buffer
containing 10 mM Tris pH 8, 5 mM magnesium acetate, 8 M urea
and 2% ASB14. Lysed tissue was then subjected to ﬁve freeze–
thaw cycles and left at room temperature for 1 h to aid solubiliza-
tion of proteins. Samples were subsequently sonicated (434 min
with 2 min intervals to prevent the overheating of urea in lysis
buffer) and centrifuged at 13,000 r.p.m. for 15 min. Following
sample cleanup using an ammonium acetate precipitation, protein
pellets were re-suspended in approximately 70 ml of lysis buffer
and protein concentration determined using Pierce’s BCA Protein
Assay Kit (Perbio Science UK Ltd., Cheshire, UK).
Sample CyDye labeling
Fifty micrograms of each protein sample was labeled with 400
pmol of either Cy2, 3 or 5 according to the manufacturer’s instruc-
tions (GE Healthcare, Amersham, Little Chalfont, UK). Treatment
samples were assigned randomly across six to eight gels (sup-
plementary methods Table 1). Prior to the 1st dimension Cy2, 3
and 5 samples were pooled and added to the same volume of 23
sample buffer containing 8 M urea, 2% ASB14, 20 mg/ml DTT and
2% IPG buffer and then corrected to a ﬁnal volume of 450 ml using
rehydration buffer (8 M urea, 2% ASB14, 2 mg/ml DTT and 1%
IPG buffer).
2D gel electrophoresis
The 1st dimension of the 2D gel electrophoresis process was
performed using the rehydration method (Rabilloud et al., 1994).
Isoelectric focusing was carried out on pH 3–10 non-linear (NL)
24 cm IPG strips. The second dimension was run on 12.5%,
homogenous polyacrylamide gels poured between low ﬂuores-
cence glass plates (GE Health Care). Gels were scanned imme-
diately after the running of the second dimension on a Typhoon
TM
9400 variable mode imager.
DiGE gel analysis
For initial studies (Fig. 1D), gel images were analyzed in differen-
tial in-gel analysis (DIA) mode in DeCyder software with spots
displaying greater than 1.5-fold change in spot density being
tentatively deﬁned as being differentially expressed. All subse-
quent experiments incorporated a Cy2 internal standard. Follow-
ing gel-to-gel matching of spots, statistical analysis (Student’s
t-test) of normalized protein abundance changes between sam-
ples was performed using BVA software module as described
(Alban et al., 2003).
Spot picking and mass spectrometry analysis
Protein spots shown to be signiﬁcantly different (P,0.05) from
control following treatment were picked, digested (porcine trypsin
0.2 mg, Promega, UK) and spotted onto a Voyager DE-Pro Maldi-
Tof target plate for subsequent mass spectrometry analysis (Per-
ceptive Biosystems, CA, USA) using the Ettan Spot Handling
Workstation (GE Health Care). Maldi-Tof mass spectrometry was
performed in positive reﬂector mode using a laser setting around
2350. The low mass gate setting was set at 750 Da, and the
spectra were acquired over a range of 750–3500 Da. The accel-
erating voltage was 20 kV, the grid voltage set to 76% and the
guide wire voltage set to 0.006%, with an extraction delay time of
160 ns. One hundred shots per spectrum were collected, with a
combination of three spectra per spot.
Spectra were then exported to Data Explorer
TM (version 4,
Applied Biosystems, Cheshire, UK) where they were internally
calibrated using the 842.5099 and 2211.1046 trypsin peaks, pro-
cessed to reduce background noise, and a monoisotopic peak list
was generated and entered into the Mascot peptide mass ﬁnger-
print (PMF) database. Data were searched using the NCBInr
database.
Those peptide mixtures that were unidentiﬁed by Maldi-Tof
analysis were sent for tandem MS analysis. Tryptic peptides were
solubilized in 0.5% formic acid and fractionated by nanoﬂow HPLC
on a C18 reverse phase column, eluting with a continuous linear
gradient to 40% acetonitrile over 20 min. The eluate was analyzed
by online electrospray tandem mass spectrometry using a Qstar
Pulsar (Applied Biosystems). Mass spectrometric analysis was
performed in IDA mode (AnalystQS software, Applied Biosys-
tems), selecting the four most intense ions for MSMS analysis. A
survey scan of 400–1500 Da was collected for 3 s followed by 5 s
MSMS scans of 50–2000 Da using the standard rolling collision
energy settings. Masses were then added to the exclusion list for
3 min. Peaks were extracted using the Mascot script (BioAnalyst,
Applied Biosystems) and automatically exported to the Mascot
(Matrix Science, London, UK) search engine.
For both the PMF and MS/MS searches, proteins were
matched with the identiﬁed peptides and each protein was
assigned a Mascot score, which was a probability-based
Mowse score (Perkins et al., 1999). In the case of PMF the
signiﬁcance threshold was 62, and in the case of MS/MS this
threshold was 36.
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Spot no.
a Master no.
b Protein ID
c Av. Ratio
d Control vs.
enriched (t-test)
e
Mass
f NCBI Acc no.
g Mowse Score
h Class
i
1 1297 1.4 0.034
2 2081 1.28 0.0017
3 1312 ATP synthase a (M) 1.28 0.021 58904 gi 114523 95 NM
4 1584 Citrate synthase 1.26 0.0063 52176 gi 18543177 174 E/M
Phosphoglycerate kinase 1 44909 gi 40254752 111 CM
5 1672 Actin, b 1.2 0.036 42066 gi 71620 261 CO&B
6 1642 1.19 0.0055
7 491 Dynamin 1 1.18 0.00048 96209 gi 18093102 215 CO&B
8 1395 4-Aminobutyrate transaminase 1.16 0.0055 57178 gi 2143559 66 NT
9 1566 1.16 0.045
10 1465 1.13 0.043
11 2232 Proteasome subunit, b type 2 1.12 0.033 23069 gi 8394079 272 PM&T
Auh protein 33605 gi 34873875 132 E/M
ATP synthase a (M) 58904 gi 114523 82 NM
RAB7 23075 gi 92022 39 ST
12 1400 1.1 0.011
13 1098 1.1 0.046
14 1253 1.07 0.02
15 1141 Protein phosphatase 3 (a) 21.1 0.046 59291 gi 8394030 105 ST
16 1101 Isoform of PSD-95/SAP90 21.11 0.028 92685 gi 1517938 49 NT
17 2270 Dynactin 3 21.11 0.029 24867 gi 34867161 144 CP
ATP synthase, subunit D (M) 18827 gi 220904 104 NM
18 1034 CRMP-2 (Mus musculus) 21.12 0.023 62638 gi 40254595 125 NG
19 1998 14–3-3 21.13 0.0095 29274 gi 13928824 63 PM&T
Tropomyosin isoform 6 29245 gi 29336093 71 MC
GFAP d 48809 gi 5030428 50 CO&B
20 1608 21.13 0.02
21 1898 Tubulin, b chain 15 21.13 0.027 50361 gi 92930 148 CO&B
22 1210 21.14 0.032
23 2034 21.14 0.035
24 1723 Enol protein 21.14 0.045 51736 gi 38649320 355 E/M
Tubulin b chain 15 50361 gi 92930 319 CO&B
Tubulin, b2-like 50225 gi 40018568 291 CO&B
Tubulin, b5 50095 gi 27465535 287 CO&B
Tubulin, a2 50804 gi 34740335 256 CO&B
Tubulin, a1 50788 gi 11560133 237 CO&B
GTP-binding regulatory protein 40568 gi 71911 135 ST
Go
Isocitrate dehydrogenase 3 (NAD1) 40044 gi 16758446 102 E/M
Tubulin, b3 50711 gi 21245098 90 CO&B
Enolase (neuronal) 47495 gi 1363309 87 E/M
Actin b 42066 gi 71620 75 CO&B
25 2086 Phosphoglycerate mutase (B) 21.16 0.012 28942 gi 8248819 121 CM
26 2253 21.16 0.032
27 1054 hnRNPK protein 21.17 0.02 51230 gi38197650 63 T/T
28 2209 RhoA 21.18 0.015 22110 gi 31542143 142 ST
29 2133 Ubiquitin thiolesterase 21.18 0.021 25096 gi 92934 168 PM&T
30 1919 Tubulin, b 21.18 0.04 50377 gi 34875329 72 CO&B
31 1995 Glutathione transferase va 1 21.18 0.049 27936 gi 12585231 56 E/M
32 2287 21.19 0.017
33 1865 Dynamin 1 21.21 0.037 96209 gi 18093102 235 CO&B
Malate dehydrogenase 1 36631 gi 15100179 226 E/M
NAD
34 1150 Synapsin lib 21.22 0.0057 52822 gi 112350 329 ST
Tyrosyl-tRNA synthetase 63385 gi 34871588 241 PM&T
Mammalian fusca gene 53964 gi 871528 214 NG
35 2431 Peptidylprolyl isomerase A 21.28 0.028 18091 gi 8394009 74 PM&T
36 2105 21.29 0.022
37 2405 Destrin 21.31 0.013 18661 gi 7441446 205 CO&B
38 1724 21.39 0.0029
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To investigate global changes in hippocampal protein
expression associated with environmental enrichment,
adult male hooded Lister rats (8 weeks old) were ex-
posed to an overnight-enriched environment regimen for
six consecutive weeks (see Experimental Procedures).
The enriched chamber comprised a 100 cm by 50 cm
open box containing an assortment of plastic toys, balls,
cardboard tubes, ladders and running wheels (Fig. 1B)
while control group animals were placed in an identical
open arena which contained only wood shavings and a
single cardboard tube shelter (Fig. 1A). Animals ex-
posed to the enriched conditions noticeably displayed
overt exploratory activity and appeared inquisitive when
the cage top was removed for routine husbandry. In
contrast, animals in the control arena were typically less
active and displayed little exploratory behavior. When
quiescent, both groups of animals tended to nest to-
gether in a corner of the arenas. At the end of the
6-week enrichment program brain tissue was harvested
and hippocampi were dissected free from the surround-
ing tissues and transverse slices cut with the aid of a
McIlwain tissue chopper. Isolated tissue samples of pre-
dominantly somatic or dendritic origin were subse-
quently obtained by carefully dissecting area CA1 stra-
tum pyramidale and stratum radiatum respectively (Fig.
1C). The entire hippocampal proteome was labeled for
DiGE to separate component proteins and enable the
quantiﬁcation of individual protein spot abundance lev-
els in tissues from enriched and non-enriched subjects.
Initial differential in-gel analysis revealed the majority of
protein spots to remain unchanged in both stratum py-
ramidale– (Fig. 1D) and stratum radiatum– (not shown)
derived tissues. However, a small discrete population of
137 protein spots did exhibit modest (.1.5-fold)
changes in spot density between enriched and non-
enriched samples. For a more detailed analysis, multiple
gel replicates were analyzed in biological variance anal-
ysis (BVA) mode (Fig. 1E). Of the 2469 protein spots
resolved across both somatic and dendritic fractions, 32
(1.3% of the detectable proteome) showed signiﬁcantly
altered abundance levels following environmental en-
richment within the dendritic fraction compared with non-
enriched controls (16 increased/16 decreased abun-
dance (21.58- to 2.98-fold change), all P,0.05). In
tissues isolated from stratum radiatum, BVA analysis
revealed 42 (1.7% of the detectable proteome) protein
spots displaying altered abundance following environ-
mental enrichment (14 increased/28 decreased abun-
dance (21.5- to 1.4-fold change), all P,0.05).
Following in-gel tryptic digestion and Maldi-Tof/Q-star
mass spectrometry, database searching revealed the iden-
tity of 50 protein spots with more than half of such spots
representing a single protein entity (Tables 1 and 2 for
somatic and dendritic samples respectively). Fig. 2 shows
representative plots of individual spots together with ex-
amples of 3D protein intensity plots (A–B) or 2D Western
blot validation of altered expression (C–D).
Identiﬁed proteins belonged to a diverse variety of
functional classes including postsynaptic density proteins
(e.g. SAP90), presynaptic proteins (e.g. dynamin 1) and
proteins associated with signaling such as small GTPase
signaling pathways (e.g. RhoA). Identiﬁed proteins were
more formally grouped by biological function using Fatigo
(Al-Shahrour et al., 2004) gene ontology analysis (Fig. 3)
which conﬁrmed that protein spots exhibiting enrichment-
related altered expression spanned a wide range of func-
tional classes. However, in both stratum radiatum– and
stratum pyramidale–derived fractions, cytoplasmic organi-
zation and biogenesis (structural) and energy metabolism
were the predominant classes of protein displaying enrich-
ment-related differential protein spot expression.
Table 1. continued
Spot no.
a Master no.
b Protein ID
c Av. Ratio
d Control vs.
enriched (t-test)
e
Mass
f NCBI Acc no.
g Mowse Score
h Class
i
39 1032 CRMP-2 (Mus musculus) 21.4 0.006 62638 gi 40254595 157 NG
40 1768 21.41 0.011
41 2156 21.5 0.0023
42 1824 Malate dehydrogenase 1 21.5 0.0066 36631 gi 15100179 214 E/M
NAD Glycerol 3-phosphate
dehydrog
38001 gi 2317252 57 E/M
Abbreviations: CO&B, cytoplasmic organization and biogenesis; E/M, energy and metabolism; PM&T, protein modiﬁcation and transport; ST, signal
transduction; NM, nucleotide metabolism; NG, neurogenesis; CM, carbohydrate metabolism; NT, neurotransmitter release and production; CP, cell
proliferation; MC, muscle contraction; T/T, transcription and translation.
List details proteins found to be signiﬁcantly (P,0.05) differentially expressed compared to tissues isolated from non-enriched rats.
a Spot number corresponds to the annotation found in ﬁgure 1C.
b Master number is the number assigned by DeCyder BVA software to each individual protein spot.
c Protein i.d. assigned to each individual protein spot following mascot database searching using the Rattus taxonomy.
d Average abundance ratio of individual protein spots (15increase, 25decrease in expression). Fold changes ranged from 40% decrease in
expression (21.4) to a 50% increase in expression (1.5).
e Student’s t-test value assigned by DeCyder BVA software, P,0.05 determines signiﬁcance.
f,g,h Mass, NCBI accession number and Mowse score obtained following Mascot PMF or MS/MS ion searching following either Maldi-Tof (bold) or Qstar
mass spectrometry.
i Protein biological processes were determined using the Fatigo gene ontology database. Proteins belong to a wide variety of functional classes.
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The main ﬁnding of the current study is that chronic expo-
sure of an enriched environment leads to the altered ex-
pression of a diverse range of hippocampal proteins.
Overall, the number of protein species showing altered
expression was in the range of 1–2% of the proteome
within the detectable range of the DiGE technique, the
altered expression of somatic and dendritic fractions being
broadly similar (1.7 and 1.3% altered respectively). More-
over, subsequent gene ontology analysis of the protein
classes showing enrichment-related alterations in expres-
sion revealed a very similar pattern of alteration when the
proteins were grouped by biological function. That the
cytoplasmic organization and biosynthesis (structural) and
energy metabolism were the dominant classes in terms of
percentage of the altered proteome is consistent with
structural and metabolic alterations occurring in associa-
tion with enhanced hippocampal activity (McNair et al.,
2006). However, structural and metabolic proteins are typ-
ically highly abundant proteins in hippocampus (Yang et
al., 2004) and will thus be more readily detectable using
protein dyes with a ﬁnite sensitivity. That said, the results
clearly indicate that these abundant proteins including
‘housekeeping’ proteins do indeed show altered expres-
sion in relation to environmental enrichment. Further-
more, less abundant proteins such as those associated
with signal transduction were also identiﬁed as display-
ing altered expression. In this respect it is interesting to
note that while structural and metabolic proteins showed
altered expression throughout both somatic and den-
dritic fractions, alterations in the expression signaling
proteins were much more pronounced in dendritic sam-
Fig. 1. Exposure to an enriched environment results in the altered expression of hippocampal proteins. Rats were exposed to either (A) an open ﬁeld
arena or (B) an identical-sized enriched environment for a total experimental period of 6 weeks (see Experimental Procedures). (C) Hippocampal
tissues were subsequently isolated from either predominantly dendritic or somatic lamina (shaded areas) of hippocampal area CA1. (D)Total protein
extracts from area CA1 stratum pyramidale following exposure to environmental enrichment revealed a distribution of protein spots corresponding to
both increased and decreased abundance when compared with control treated tissues. Scatter plot shows log abundance ratios of individual
vehicle/glutamate sample spot pairs (Œ) against maximum protein spot abundance. Individual protein spots show decreased (left, blue ), unaltered
(center, green ) and increased (right, red ) log abundance ratios. Vertical lines are included as a guide to indicate a level of 1.5-fold change in
abundance (see Experimental Procedures). The red curve shows the frequency distribution of the log abundance ratios, whereas the blue curve is
the normalized modal frequency ﬁtted to a modal peak of zero. Note that a minority of protein spots display enrichment-related increase or decrease
in expression but that the expression levels of majority of protein spots remain unaltered. (E) Statistical comparison of environmental enrichment-
associated alterations in protein abundance (four gel replicates per group comprising six pooled subjects) using BVA revealed 74 protein spots with
signiﬁcant changes in abundance (P,0.05) as indicated on gel image. Of the observed changes in abundance, 42 were conﬁned to tissues isolated
from predominantly somatic regions (open squares) while 32 protein spots displayed differential abundance only in the dendritic layer fraction (black
squares). Only two spots (gray squares) showed signiﬁcantly altered abundance levels in both somatic and dendritic later fractions. For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.
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Spot
no.
a
Master
no.
b
Protein ID
c Av. Ratio
d Control vs. enriched
(dendritic) (t-test)
e
Mass
f NCBI Acc no.
g Mowse
Score
h
Class
i
43 2030 ATP synthase a (M) 2.98 0.0058 58904 gi 114523 293 NM
VAMP-associated protein B ST
VAMP-associated protein A 27476 gi 61889097 59 ST
Glyceraldehyde 3-phosphate-dehydrogenase 36098 gi 56188 320 E/M
44 2080 Phosphoglycerate mutase B 1.48 0.00083 28942 gi 8248819 98 E/M
Hsc 70-psI 71112 gi 56385 402 CO&B
Rho-associated coiled-coil forming kinase 2 160475 gi 6981478 31 ST
45 2075 Pgam1 protein 1.43 0.025 28928 gi 12805529 97 CM
Chain F, Enoyl-Coa hydratase complexed with
octanoyl-Coa
28555 gi 3212683 145 E/M
46 2078 Pgam1 protein 1.41 0.0096 28928 gi 12805529 225 CM
Proteasome 26S non-ATPase subunit 9 24985 gi 18426862 121 PM&T
47 2365 ATP synthase, subunit D (M) 1.4 0.043 18809 gi 9506411 424 NM
Enolase (neuronal) 47495 gi 1363309 58 E/M
Transgelin 3 24981 gi 13928938 48 CO&B
Ubiquitin-conjugating enzyme 42505 gi 34933268 36 PM&T
48 1579 Pyruvate dehydrogenase E1 a 1.27 0.014 43853 gi 57657 781 E/M
Phosphoglycerate kinase 1 44909 gi 40254752 281 E/M
SEC14-like protein 2 46593 gi 21542226 158 T/T
Citrate synthase 52176 gi 18543177 104 E/M
RNA binding protein p42 AUF1 36164 gi 9588098 72 T/T
49 757 Aconitase 2, mitochondrial 1.26 0.035 86121 gi 40538860 682 CM
GFAPd 48809 gi 5030428 63 CO&B
50 1288 Heat shock protein 60 precursor 1.25 0.024 58061 gi 1334284 87 CO&B
51 1365 Enolase 1 1.23 0.036 47428 gi 56107 98 E/M
52 1289 Aldehyde dehydrogenase 7, A1 1.21 0.0097 25313 gi 25090044 49 E/M
53 1967 Actin, b 1.21 0.019 42066 gi 71620 260 CO&B
Tubulin, b 50095 gi 27465535 39 CO&B
54 1844 Malate dehydrogenase (M) 1.18 0.027 36117 gi 42476181 112 E/M
55 1858 GFAPd 1.15 0.043 48809 gi 5030428 122 CO&B
56 1301 1.15 0.047
57 1266 1.1 0.041
58 1931 Fumarylacetoacetate hydrolase 1.08 0.038 40884 gi 34858672 66 E/M
Creatine kinase (M) 47398 gi 57539 44 E/M
Glyceraldehyde 3-phosphate-dehydrogenase 36090 gi 37590767 43 E/M
59 1574 GFAPd 21.08 0.047 48809 gi 5030428 86 CO&B
60 1144 GRP58 21.09 0.021 57044 gi 38382858 174 PM&T
61 1296 21.13 0.019
62 859 Heat shock 70 kD protein 5 21.15 0.016 72473 gi 38303969 78 CO&B
63 1719 GNBP a inhibiting 2 21.17 0.019 41043 gi 13591955 511 ST
GTP-binding regulatory protein Go a chain, splice
form a-2
40568 gi 71911 222 ST
A326s Mutant of an inhibitory a subunit 36325 gi 3891516 166 ST
Tubulin, a 50804 gi 34740335 162 CO&B
Actin, b 42066 gi 71620 88 CO&B
GNBP3 40781 gi 27465609 81 ST
GNBP a 13 44326 gi 61557003 63 ST
64 1588 Actin, b 21.2 0.03 42066 gi 71620 276 CO&B
Tubulin, b5 50095 gi 27465535 153 CO&B
Tubulin b chain 15 50361 gi 95930 146 CO&B
GFAPd 48809 gi 5030428 127 CO&B
Hsc70-psI 71112 gi 56385 68 CO&B
65 1663 21.21 0.044
66 1793 Lactate dehydrogenase B 21.21 0.047 36874 gi 6981146 79 E/M
67 1908 Septin 5 21.23 0.035 44349 gi 16758814 66 ST
Crystallin, 1 35717 gi 28461157 78 E/M
68 2133 Ubiquitin thiolesterase 21.24 0.032 25096 gi 92934 168 PM&T
69 1637 21.25 0.023
70 934 ATPase, H1 transporting, V1 subunit A, isoform 1 21.28 0.036 68584 gi 34869154 56 NM
71 2005 Cyclin-dependent kinase 5 21.29 0.0073 33689 gi 18266682 232 NG
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may result in behavioral alterations (Kirchner et al.,
2004) and environmental enrichment has, possibly as a
result of such differential protein expression, consis-
tently enhanced behavioral learning (Duffy et al., 2001;
Huang et al., 2006).
Proteins involved in small GTPase signaling pathways
(RhoA, Rho-associated coil-forming kinase 2), guanine nu-
cleotide binding proteins (GNBP) and protein tyrosine ki-
nase pathways in particular were shown to display altered
expression. This may be consistent with the role of
GTPase and tyrosine kinase signaling pathways in hip-
pocampal neuronal plasticity (O’Kane et al., 2004; O’Dell
et al., 1991; Ho et al., 2004). RhoA in particular is known to
be important in the maintenance of dendritic structures in
rat hippocampal neurones (Nakayama et al., 2000).
A feature unique to the current study is that only a
single protein entity was found to display altered abun-
dance in both dendritic and somatic fractions. Spot number
2133 subsequently identiﬁed as ubiquitin thiolesterase was
found to decrease in both fractions. This ﬁnding suggests
that while overall numerous proteins throughout the so-
mato-dendritic axis display altered expression, these
changes in abundance are nevertheless speciﬁc for the
domain in terms of whether they occur in the perisomatic or
axon termination zones, and these changes are not nec-
essarily accessible when the hippocampus as a whole is
considered (Yang et al., 2004).
Environmental-related alterations in motor activity and
other exercise related processes may potentially contrib-
ute to the alterations in expression observed. Indeed, en-
vironmental enrichment has been reported to result in
increased dendritic spine density in motor cortex and stri-
atum (Turner et al., 2003). However, the same study did
not ﬁnd any change in granule cell spine density in the
same animals. That said, the possible contribution of ex-
ercise or other physiological processes on environmental
enrichment-related alterations in the hippocampal pro-
teome cannot be excluded.
The current study focused upon a single time point at 6
weeks following the introduction of the enriched environ-
ment. This time-point was chosen as it has been shown in
many previous studies that, by around this point, rodents
exhibit alterations in synaptic plasticity mechanisms (Artola
et al., 2006; Duffy et al., 2001) as well as hippocampal
dependent learning (Rampon et al., 2000; Williams et al.,
2001). Also around this time structural changes, including
changes in spine density and size as well as increases in
neuronal number are apparent (Turner et al., 2003). Such
structural modiﬁcations are also found in this study as
indicated by the relatively large number of altered proteins
belonging to the cytoplasmic organization and biogenesis
class of biological function. Given that environmental en-
richment–associated neurogenesis is widely reported to be
predominantly restricted to the dentate gyrus (Bruel-
Jungerman et al., 2005), it is likely that the altered expres-
sion of structurally related proteins in CA1 is mainly due to
the structural reorganization of existing neurones. This
would be consistent with morphological studies showing
experience-dependent plasticity to be associated with the
creation of new and bulking up of existing synapses (Fa-
herty et al., 2003; Turner et al., 2003). Indeed, a recent
report by Meshi et al. (2006) demonstrated behavioral
effects of environmental enrichment such as improved
hippocampal-dependent spatial learning and habituation to
an unfamiliar environment to be independent of neurogen-
esis and instead may be due to changes in morphology
Table 2. continued
Spot
no.
a
Master
no.
b
Protein ID
c Av. Ratio
d Control vs. enriched
(dendritic) (t-test)
e
Mass
f NCBI Acc no.
g Mowse
Score
h
Class
i
VDAC 3 31178 gi 3786204 69 ST
Inducible carbonyl reductase 30920 gi 1906812 80 E/M
B-36 VDAC 32327 gi 299036 68 ST
Lymphocyte protein tyrosine kinase 58366 gi 34871627 55 ST
ATP synthase g 29972 gi 310190 55 NM
Protein tyrosine kinase 57290 gi 57582 52 ST
72 1526 21.3 0.028
73 1617 21.31 0.017
74 1586 Diacylglycerol kinase z 21.58 0.006 105426 gi 13592131 56 E/M
Abbreviations: CO&B, cytoplasmic organization and biogenesis; E/M; energy and metabolism; PM&T, protein modiﬁcation and transport; ST, signal
transduction; NM, nucleotide metabolism; NG, neurogenesis; CM, carbohydrate metabolism; NT, neurotransmitter release and production; CP, cell
proliferation; T/T, transcription and translation.
List details proteins found to be signiﬁcantly (P,0.05) differentially expressed compared to tissues isolated from non-enriched rats.
a Spot number corresponds to the annotation found in ﬁgure 1C.
b Master number is the number assigned by DeCyder BVA software to each individual protein spot.
c Protein i.d. assigned to each individual protein spot following mascot database searching using the Rattus taxonomy.
d Average abundance ratio of individual protein spots (15increase, 25decrease in expression). Fold changes range from a 198% decrease (22.98)
in expression to a 58% increase in expression (1.58).
e Student’s t-test value assigned by DeCyder BVA software.
f,g,h Mass, NCBI accession number and Mowse score obtained following Mascot PMF or MS/MS ion searching following either Maldi-Tof (bold) or Qstar
mass spectrometry.
i Protein biological processes were determined using the Fatigo gene ontology database. Proteins belong to a wide variety of functional classes.
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2000).
As discussed, the current study demonstrates a de-
gree of overlap with complementary microarray-based
gene expression studies (Rampon et al., 2000). Rampon
et al. (2000) investigated gene expression following both
short and long term exposure of mice to an enriched
environment. Both our study and the Rampon et al. (2000)
report provide a consensus ﬁnding in which a variety of
mRNAs and corresponding proteins display altered ex-
pression following environmental enrichment. Overall, for
example, the small GTPase RhoA, the structural protein
actin and other molecules including GRP-78 and PSD-95
were shown to display altered abundance at both mRNA
and protein levels. The alteration in RhoA and in hnRNPK
expression identiﬁed using the DiGE approach was addi-
tionally conﬁrmed by Western blot. Furthermore, we here
extend previous studies by identifying several novel envi-
ronmental enrichment-related proteins including hnRNPK
which is thought to be involved in the translation of mRNAs
(Evans et al., 2003) and which we have previously identi-
ﬁed as differentially expressed shortly after the induction of
hippocampal plasticity (McNair et al., 2006). Overall, it is
interesting to note that 18% of proteins identiﬁed in this
study have been shown to be regulated during LTP
using an identical DIGE approach in vitro (McNair et al.,
2006). This may suggest that synaptic plasticity–related
changes are indeed a major component of the altered
expression seen with environmental enrichment. In-
deed, several other proteins identiﬁed in this study have
also previously been linked to synaptic plasticity–related
processes such as LTP, LTD, learning and memory.
These include PSD-95 (Migaud et al., 1998; Stein et al.,
2003), synapsin (Sato et al., 2000), Rock (O’Kane et al.,
2004) and CDK-5 (Wang et al., 2004) and provide com-
pelling evidence for the notion that environmental en-
richment recruits mechanisms similar to those activated
during neuronal plasticity.
Fig. 2. Effects of environmental enrichment on identiﬁed hippocampal proteins. Representative scatter plots showing examples of identiﬁed protein
spots displaying decreased (A, C–D) and increased (B) spot protein abundance in hippocampal tissues isolated following environmental enrichment.
Gray points represent individual DiGE gel replicates while black points indicate mean abundance in tissues from rats exposed to ‘poor’ (open ﬁeld)
and enriched conditions. Insets in A and B show representative spot proﬁle (protein intensity peak) of identiﬁed proteins on DiGE gels in poor and
enriched group samples. Insets in C and D show 2D Western blot validation for enrichment-related altered hnRNPK and RhoA spot intensity
respectively. Note that the prominent anti-hnRNPK spot in the ‘poor’ sample (downward arrow) is reduced in intensity in enriched sample to reveal a
chain of small spots (upwards arrows) likely representing a charge chain. Control gel below shows hnRNPK blocking peptide to abolish immunore-
activity.
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inability to resolve very low abundance proteins as well as
highly membrane bound proteins, which tend not to enter
the second dimension of the 2D gels. This is an important
consideration given that there are likely to be many envi-
ronmental enrichment–related changes occurring with the
population of membrane bound proteins. For instance,
Naka et al. (2005) reported alterations in AMPA receptor
subunits following environmental enrichment while Ram-
pon et al. (2000) reported alterations in the expression of
genes involved in NMDA receptor expression. However,
the current report complements these studies by demon-
strating that proteins with non-membranous and in many
cases non-synaptic loci also show altered abundance in
relation to environmental enrichment. Moreover, while the
Rampon et al. (2000) report demonstrated altered expres-
sion at the mRNA level, it is likely that many of the changes
reported here are not only due to alterations in de novo
synthesis but also due to altered protein degradation and
posttranslational modiﬁcations. That a limited subset of
proteins identiﬁed in this study corresponds to differentially
expressed mRNAs identiﬁed in the Rampon et al. (2000)
study likely reﬂects the fact that the current analysis is
restricted to more soluble and abundant proteins. How-
ever, this limitation is tempered by the ability to identify
actual changes in functional protein levels per se, including
alterations due to differential mRNA-independent post-
translational modiﬁcation, trafﬁcking and degradation.
CONCLUSION
In conclusion, the current study demonstrates a signiﬁcant
alteration in a diverse range of hippocampal proteins fol-
lowing exposure to an enriched environment and extends
previous ﬁndings describing enrichment-related alterations
in gene expression. The ﬁndings highlight the occurrence
of structural, metabolic and signaling changes associated
with environmental enrichment and suggest that the asso-
ciated cognitive beneﬁts may result from selective adapta-
tions, which differ for synaptosomal and somatic compart-
ment of the neurons.
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Fig. 3. Gene ontology analysis of hippocampal proteins showing al-
tered abundance in response to exposure to an enriched environment.
Bar chart illustrating a functional cluster analysis of identiﬁed proteins
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dendritic layer (‘dendritic sample,’ black-ﬁlled boxes) tissues. Note that
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tion and biogenesis (cytoskeletal and associated proteins) and energy
metabolism groups but that dendritic sample additionally exhibits a
substantial proportion of synaptic transmission-related proteins dis-
playing differential expression (†). Abbreviations: CO&B, cytoplasmic
organization and biogenesis; E/M, energy and metabolism; PM&T,
protein modiﬁcation and transport; ST, signal transduction; NM, nucle-
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